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Abstract of the Thesis
Trypanosoma brucei, a member of the early diverged phylogenetic order Kinetoplastida, is a
vector-borne parasite that causes lethal disease in both humans and livestock. Unfortunately,
progress has been slow on developing new treatments, and there is a need for new therapeutics, as
current therapies have issues of resistance, toxicity, and difficult administration. In order to design
new therapeutics, molecules and interactions unique to the parasite must be detailed, in hopes that
some will afford suitable drug targets.
One unique process in T. brucei that might be targeted is RNA polymerase I-mediated
transcription. T. brucei is unique in that RNA polymerase I not only transcribes ribosomal gene
units, as in all other organisms, but is also used to transcribe gene arrays that encode its major cell
surface proteins, namely the variant surface glycoprotein, or VSG in the mammalian bloodstream
stage of the parasite. The importance of VSG to T. brucei is highlighted by the fact that interference
with VSG mRNA rapidly halts bloodstream form culture growth and leads to the clearance of
trypanosomes from infected mice. Thus, targeting proteins and interactions essential for VSG
production is a valid strategy against T. brucei.
Chapter II details an investigation of the interaction between LC8 and a class I
transcription factor A (CITFA) subunit, CITFA2, which was the focus of my thesis work. Both of
these proteins, and their interaction, are essential for VSG transcription and trypanosome viability,
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and interrupting either protein or their interaction could be a potential anti-trypanosome therapy.
Chapter III contains the generation of a method that allows for gene silencing using heterologous
sequences, which was necessary for the work in chapter II. Chapter IV focuses on RPB7, an RNA
pol II subunit, which was published to be utilized by RNA pol I for transcription. While this finding
was intriguing, it contradicted our biochemical RNA pol I characterizations. Data presented in this
chapter clearly demonstrated that RPB7 is not a subunit of RNA pol I and not required for the
transcription process by this polymerase.

Investigating the Functional Roles of LC8, CITFA, and
RPB7 in the Multifunctional RNA Polymerase System of
Trypanosoma brucei

Justin K. Kirkham
B.S., University of Utah, 2008

A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
at the
University of Connecticut
2017

i

Copyright by
Justin K. Kirkham
2017

ii

APPROVAL PAGE
Doctor of Philosophy Dissertation

Investigating the Functional Roles of LC8, CITFA, and RPB7 in the
Multifunctional RNA Polymerase System of Trypanosoma brucei
Presented by Justin K. Kirkham, B.S.

Major Advisor
______________________________________________________________________________
Arthur Günzl, Ph.D.

Associate Advisor
______________________________________________________________________________
Stephen King, Ph.D.

Associate Advisor
______________________________________________________________________________
Bruce Mayer, Ph.D.

Associate Advisor
______________________________________________________________________________
Justin Radolf, M.D.

Associate Advisor
______________________________________________________________________________
Blanka Rogina, Ph.D.

University of Connecticut
2017
iii

Acknowledgements

First and foremost, I wish to thank Arthur for his kindness, his mentorship, and his
investment in me and my education. It has been a humbling experience to look back over the last
few years and to realize how much of my time I have spent poorly, lazily, and ignorantly, which
resulted in a lack of progress for both myself and the lab. Yet, through it all, Arthur was patient
with me, and instructed me on how to change so that I might have greater success. The amount of
time he devoted to me was immense and undeserved. I am now in contact with my new PI,
designing a project, and I already have a series of experiments I wish to conduct, once I have my
own lab – this scientific future is thanks to Arthur.
I would also like to thank Tu Nguyen, Ju Huck Lee, Bao Nguyen, Sung Hee Park, and
Nitika Badjatia for all that they have taught me and done for me. Tu and Ju deserve special thanks,
as they taught me almost all of the technical aspects of laboratory work. Sung Hee and Nitika have
also been incredibly helpful in humoring me and my tendency to talk too much as I was struggling
to understand how best to move forward.
I would also like to thank my thesis committee members: Stephen King, Bruce Mayer,
Justin Radolf, and Blanka Rogina, who have been incredibly encouraging throughout the difficult
process of learning how to do rigorous research. It is a credit to them that I did not fear committee
meetings with them, even though they were evaluating me. Their desire to help me was so clear
that I was never worried when they had input or suggestions.
I would similarly like to thank Dr. Carol Pilbeam, Dr. Barbara Kream, and all of the
individuals who work to make the MD/PhD program and the graduate school a success. Many
individuals met with me and offered me guidance on my research, my career, and my future.
iv

I wish to thank my parents, Brian and Diane Kirkham, who have been so supportive and
helpful while I have been away from them for my education. Even when I was not sure of myself,
they have always loved me and encouraged me onward, trusting in my abilities in a way that has
given me strength.
Finally, I would like to thank Lindsay and Mariah Kirkham, my amazing wife and my
wonderful daughter. Lindsay has forgone a career in linguistics to devote more of her time to our
family and to make up for my absence. Her dedication allowed me to focus on work while I was
at work, with complete confidence that my daughter and our home were in good hands.
Additionally, I would often have experiments and data on my mind even after I came home, and
she was willing to bear the stresses of my education with me. She has been my strength, my friend,
and my comfort for many years. Mariah, born and now 4 during my time in Arthur’s lab, is my
source of energy and motivation. When I come home she doesn’t care much about ‘the bugs that
make people sick that Dada is trying to stop’, instead asking me if I want to play a game as soon
as I step in the door. Games with her were my therapy, and I thank her for all of them. In addition,
the idea of helping other children that are as sweet and wonderful as my daughter motivated me to
come back to the lab after the many days of depressing data or failed experiments.

v

Table of Contents
Title Page……………………………………………………………………………………...…...i
Approval Page……...………………………………………….………………………….………iii
Acknowledgements………………………………………………………………………..……...iv
Publications and Contributions to the Thesis………..…………..…………...………….…….....vii
List of Tables…………………………………………………………………………...……........ix
List of Figures……………………………………………………………………………….…….x
Chapter I. Introduction……………...…………………………………………………..................1
Chapter II. The dynein light chain LC8 is required for RNA polymerase I-mediated
transcription in Trypanosoma brucei, facilitating assembly and promoter
binding of class I transcription factor A………..…...…….………………......................24
Chapter III. A new strategy of RNA interference that targets heterologous
sequences reveals CITFA1 as an essential component of class I
transcription factor A in Trypanosoma brucei…………………………………….…..…67
Chapter IV. Transcription by the multifunctional RNA polymerase I in Trypanosoma
brucei functions independently of RPB7………………………………………..….…..107
Chapter V. Mono-allelic VSG expression by RNA polymerase I in Trypanosoma
brucei: expression site control from both ends? (Review).............................…………..134
Chapter VI. Discussion and future directions………….………………………………...……..152
References………………………….……...…………………………………………...…….....163
Copyright permissions ……………………………………………………………………........185

vi

Publications and Contributions to the Thesis
Chapter II. In this study I investigated the role of LC8 and CITFA2 in transcription by RNA
polymerase I. I performed all experiments, save for the following: Dr. Sung Hee Park performed
the sucrose gradient sedimentation of the CITFA7-purified CITFA complex, the related EMSA,
UV crosslinking analysis, and the chromatin immunoprecipitation of CITFA3 in CITFA2
knockdown cells. Dr. Tu N. Nguyen generated the plasmid for knockdown of LC8, the
immunoblots monitoring the knockdown, and the original transgene expression plasmid, while Dr.
Ju Huck Lee produced the LC8 recombinant protein and LC8 immune serum. Dr. Arthur Günzl
performed the phylogenetic analysis. This work is in preparation to be published as Kirkham JK,
Park SH, Nguyen TN, Lee JH, Günzl A. The dynein light chain LC8 is required for RNA polymerase
I-mediated transcription in Trypanosoma brucei, facilitating assembly and promoter binding of
class I transcription factor A.

Chapter III. In this study, we developed a new method for specifically silencing mRNA through
targeting a fused heterologous sequence, and then used this technique to study the role of CITFA1
in transcription by RNA polymerase I. I aided Dr. Park in this work by purifying the CITFA3
antibody, and producing related immunoblots. Additionally, I performed the immunofluorescence
monitoring the effect of CITFA1 silencing, aided in plasmid generation, and produced detailed
maps for the two newly generated plasmids. The result of this work was published as Park SH,
Nguyen BN, Kirkham JK, Nguyen TN, Günzl A. A new strategy of RNA interference that targets
heterologous sequences reveals CITFA1 as an essential component of class I transcription factor
A in Trypanosoma brucei. Eukaryot Cell. 2014 Jun;13(6):785-95.

vii

Chapter IV. We investigated whether RPB7, a known subunit of RNA polymerase II, was being
utilized by RNA pol I in T. brucei, a claim published by the research group of Dr. Miguel Navarro
(Spanish National Research Council, Granada, Spain) (Peñate et al., 2009). I aided Dr. Park in this
work by performing a tandem affinity purification of RPB7, and investigating co-purifying
proteins. Additionally, I performed transient transfection and immunofluorescence to determine
the degree of colocalization between RPB7 and the nucleolar protein NOP10. This work was
published as Park SH, Nguyen TN, Kirkham JK, Lee JH, Günzl A. Transcription by the
multifunctional RNA polymerase I in Trypanosoma brucei functions independently of RPB7. Mol
Biochem Parasitol. 2011 Nov;180(1):35-42. A response letter to the editor discussing the
discrepancy of our data and those published by the Navarro grojup was published as Günzl A, Park
SH, Nguyen TN, Kirkham JK, Lee JH (2011). Response to "Role of RPB7 in RNA pol I transcription
in Trypanosoma brucei". Mol Biochem Parasitol 2011 180, 45-46.

Chapter V. In this chapter we reviewed transcriptional regulation of RNA pol I-transcribed VSG
genes in T. brucei, developing a model of how trypanosomes restrict expression of the VSG gene
family to a single gene. I co-wrote the review with Dr. Günzl, aided by all lab members, who
worked together to examine the literature regarding each regulatory protein. In addition to this, I
designed and produced the figures included in the review, which was published as Günzl A,
Kirkham JK, Nguyen TN, Badjatia N, Park SH. Mono-allelic VSG expression by RNA polymerase
I in Trypanosoma brucei: expression site control from both ends? Gene. 2015 Feb 1;556(1):6873.

viii

List of Tables
Table I-1. T. brucei CITFA subunits…………………………………………………………....18
Table II-S1. Accession numbers of kinetoplastid CITFA2 genes………………………………64

ix

List of Figures
Figure I-1. Antigenic variation can occur through three different mechanisms………………10
Figure I-2. Current model of LC8 interaction with a generic partner protein…………………25
Figure II-1. LC8 silencing has pleiotropic effects on BF trypanosomes………………………38
Figure II-2. LC8 binds to the N-terminus of CITFA2, promoting its dimerization……………41
Figure II-3. Mutation of the LC8 binding site is lethal…………………………..…………….46
Figure II-4. Mutation of the LC8 binding site prevents recruitment of CITFA2 to
promoters and its assembly into the CITFA complex…………………........…………...50
Figure II-5. CITFA2 directly contacts the BES promoter and is required for CITFA
to bind to RNA pol I promoters in vivo…………………………....…………………….54
Figure II-6. LC8 is required for recruitment of CITFA to the BES promoter………………......57
Figure II-7. Model of the LC8-CITFA2 interaction and function for BES promoter
transcription……………………………………………………………...………………59
Figure II-S1. Kinetoplastids harbor two distinct, conserved LC8 genes…………………...…...65
Figure II-S2. LC8 silencing results in an increase in both cell size and DNA content......……..68
Figure III-1. Gene silencing system targeting a heterologous sequence (HS)………………….81
Figure III-2. The 3/ gene flank and UTR of T. cruzi (Tc)U2AF35 are functional in T. brucei…83

x

Figure III-3. Proliferation of smTc3 and smPTP cells is not affected by heterologous
dsRNA expression……………………………………………………………………….85
Figure III-4. Effective and specific CITFA7 silencing by targeting heterologous sequences….88
Figure III-5. Effective and specific CITFA1 silencing by targeting the TcU2AF35 3/ UTR…..91
Figure III-6. CITFA1 is required for CITFA promoter binding in vivo………………………...94
Figure III-S1. Plasmid CITFA7-HA-Tc3-BLA………………………………………………..103
Figure III-S2. Plasmid CITFA7-PTP-BLAv2…………………………………………………106
Figure III-S3. Anti-CITFA3 co-immunoprecipitation………………………………………...108
Figure IV-1. RPB7 does not detectably interact with RNA pol I in transcriptionally active
extract…………………………………………………………………………………...120
Figure IV-2. ChIP analysis of RPB6z, RPB7 and RPB9………………………………………124
Figure IV-3. In vitro transcription analysis of RPB7-depleted extracts…………………….…127
Figure IV-4. Immunofluorescence light microscopy of procyclic trypanosomes………..……129
Figure V-1. Schematic outline of BES5 and interacting proteins………………………………139
Figure V-2. Model of BES regulation in T. brucei………………………………………..……151

xi

Chapter I
Introduction
I-1. Kinetoplastids, trypanosomatids, and relevant human disease
Kinetoplastida comprise a group of flagellated unicellular eukaryotes which contain a uniquely
organized collection of DNA in their single, large mitochondrion known as a ‘kinetoplast’ (Stuart
et al., 2008). This phylogenetic order contains Trypanosoma brucei, T. cruzi, and Leishmania spp.,
parasites which cause a number of devastating diseases in both humans and livestock (Brun and
Blum, 2012). T. brucei is the causative agent of Human African Trypanosomiasis, while T. cruzi
causes Chagas disease in Central and South America. Leishmania spp. cause the leishmaniases,
including visceral, mucosal, and cutaneous leishmaniasis, in 88 different tropical and subtropical
countries. In total, kinetoplastids account for 17% (3 of 17) of neglected tropical diseases,
according to the World Health Organization (WHO, 2015). Collectively, they currently infect 20
million people worldwide, resulting in ~100,000 deaths a year, and place half a billion people at
risk for infection in over 100 countries (Bilbe, 2015; Stuart et al., 2008). While 6,000 of 8,000
protein coding genes are shared among these parasites, their vectors, mechanisms of immune
evasion, and resulting infections are quite different (Bilbe, 2015; Stuart et al., 2008). Yet despite
these differences, it is an obvious hope that chemotherapies designed against any one kinetoplastid
parasite may be useful against all members of this order.
T. brucei consists of three subspecies: T. brucei gambiense, T. brucei rhodesiense, and T.
brucei brucei. While closely related, T. b. brucei is unable to cause human infection, due to the
trypanolytic effect of apolipoprotein L1 (ApoL1), a regular constituent of human serum (Pays et
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al., 2006; Vanhamme et al., 2003). ApoL1, as part of a distinct class of high density lipoproteins,
after endocytosis, is inserted into the membrane of the lysosome, resulting in a pore which causes
the lysosome to swell, resulting in osmotic stress and cell death (Wheeler, 2010). T. b. rhodiense
is characterized by resistance to lysis by ApoL1 due to the presence of the serum resistance
associated (SRA) gene (Shiflett et al., 2007; Vanhamme et al., 2003). The SRA protein binds
ApoL1 in the endosome, preventing its insertion into the lysosomal membrane, thereby blocking
its trypanolytic effect. T. b. gambiense’s resistance to ApoL1-induced lysis, however, is primarily
due to a T. b. gambiense-specific glycoprotein (TgsGP), which is present in parasitic cellular
membranes. The insertion of this glycoprotein results in a stiffer membrane that is resistant to the
effects of ApoL1, a resistance that is not mediated by a direct interaction between host and parasite
proteins (Berberof et al., 2001; Uzureau et al., 2013). Though T. b. brucei is an important animal
parasite, its inability to combat human ApoL1 has resulted in it being widely used in laboratory
investigations of T. brucei, as it represents a safe alternative which is, genetically, almost identical
to the infective subspecies.
All subspecies of T. brucei are introduced into a mammalian host by the bite of an infected
tsetse fly (genus Glossina), which currently limits the range of this disease to Sub-Saharan Africa
(Franco et al., 2014). Though only 1% of tsetse flies are infective for T. brucei, a single bite is
sufficient to establish infection (Maudlin and Welburn, 1989; Thuita et al., 2008). T. b. gambiense,
which is responsible for almost all cases (98%) of Human African Trypanosomiasis (HAT) also
known as Sleeping Sickness, results in a chronic disease. After introduction of the parasite into the
bloodstream, individuals experience a hemolymphatic stage of the disease. The primary symptoms
during this stage are headache, pruritus, and lymphadenopathy, which are all non-specific for HAT
(Brun and Blum, 2012). Upon entry of the parasite into the central nervous system (CNS),
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however, the neurological deficits characteristic of the second stage of this disease are observed.
These include disturbances of the sleep cycle, presented as both daytime sleep and insomnia,
alterations of mood and behavior, and muscular disturbances, such as weakness and tremors (Blum
et al., 2006; Brun and Blum, 2012). If untreated, infection will almost invariably lead to death after
an average of 3 years (Checchi et al., 2008). Infection with T. b. rhodesiense results in progression
through the same stages, but at a much faster rate, resulting in death after an average of 6 months.
Clinically, there is a greater likelihood of symptoms related to an acute infection, including fever,
malaise, abdominal discomfort, and vomiting with T. b. rhodesiense-related HAT (Kato et al.,
2015).

I-2. Current chemotherapeutics for HAT
Though these diseases have been well documented as important to both humans and livestock for
over a century, treatment options remain poor (Bilbe, 2015; Lutje et al., 2010; Steverding, 2008).
Four compounds are currently used for the treatment of HAT and will be briefly reviewed.
Pentamidine is effective against the hemolymphatic, or first stage, of T. b. gambiense infection,
and is one of the easiest anti-trypanosome therapies to administer, requiring only 7-10 daily
intramuscular injections (Babokhov et al., 2013). It is not effective against either stage of T. b.
rhodesiense, nor can it be used against stage II T. b. gambiense infection, as it does not cross the
blood brain barrier (BBB), which limits its use. Suramin is the T. b. rhodesiense counterpart to
pentamidine, as it is effective against stage I T. b. rhodesiense, but not against stage I T. b.
gambiense, and is not effective against stage II of either disease. Even though it cannot cross the
BBB, it does have some synergistic effects with stage II therapies, and can be used to pre-treat
stage II T. b. rhodesiense HAT. It requires five intravenous (IV) injections, repeated every 5-7
days, over a period of 4 weeks (Brun et al., 2010). While resistance has not been seen, the length
3

of treatment, the requirement for IV injection, and the lack of activity against stage II disease limit
the usefulness of this drug, as well. Melarsoprol, on the other hand, is an arsenic-based compound
which is widely used due to its effectiveness against stage II HAT involving either subspecies
(Brun et al., 2010). Furthermore, it is the only treatment for stage II T. b. rhodesiense HAT.
Different dosing schedules are in use, with the current recommendation being one IV injection
each day for ten consecutive days (Schmid et al., 2005). These dosing schedules have resulted
from attempts to alleviate some of the difficulties and dangers of melarsoprol treatment. Firstly,
the compound must be dissolved in a propylene glycol solution for injection, which causes
significant irritation and discomfort in recipients. Secondly, due to the arsenic group within the
drug, 5-10% of patients given melarsoprol experience post-treatment reactive encephalopathy
(PTRE) (Babokhov et al., 2013). PTRE has a 50% mortality rate, resulting in the death of up to
5% of patients treated with this drug. Lastly, a significant increase in melarsoprol resistance has
been observed, with relapse rates rising from 17.7% to 25.4% over the course of one 3-year study
(Robays et al., 2008). This has resulted in melarsoprol being used at historically low levels
(Babokhov et al., 2013). The last treatment to discuss is nifurtimox-eflornithine combination
therapy (NECT), which is effective against stage II T. b. gambiense HAT. Current
recommendations are for orally active nifurtimox to be taken three times daily, for ten days. At the
same time, eflornithine is given as twice daily IV infusions for seven days. While this treatment
has much lower toxicity and lower rates of relapse than melarsoprol, administration of NECT
requires a skilled medical team, due to the need for IV infusions, is expensive, and resistance has
been seen in the laboratory setting (Babokhov et al., 2013). In summary, few compounds are
currently available to treat HAT, all of which are difficult to administer, costly, or have issues of
resistance. There is a great need, therefore, for the pursuit of new compounds which can treat
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trypanosomiasis. This would be aided by an improved understanding of molecules essential to the
parasite which could serve as drug targets (Bilbe, 2015). Although not yet approved, two
promising, orally available drugs are currently in the later stages of development: fexinidazole,
currently in phase III clinical trials, and oxaborole SCYX-7158, which is in phase I clinical trials
(Matthews, 2015).

I-3. VSG and antigenic variation
One molecule that is absolutely essential to T. brucei but absent from any of its host species is its
variant surface glycoprotein, or VSG. VSG is a 58-kDa glycophosphatidylinositol (GPI)-anchored
glycoprotein, with most of the protein, therefore, existing extracellularly (Manna et al., 2014). A
single trypanosome produces 10 million identical copies of the VSG protein from a single VSG
gene, all of which is sent to the cell surface, which results in VSG constituting 90% of cell surface
peptides. This dense coat has numerous known functions: it prevents activation of the complement
system (Ferrante and Allison, 1983), it allows for the removal of bound antibody through
endocytosis of antibody-bound VSG (Engstler et al., 2007), after which the VSG molecule is
returned to the cell surface (Pal et al., 2003), and, most importantly, it acts as a barrier to host
antibodies (Schwede et al., 2011). Specifically, it was shown that antibody raised against the Nterminus of the VSG protein, the portion that is furthest away from the cell surface, is able to bind
VSG, while antibody targeting the C-terminus of VSG, which is near the cell surface, is unable to
bind (Schwede et al., 2011). The net result of densely packing 10 million copies of VSG protein
on the cell surface is, therefore, to block recognition of its C-terminus and other constituents of the
parasite surface from immune recognition. This, by itself, does not protect the parasite from
clearance by the immune system, as numerous studies have demonstrated that the immune system
is capable of generating antibodies which target VSG, and that this response is capable of clearing
5

an infection. For one such study, see Hall et al. (2013). Trypanosomes have evolved a system of
VSG switching, however, which, coupled with its dense VSG coat, allows for antigenic variation
and immune evasion. T. brucei possesses more than 2,500 VSG genes and pseudogenes (Cross et
al., 2014), which vary dramatically in their sequence and antigenicity, while having a remarkably
conserved structure, likely through disulfide bonds (Blum et al., 1993). Every 102 to 106 cell
divisions, the specific VSG expressed stochastically changes, resulting in a parasite which is
antigenically different, allowing it to escape recognition by antibodies generated against the last
expressed VSG (Horn, 2014; Turner, 1997; Turner and Barry, 1989). This leads to an expansion
of parasites with newly-expressed VSGs. Once antibodies are generated which bind a new VSG
well, the clonal expansion is halted, and parasites are rapidly cleared. Repetitions of this cycle are
observed in an infected host as waves of parasitemia, which occur approximately every seven days
(Ross and Thomson, 1910). The switch to an alternative VSG gene is not in response to immune
pressure, as switching is observed with in vitro cultures (Doyle et al., 1980). While the antigenic
variation of VSG is essential for the parasite to maintain an infection, the importance of VSG to
T. brucei is not limited to immune evasion. VSG silencing experiments demonstrated that a drop
in VSG mRNA, even without a detectable drop in VSG protein levels, causes a specific cell cycle
arrest in culture and a rapid clearance of parasites from infected mice (Sheader et al., 2005).
VSG genes exist in several genetic contexts (Cross et al., 2014), yet are invariably
expressed from only one of 15 specialized bloodstream expression sites (BESs) (Hertz-Fowler et
al., 2008). BESs contain an array of, typically, 8–9 expression-site associated genes (ESAGs),
followed by a terminal VSG gene (Hertz-Fowler et al., 2008). ESAGs are likely important for the
successful infection of the mammalian host, as they encode a variant heterodimeric transferrin
receptor (ESAG6 and ESAG7), whose varying afﬁnity for the transferrins of different host species
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is thought to expand the parasite's list of potential hosts (Bitter et al., 1998). These also encode
adenylate cyclases (ESAG4) that inhibit the innate immune system upon trypanosome lysis
(Salmon et al., 2012). Switching from the expression of one VSG to another can be done by gene
conversion, telomere exchange, or transcriptional switching, which are represented in Figure I-1,
as reviewed in Horn (2014), and Schwede and Carrington (2010). In the case of gene conversion,
an active expression site has its VSG gene replaced with a VSG gene from another location in the
genome. This leaves the promoter region, ESAGs, and telomere unchanged. A second method of
VSG switching involves a larger scale recombination, which exchanges the VSG gene and
associated telomere, while leaving the promoter and ESAGs intact. An additional nuance is that
VSGs need not be exchanged as indivisible units. Recombinations involving only portions of a
given VSG gene, resulting in the formation of a new, mosaic VSG, have been shown to further
increase VSG diversity beyond the 2,500 VSG genes contained in the genome, and appears to be
important for the maintenance of a persistent infection (Cross et al., 2014; Hall et al., 2013;
Mugnier et al., 2015). The last type of switching involves no recombination, occurring instead
through in situ [in]activation. In transcriptional switching, the active BES is down-regulated, while
expression of a second, formerly silent BES increases. An additional unique aspect of VSG
transcription in T. brucei is that the active VSG gene is located in an extranucleolar focus. This
subnuclear compartment contains both the actively transcribed BES and an accumulation of RNA
pol I and VSG mRNA, and was maintained after DNase digestion (Chaves et al., 1998; Navarro
and Gull, 2001). It was termed the expression site body, or ESB. The importance of this location
was confirmed by experiments in which the integration of selectable markers into two BESs
allowed for the partial co-activation of two BESs within the same cell (Chaves et al., 1999). When
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Figure I-1. Antigenic variation can occur through three different mechanisms. In bloodstream
form (BF) T. brucei, the actively expressed VSG gene is located within a subtelomeric array known
as a BES. Each BES contains a promoter, a variable number of ESAG genes, typically 8-9, and a
terminal VSG gene near the telomere. Only one of the approximately 15 BESs within a cell is
active, indicated here by a green flag, representing an active site of transcription initiation, and a
green arrow, indicating transcription. T. brucei can switch from the actively expressed VSG (blue)
to a silent VSG (orange) by three different mechanisms. Gene conversion allows for VSG genes
from any genomic context, here shown as a silent BES, to be introduced into the active site, leaving
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(Figure I-1 legend cont.) all other elements of the active BES intact (A). Telomere exchange, a
similar process, results in the exchange of both the VSG gene and its associated telomere (B). This
method of switching can only be used with a VSG gene adjacent to a telomere. Transcriptional
switching, on the other hand, is accomplished through epigenetic mechanisms, and results in a
change of expression in both VSG and ESAGs (C). Figure not to scale. For a scaled depiction of a
BES, see Figure V-1.
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co-selection was induced, the two BESs were found to be in close spatial proximity, and the
authors concluded that some factor in the active site was essential for BES activation.

I-4. Polycistronic transcription and RNA pol I
The majority of eukaryotic genomes are arranged for monocistronic transcription, with a
stoichiometry of one promoter to one gene to one transcription termination site. T. brucei is one
notable exception to this rule, however, along with a number of other eukaryotic organisms (Lasda
and Blumenthal, 2011). T. brucei’s genome is organized into functionally unrelated polycistronic
gene arrays which, after transcription, are resolved into individual mRNAs by spliced-leader (SL)
trans-splicing and polyadenylation (Günzl, 2010; Michaeli, 2011). BESs are one such
polycistronic array, in which a single BES promoter drives the expression of 8-9 ESAGs, in
addition to one VSG gene (Hertz-Fowler et al., 2008). This process of adding a 39-bp long SL cap
to every mRNA in the cell by trans-splicing has an additional implication beyond allowing for
fewer promoters and termination sites. It decouples the process of mRNA capping from
transcription by RNA polymerase (pol) II (Günzl, 2010; Michaeli, 2011; Preußer et al., 2012), and
has allowed for the evolution of a unique characteristic of T. brucei, namely the use of RNA pol I
for protein coding gene expression.
The ability for RNA pol I to synthesize functional mRNA in trypanosomes was first
appreciated when an RRNA promoter was used to express a reporter gene. In mice, the reporter
gene was well transcribed, yet the resulting protein levels were very low (Grummt and Skinner,
1985). In trypanosomes, however, the RRNA promoter caused a high level of functional reporter
protein to be produced (Rudenko et al., 1991; Zomerdijk et al., 1991a). Additional evidence for
RNA pol I having a role in protein coding gene expression in the mammalian-infective
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bloodstream form (BF) trypanosomes came when α-amanitin, an amatoxin found in the Aminita
genus of mushrooms which blocks RNA pol II transcription, was shown to not block VSG
transcription (Kooter and Borst, 1984). These implications were directly tested by silencing the
largest subunit of RNA pol I, which resulted in a drop in transcription of RRNA, VSG, and
procyclin, without affecting RNA pol II-mediated transcription (Günzl et al., 2003). Furthermore,
it was shown that depletion of RNA pol I from extract by immunoprecipitation resulted in a drop
of in vitro transcription from RRNA and BES promoters, while RNA pol II transcription was
unaffected (Günzl et al., 2003). Procyclin, the major cell surface antigen in insect-stage, or
procyclic form (PF) T. brucei is thought to protect against the digestive enzymes of its host
(McConville and Ferguson, 1993). Though this is different from VSG in the type of protection it
provides the parasite, it has been shown to be essential for full PF infectivity, and is somewhat
considered, therefore, the PF counterpart to VSG (Ruepp et al., 1997).

I-5. The search for a class I transcription factor
After it was established that VSG transcription relies on RNA pol I, the search for other proteins
essential to the production of VSG began. Given the high level of divergence between
kinetoplastids and other eukaryotes, no class I transcription factors were annotated by sequence
homology in completed trypanosome genomes (Berriman et al., 2005; Ivens et al., 2005). A first
indication as to the nature of T. brucei’s class I factor came from in vitro transcription experiments
using the RRNA, BES, and procyclin promoters. The BES promoter is short, extending 67 bp
upstream of the transcription initiation site, and only contains two small required sequence
elements (Pham et al., 1996; Vanhamme et al., 1995). The RRNA and procyclin promoters, on the
other hand, are much longer, reaching ~250 bp upstream of the transcription initiation site (TIS),
each containing four sequence elements (Brown et al., 1992; Janz and Clayton, 1994; Laufer and
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Günzl, 2001; Sherman et al., 1991). Despite these differences, it was observed that all of these
three promoters were capable of competing for a common trans-activating factor, making it likely
that a common class I transcription factor was being utilized in all three cases (Laufer and Günzl,
2001). Additionally, it was shown that trypanosome nuclear extract was capable of specifically
binding and shifting the BES promoter in an electrophoretic mobility shift assay (EMSA) (Pham
et al., 1997). Deoxycholate treatment, which is able to disrupt protein-protein interactions, led to
multiple, faster migrating bands in an EMSA, which the authors suggested were indicative that the
promoter binding element consisted of more than one protein, which perhaps formed a larger
complex. These two observations led to the key series of experiments that revealed the transactivating factor (Günzl, 2012). Brandenburg et al. prepared crude trypanosome extract from 30
liters of trypanosome culture, and tested fractions for BES promoter binding using EMSA
(Brandenburg et al., 2007). EMSA, in combination with ion exchange, heparin afﬁnity, and DNA
afﬁnity chromatography, allowed the authors to partially purify the BES promoter binding activity.
Since a ~50 kDa protein band was found to specifically UV-crosslink to the BES promoter, mass
spectrometric analysis of the final eluate was concentrated on proteins migrating in SDS-PAGE at
this size range. Seventeen putative BES promoter interactors were identified, most of which were
without annotation. Tagging four of these proteins in individual trypanosome cell lines, combined
with a promoter pull-down assay, identified one protein that bound the BES promoter while not
binding an RNA pol II promoter or a non-specific DNA control. This binding required both
promoter elements, and this protein was also found to bind to the RRNA and procyclin gene
promoters, indicating that it could be the general trans-activating factor suggested in earlier work.
Brandenburg et al. went on to show that silencing this gene by RNAi resulted in rapid cell death
and a decrease in RRNA and VSG mRNA, while RNA pol II and RNA pol III transcripts were
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unaffected (Brandenburg et al., 2007). In vitro transcription assays in the presence of an immune
serum raised against this protein then unambiguously showed that it was absolutely essential for
transcription from the RRNA, BES, and procyclin promoters.
Tagging of this protein, followed by tandem affinity purification and mass spectrometry,
identified six proteins unique to kinetoplastids, which were all annotated as ‘hypothetical’ proteins,
and a dynein light chain, termed DYNLL1 (Brandenburg et al., 2007) (Please note that due to work
presented in Chapter II of this thesis, it has been proposed to rename DYNLL1 as LC8). Coimmunoprecipitation and sucrose gradient sedimentation confirmed that these proteins formed a
complex, and the purified complex was capable of specifically binding the BES promoter in
EMSAs. Finally, depleting the complex from extract via a tag abolished the ability of that extract
to initiate transcription from RRNA, BES, or procyclin gene promoters. Adding back the purified
complex to these depleted extracts was able to partially reconstitute transcriptional activity
(Brandenburg et al., 2007). Since, together, these experiments identified this protein complex as
the first promoter-binding factor essential for RNA pol I-mediated transcription in a kinetoplastid
organism, it was termed class I transcription factor A, or CITFA, with subunits numbered
according to their predicted size, from largest to smallest. Due to high sequence conservation of
CITFA subunits in other kinetoplastids, and CITFA’s indispensability for RRNA transcription, it
is likely that its function in RNA pol I-mediated transcription is shared with other members of this
order.

I-6. The discovery of an additional CITFA subunit
The lack of sequence homology to known transcription factors and of recognizable amino acid
sequence motifs has hindered attribution of specific functions to individual CITFA subunits.
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Nevertheless, additional studies built upon the above work, provided new insights into the
composition of the complex, and its role in transcription by RNA pol I in T. brucei. Through
tandem affinity purification of CITFA6, in conjunction with mass spectrometry, an additional
CITFA subunit, CITFA7, was identified (Nguyen et al., 2012). In turn, co-immunoprecipitation
and tandem affinity purification of a tagged CITFA7 quantitatively co-precipitated and copurified
all other CITFA subunits confirming it as a bona fide subunit of CITFA. As expected, CITFA7
silencing in BF T. brucei resulted in a drop in both rRNA and VSG mRNA, and was lethal.
Furthermore, similar experiments were performed to investigate CITFA7 as had been done in
CITFA2, and revealed that depletion of CITFA7 in cells or in extract greatly reduced in vitro
transcription from both a BES and an RRNA promoter (Nguyen et al., 2012). In accordance with
CITFA7 being a vital component of CITFA, immunofluorescence revealed that CITFA7 and
RPB6z, an RNA pol I-specific subunit (Nguyen et al., 2006), colocalized in both the nucleolar
periphery, where RRNA genes are transcribed, and in an extranucleolar foci, likely representing
the ESB. These results confirmed that CITFA7 is a class I transcription factor subunit required by
RNA pol I. No new members of CITFA have since been identified. The complete list of CITFA
subunits, along with their predicted sizes and accession numbers, is presented in Table I-1.

I-7. A possible role for CITFA in monoallelic VSG expression
Silent BESs are not completely silent in their promoter region. A selectable marker gene inserted
downstream of a silent BES is able to make trypanosomes resistant to the corresponding antibiotic
at a level 100 fold below that achieved when the marker gene is inserted at the same position in
the active BES (Horn and Cross, 1997). Moreover, a study using mild DNase I digestion of
chromatin showed that the same DNase-sensitive sites, indicative of specific protein binding, were
observed at both silent and active BES promoters, leading to the conclusion that promoters of both
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active and silent BESs are occupied by the same transcription factor (Navarro and Cross, 1998).
Since this factor likely was CITFA, Nguyen et al. next quantitatively investigated whether CITFA
was associating with all BES promoters to the same extent, or if it was predominately associating
with the promoter of the active BES. To test this, they used a previously published cell line in
which two BESs had selectable markers integrated downstream of the promoter (Figueiredo et al.,
2008). Through addition of antibiotics, neomycin-resistance or puromycin-resistance could be
selected for. The changing of medium antibiotics did not convert the population of T. brucei to be
resistant, rather it allowed those stochastic switchers, which had activated the alternative BES with
the selectable marker through transcriptional switching (see Figure I-1), to be resistant to the new
antibiotic.
An extensive chromatin immunuprecipitation study revealed that CITFA7 predominately
associated with the active BES promoter (Nguyen et al., 2014). This biased association was
maintained through consecutive rounds of antibiotic-selected transcriptional switching between
the two marked BESs. In every experiment a high level of CITFA7 occupancy correlated with a
high degree of promoter-proximal transcripts originated from that BES, while a low level of
occupancy correlated with a low level of expression. They also showed, through ChIP experiments
involving RPB6z, an RNA pol I subunit, that RNA pol I had a promoter occupancy similar to
CITFA7 – it was present at the active BES, while being relatively absent from the marked silent
BES. These data showed that CITFA7 and RNA pol I are both predominately associated with the
active site, revealing that the activation of a single BES and the monoallelic expression of VSG
may be regulated at the level of transcription initiation, perhaps through sequestering CITFA or
RNA pol I to the active BES.

15

Subunit

GeneDB accession

CITFA1
CITFA2
CITFA3
CITFA4
CITFA5a

Tb927.11.1390
Tb927.9.12450
Tb927.11.1410
Tb927.11.8310
Tb927.8.4030
Tb927.8.4080
Tb927.8.4130
Tb927.5.970
Tb927.7.2600
Tb927.11.18680
Tb11.0845

CITFA5b
CITFA6
CITFA7
LC8

Approximate
size (kDa)
55
55
55
43
28
28
23
17
10

Table I-1. T. brucei CITFA subunits, along with their GeneDB accession numbers and
approximate sizes.
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Analyzing RRNA units, a key experiment demonstrated that CITFA is directly responsible
for RNA pol I occupancy of chromatin. Nguyen et al. performed ChIP experiments with RPA31,
another RNA pol I subunit (Nguyen et al., 2007), in cells wherein CITFA7 could be conditionally
silenced through addition of doxycycline. While in non-induced cells RNA pol I was found to be
present at both the RRNA promoter and the downstream 18S rDNA gene, it became relatively
depleted from both of these regions upon CITFA7 silencing, with RPA31 occupancy dropping
~80% compared to non-induced cells (Nguyen et al., 2014). This confirmed in vivo that CITFA is
required for the recruitment of RNA pol I to its cognate genes.
Given that CITFA2 had previously been shown to be essential for RNA pol I-mediated
transcription (Brandenburg et al., 2007), Nguyen et al. sought to determine whether CITFA2
showed the same preferential occupancy of the active BES promoter as CITFA7. Using cells with
two marked BESs, as before, ChIP experiments revealed that CITFA2, like CITFA7, was
predominately associated with the active BES, and that this relationship was maintained through
multiple rounds of transcriptional BES switching. To further confirm the predominant association
of CITFA with the actively transcribed BES, a cell line was created in which CITFA7 and RPB6z
were tagged with eYFP and mCherry, respectively, allowing detection by direct fluorescence
microscopy. The enhanced sensitivity of this method revealed that CITFA7 and RPB6z colocalized
both in the nucleolus and the extranucleolar ESB, the sites of RRNA and VSG transcription,
respectively. Given that there are approximately 15 BESs in T. brucei (Hertz-Fowler et al., 2008),
with one being active and 14 being silent, distributed extranucleolarly throughout the nucleus, the
failure to detect additional foci of CITFA and RNA pol I, beyond the ESB, confirmed that CITFA
and RNA pol I are not concentrated at the silent BESs.
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Through quantification of immunoblots and fluorescence images, Nguyen et al. estimated
that approximately 180 molecules of CITFA7 are present in the ESB. This number was
surprisingly high, since DNA-bound RNA pol I transcription factors in other systems are known
to remain associated with the promoter through multiple rounds of transcription initiation and the
short BES promoter could only accommodate one or two CITFA complexes at a time. To
investigate whether CITFA was accumulating in the ESB through binding additional regions of
the BES, beyond the promoter, CITFA7 ChIP-seq was performed. In line with their earlier CITFA7
ChIP results, ChIP-seq revealed a strong read density peak at the BES promoter, which declined
rapidly both upstream and downstream of the promoter. No other peaks were observed along a
BES. This confirmed that CITFA is a promoter binding factor, and that it does not travel with the
polymerase during transcription. The amount of CITFA7 present in the ESB is likely the result,
therefore, of a concentration of CITFA to the active BES by a DNA-independent process. Taken
together, these data confirmed that CITFA is a promoter binding RNA pol I transcription factor,
and show that CITFA predominantly associates with the active site. They also show that the
recruitment of RNA pol I to the RRNA promoter requires CITFA. It is possible, therefore, that
monoallelic expression of VSG is achieved through the association of CITFA with a single BES.
Several molecules, in addition to CITFA, have been shown to predominately associate with
either active or silent BESs and appear to play a role in monoallelic VSG transcription. These were
recently reviewed by Günzl et al. (2015), which was included as Chapter V.

I-8. The development of new tools required for further investigations of CITFA
During their efforts to characterize the function of individual CITFA subunits, Park et al. attempted
to silence CITFA1 by RNAi. Though different regions of CITFA1 were targeted for degradation,
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none of these efforts led to a detectable reduction in CITFA1 mRNA. In order to circumvent this
problem, we developed a new system of gene silencing, which relied on targeting heterologous
sequences fused to the gene of interest (Park et al., 2014). This work is covered in depth in Chapter
III, and only a brief summary is included here. As proof of principle, the system was first
developed for CITFA7 since this subunit had been meticulously analyzed before. CITFA7 was
exclusively expressed with a 3/ UTR from a T. brucei-related trypanosomatid, T. cruzi, or with the
PTP tag sequence. Expression of double-stranded RNA (dsRNA) targeting either heterologous
sequence resulted in a strong reduction of CITFA7 mRNA, and caused the same RNA pol I defects
as before, when CITFA7 was silenced by a dsRNA that targeted its coding sequence. Fusing the
T. cruzi 3/ UTR to CITFA1 then indeed enabled a specific knockdown of this gene and caused a
drop in RRNA and VSG mRNA levels similar to those observed upon silencing CITFA7 (Park et
al., 2014). CITFA1 silencing was equally lethal to the parasite. Immunoblotting and sucrose
gradient sedimentation of the CITFA complex showed that the expression of other CITFAs was
not affected and the formation of the CITFA complex not disrupted by this knockdown. Similarly,
immunofluoresence microscopy using a polyclonal antiCITFA3 antibody revealed that the
localization of the CITFA complex was not affected by CITFA1 silencing. Finally, ChIP
experiments revealed that depletion of CITFA1 caused CITFA to no longer occupy either the
RRNA or BES promoters, indicating a specific function of this subunit in DNA binding of the
complex. The fact that CITFA remains localized to the nucleolus, and to an extranucleolar focus
likely to be the ESB, upon CITFA1 silencing indicates that CITFA does not rely on DNA binding
for localization. This supports the notion that the ESB specifically contains a factor that is required
for transcription of the active BES (Nguyen et al., 2014), and suggests that CITFA may be that
factor.
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I-9. The discovery and essential nature of a widely-conserved dynein light chain homologue
The only CITFA subunit conserved outside of kinetoplastids is the dynein light chain LC8. LC8
was originally discovered as a component of the outer arm axonemal dynein in Chlamydomonas
reinhardii (Pfister et al., 1982). Genetic analysis suggested that this light chain was 88% identical
to a homologue in C. elegans (King and Patel-King, 1995). Given that nematodes do not have
flagella or motile cilia at any stage of their life cycle, the authors suggested that this dynein light
chain homologue must function in the cytoplasm, likely as a component of cytoplasmic dynein.
This was shortly thereafter confirmed, when the mammalian homologue of the dynein light chain
was found to specifically co-purify with cytoplasmic dynein (King et al., 1996).
Immunofluorescence microscopy revealed that this homologue co-localized with cytoplasmic
dynein, but not with kinesin, providing additional evidence to the concept that this light chain
homologue was shared between axonemal and cytoplasmic dynein, and that it was widely
conserved among eukaryotes. Most commonly, this dynein light chain is termed DYNLL or LC8,
though gene names vary based on organism and discovery history.
Cytoplasmic dynein exists as two different complexes: dynein-1, which has been better
characterized, is involved in membrane trafficking, organelle dynamics, and chromosome
segregation during mitosis (Paschal and Vallee, 1987), and dynein-2, which regulates retrograde
intraflagellar transport (IFT), a process important to motile cilia and flagella (Criswell et al., 1996;
Gibbons et al., 1994). LC8 has been shown to be a part of both of these cytoplasmic dynein
complexes (Asante et al., 2014), where it binds to intermediate chains, as shown by Lo et al. (2001)
and reviewed by Wu and King (2003), and appears to contribute to their structural arrangement
(Makokha et al., 2002). Additional complexity became appreciated when it was demonstrated that
two, nearly identical LC8 genes exist in humans and numerous other organisms (Naisbitt et al.,
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2000; Wilson et al., 2001). These two genes, termed DYNLL1 and DYNLL2, give rise to proteins
that differ in only six of 89 amino acids, and many investigation of LC8 function do not allow for
differentiation between these two proteins (Pfister et al., 2006). Furthermore, it has been shown
that DYNLL1 and DYNLL2 are shared between dynein-1 and dynein-2, making a general
differentiation of their functions difficult (Asante et al., 2014). Hereafter, DYNLL1 and DYNLL2
will be collectively referred to as LC8. LC8 is conserved throughout eukaryotic genomes
(Wickstead and Gull, 2007), and while not essential in yeast (Stuchell-Brereton et al., 2011),
mutation or knockdown of LC8 causes a mitotic block in HeLa cells (Asthana et al., 2012), and is
embryonic lethal in animals (Dick et al., 1996; Goggolidou et al., 2014; Li et al., 2015; Lightcap
et al., 2009), causing pleiotropic defects.
I-10. LC8 outside of the dynein motor complex
Given that LC8 is more conserved between species than other components of the dynein motor,
and that LC8 is present in organisms which lack a dynein motor, it was likely that LC8 had nondynein functions (King and Patel-King, 1995; Wickstead and Gull, 2007). LC8 has since been
shown to interact with 50+ different proteins and to affect numerous cellular processes independent
of its involvement with dynein, as reviewed by Barbar (2008) and Rapali et al.,(2011b). Though
diverse in their function, LC8’s binding partners tend to congregate into the functional categories
of intracellular transport, nuclear transport, mitosis, apoptosis, and transcriptional regulation
(Rapali et al., 2011b).
At physiological pH, LC8 exists almost exclusively as a dimer (Barbar et al., 2001; Benashski
et al., 1997), interacting with partner proteins via two identical sites generated at the dimer
interface which bind to diverse short, linear motifs (Benashski et al., 1997; Lo et al., 2001; Rapali
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et al., 2011a). Structurally, each LC8 monomer possesses five β-strands and two α-helices, and
LC8 dimerization requires β-strand swapping (Wang et al., 2003). LC8 promotes the dimerization
of its binding partners through aligning dimerization domains present in the partner protein
(Barbar, 2008; Barbar and Nyarko, 2014; Hodi et al., 2006; Wagner et al., 2006). Thus, while it
was previously hypothesized that LC8 functions as a linker, allowing attachment of the dynein
motor to its cargo, the emerging view is that interaction with LC8 induces homodimerization,
imparting new structure and function, which is supported by detailed investigations of LC8
interactions (Barbar and Nyarko, 2015; Radnai et al., 2010; Wang et al., 2004; Williams et al.,
2007). Figure I-2 depicts a simplified current model of LC8 binding: LC8 binds a protein that is
already dimerized, as depicted, or which has a propensity for self-association. Through interacting
with a partner protein via a binding site created at its dimer interface, LC8 confers stability and
structure, which often includes an increase in self-association. Due to the conserved nature of LC8,
its diverse binding network, and its ability to modulate several aspects of cell biology, it has been
termed a molecular hub (Barbar, 2008).
In addition to this improved understanding of LC8, interest in this molecule has grown as LC8
has been shown to have unique and important roles in an increasing number of human pathogens.
These include viruses, such as HIV (Jayappa et al., 2015), Ebola (Luthra et al., 2015), and rabies
(Tan et al., 2007), and the protistan parasite Toxoplasma gondii (Qureshi et al., 2013).
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Figure I-2. Current model of LC8 interaction with a generic partner protein. LC8 exists as a dimer,
which creates two identical binding sites at its dimer interface. The structure and/or dimerization
state of the partner protein is often affected through interaction with LC8.
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Chapter II
The dynein light chain LC8 is required for RNA polymerase I
mediated transcription in Trypanosoma brucei, facilitating assembly
and promoter binding of class I transcription factor A

Abstract
Dynein light chain LC8 is highly conserved among eukaryotes and has both dynein motor and
dynein-independent functions. Interestingly, LC8 was identified as a subunit of the class I
transcription factor A (CITFA), which is essential for transcription by RNA polymerase (pol) I in
the parasite Trypanosoma brucei. Given that LC8 has never been identified with a basal
transcription factor and that T. brucei relies on RNA pol I for expressing the variant surface
glycoprotein (VSG), the key protein in antigenic variation, we investigated the CITFA-specific
role of LC8. Depletion of LC8 from mammalian-infective bloodstream trypanosomes affected cell
cycle progression, reduced the abundances of rRNA and VSG mRNA, and resulted in rapid cell
death. Sedimentation analysis, co-immunoprecipitation of recombinant proteins, and
bioinformatic analysis revealed an LC8 binding site near the N-terminus of the subunit CITFA2.
Mutation of this site prevented the formation of a CITFA2-LC8 heterotetramer and, in vivo, was
lethal, affecting assembly of a functional CITFA complex. Gel shift assays and UV-crosslinking
experiments identified CITFA2 as a promoter-binding CITFA subunit. Accordingly, silencing of
LC8 or CITFA2 resulted in a loss of CITFA from RNA pol I promoters. Hence, we discovered an
LC8 interaction that, unprecedentedly, has a basal function in transcription.
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II-1. Introduction
Dynein light chain LC8 was originally discovered as a component of the outer arm axonemal
dynein in Chlamydomonas reinhardii (Pfister et al., 1982), but was later found to also be present
in cytoplasmic dyneins 1 and 2 (Asante et al., 2014; Hou and Witman, 2015; King and Patel-King,
1995; Pfister et al., 2006). LC8 is conserved throughout eukaryotic genomes (Wickstead and Gull,
2007). As a part of the dynein motor, it is important for fundamental cellular processes, such as
tubulin minus end-directed intracellular transport, chromatid separation during mitosis, and
nuclear migration (Fridolfsson et al., 2010), as well as flagella-specific functions, namely motility,
intraflagellar transport (Pazour et al., 1998), and ciliogenesis (Goggolidou et al., 2014; Li et al.,
2015). While not essential in yeast (Stuchell-Brereton et al., 2011), mutation or knockdown of LC8
is embryonic lethal in animals (Dick et al., 1996; Goggolidou et al., 2014; Li et al., 2015; Lightcap
et al., 2009). Given that LC8 is more conserved between species than other components of the
dynein motor, and that LC8 is present in organisms which lack a dynein motor, it was likely that
LC8 had non-dynein functions (King and Patel-King, 1995; Wickstead and Gull, 2007). LC8 has
since been shown to interact with several different proteins and to affect various cellular processes,
including protein localization and stability, transcription regulation, and apoptosis (Asthana et al.,
2012; Barbar, 2008; Rapali et al., 2011b).
It was previously hypothesized that LC8 functions as a linker, allowing attachment of the
dynein motor to its cargo. It has been shown since, however, that at physiological pH, LC8 exists
almost exclusively as a dimer (Barbar et al., 2001; Benashski et al., 1997), interacting with partner
proteins via two identical sites generated at the dimer interface which bind to diverse short, linear
motifs (Benashski et al., 1997; Lo et al., 2001; Rapali et al., 2011a). LC8 promotes the dimerization
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of its binding partners through aligning dimerization domains present in the partner protein
(Barbar, 2008; Barbar and Nyarko, 2014; Hodi et al., 2006; Wagner et al., 2006). The emerging
view, therefore, is that interaction with LC8 induces dimerization, imparting new structure and
function, which is supported by detailed investigations of LC8 interactions (Barbar and Nyarko,
2015; Radnai et al., 2010; Wang et al., 2004; Williams et al., 2007). In addition to this improved
understanding of LC8, interest in this molecule has grown as LC8 has been shown to have unique
and important roles in an increasing number of human pathogens. These include viruses, such as
HIV (Jayappa et al., 2015), Ebola (Luthra et al., 2015), and rabies (Tan et al., 2007), and the
protistan parasite Toxoplasma gondii (Qureshi et al., 2013).
Trypanosoma brucei, a member of the early diverged phylogenetic order Kinetoplastida, is a
vector-borne parasite that causes lethal disease in both humans and livestock (Brun and Blum,
2012). In T. brucei, LC8 was identified in mass spectrometry analysis of the flagellar matrix
(Broadhead et al., 2006; Oberholzer et al., 2011) and, surprisingly, as a subunit of the class I
transcription factor A (CITFA) (Brandenburg et al., 2007; Nguyen et al., 2012). As CITFA is a
core promoter-binding factor required for initiation of RNA polymerase (pol) I-mediated
transcription, this represents the first time LC8 has been found to associate with basal transcription
machinery. T. brucei is unique in that RNA pol I not only transcribes ribosomal gene units (RRNA),
as in all other organisms, but is also used to transcribe gene arrays that encode its major cell surface
proteins, namely the variant surface glycoprotein, or VSG, in the mammalian-infective
bloodstream form (BF) and procyclin in the insect-stage procyclic form (Günzl et al., 2003). This
production of functional mRNA by RNA pol I is possible in T. brucei due to a unique mRNA
processing mechanism, called spliced leader (SL) trans-splicing, which caps mRNA posttranscriptionally by an RNA pol II-independent process (Rudenko et al., 1991; Wirtz et al., 1994;
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Zomerdijk et al., 1991a). By densely covering the cell in ~10 million copies of the same VSG
protein, T. brucei is able to shield invariant proteins from antibody recognition (Schwede et al.,
2011). The source of this massive protein expression is a single VSG gene located in one of ~15
bloodstream expression sites (BESs) that are monoallelically expressed (Hertz-Fowler et al.,
2008). Antigenic variation of VSG, which occurs by switching to the expression of another of the
~2000 VSG genes in the trypanosome genome, allows for an indefinite infection to be maintained
(Cross et al., 2014; Horn, 2014). The importance of VSG to T. brucei is highlighted by the fact
that interference with VSG mRNA rapidly halts BF culture growth in the absence of
immunological pressure and leads to the clearance of trypanosomes from infected mice (Sheader
et al., 2005).
While it was previously shown that the CITFA complex, consisting of subunits CITFA1-7 and
LC8, is essential to RNA pol I-mediated transcription and binds the BES promoter in purified form
(Brandenburg et al., 2007)), the specific role of individual complex members, including knowledge
of the LC8 binding partner, has remained unclear. Furthermore, given that CITFA subunits except
LC8 are conserved only among kinetoplastids and are without recognizable sequence motifs, that
LC8 has never been implicated in the basal process of transcription initiation, and that LC8 has
not been studied in a kinetoplastid organism, we set out to understand the specific role of LC8 in
RNA pol I-mediated transcription.
Kinetoplastids encode two distinct LC8 proteins, only one of which was found to be associated
with CITFA. We found that this LC8, previously termed DYNLL1 (Brandenburg et al., 2007;
Nguyen et al., 2012), is essential for cell viability in culture and that RNAi-mediated silencing of
the gene led to defects in both cell cycle and transcription by RNA pol I. To understand LC8’s
specific role in the latter, we identified an LC8 binding site near the N-terminus of the essential
27

CITFA2 subunit. Mutation of this site was lethal to trypanosomes, preventing the incorporation of
this subunit into the CITFA complex. Moreover, we show that CITFA2 directly interacts with BES
promoter DNA and is required for the CITFA complex to bind to the BES promoter in vivo,
functions that crucially depend on the CITFA2-LC8 interaction. These data revealed an essential
role for LC8 in T. brucei, and the first evidence that LC8 is required for the formation of a
transcription pre-initiation complex in any organism.

II-2. Materials and Methods
DNAs and cell lines. pT7-LC8-stl, for conditional silencing of LC8 genes (accession numbers
Tb927.11.18680 and Tb11.0845 [www.genedb.org or www.tritrypdb.org]), was generated by
inserting portions of the LC8 coding region and its adjacent 3/ UTR, nucleotides +97 to +602
relative to the translation initiation codon, into the pT7-stl vector (Brandenburg et al., 2007) in a
sense-stuffer-antisense arrangement, according to a published protocol (Shi et al., 2000).
Transfection of SacII-linearized pT7-LC8-stl into single marker (sm)BF cells (Wirtz et al., 1999)
generated smLC8 cells. pCITFA7-PTP-NEO, pCITFA4-PTP-NEO (Nguyen et al., 2012), and
pPTP-CITFA2-PURO (Brandenburg et al., 2007) are plasmids that were described previously, and
were used to fuse the sequence of the composite PTP tag, consisting of a tandem protein A domain
(ProtA), a Tobacco etch virus cleavage site, and a protein C (ProtC) epitope, to endogenous alleles.
Similarly, the gene silencing vector pT7-PTP-stl (Park et al., 2014), and pT7-CITFA2-stl
(Brandenburg et al., 2007), along with accompanying cell lines, were described previously. smC2PTP cells allow for the conditional silencing of CITFA2 through targeting the PTP tag coding
sequence, and was generated in two steps: starting with a previously published smPTP cell line
(Park et al., 2014), which conditionally expresses double stranded RNA targeting the PTP tag
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sequence, we first used site-directed integration of SphI-linearized pPTP-CITFA2-PURO into one
CITFA2 allele to fuse the PTP tag sequence to the 5/ end of the CITFA2 coding region. In a second
step, the remaining CITFA2 allele was replaced by a PCR product in which 100bp of CITFA2 gene
ﬂanks surrounded the hygromycin phosphotransferase coding sequence. In order to conditionally
express exogenous transgenes of CITFA2, pT7-trans was developed. We inserted into pT7-stl,
using HindIII and XbaI restriction sites, a PCR product which contained (5/ to 3/) 490bp of the
HSP70 genes 2 and 3 intergenic region, NdeI and NotI restriction sites, a hemagglutinin (HA) tag
sequence ending with a stop codon, and 741bp of the β-/α-tubulin intergenic region. pT7-CITFA2HA was generated from pT7-trans through insertion of the full coding sequence of CITFA2 using
NdeI and NotI restriction sites. pT7-NDel-HA was generated similarly, save that bases +4 through
+31, corresponding to amino acids 2 through 10 of CITFA2 (PEVGTQVYW), were deleted by
PCR. pT7-3Amut-HA was generated using a CITFA2 insert which had bases +16 through +24
(ACTCAAGTT, coding for amino acids TQV) replaced with GCCGCGGCA, which coded for
three alanines. Transfection of these three plasmids, after linearization by EcoRV, into smC2-PTP
cells generated cell lines smC2-PTP-CITFA2-HA, smC2-PTP-NDel-HA, and smC2-PTP-3AmutHA. Transfection of these same plasmids into wild-type sm cells resulted in cell lines smC2CITFA2-HA, smC2-NDel-HA, and smC2-3Amut-HA.
DNAs and recombinant protein. To generate recombinant proteins for pulldown assays and
sucrose gradients, seven different recombinant protein expression plasmids were created.
pCITFA2-PTH, which allowed for the expression of full-length wild-type recombinant
(r)CITFA2, was produced by inserting the full coding sequence of CITFA2 into the expression
vector pET100/D-TOPO (Invitrogen) using NdeI and NotI restriction sites. This resulted in
rCITFA2 which had fused to its C-terminus a ProtC epitope, followed be a thrombin cleavage site,
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and a 6xHis tag. Four additional plasmids were produced which only differed in the length of the
integrated CITFA2 sequence: pCITFA2-N-PTH contains sequence for only the N-terminal half of
CITFA2 (bases +1 to +624), while pCITFA2-C-PTH codes for the C-terminal half (bases +621 to
+1263). pCITFA2-N1/4-PTH, coding for the N-terminal quarter of CITFA2, contained bases +1
to +303, while pCITFA2-N2/4PTH, coding for the second quarter, contained bases +289 to +624.
p3Amut-PTH, however, uniquely coded for mutated full-length rCITFA2 - the same triple-alanine
mutation as detailed above for pT7-C2-3Amut. These vectors were transformed into BL21
Escherichia coli, and protein expression was induced for 15 min to 1 hour at 37°C by adding 1
mM IPTG. Shorter incubations were required for plasmids which included the C-terminus of
CITFA2, as its expression appears to be toxic to E. coli (data not shown). Recombinant LC8 was
generated by placing the entire LC8 coding sequence downstream of the glutathione S-transferase
(GST) sequence in the pGEX-4T-2 vector (GE Healthcare) using BamHI and NotI restriction sites.
Recombinant GST-LC8 was expressed in BL21 E. coli and puriﬁed by glutathione afﬁnity
chromatography (GE Healthcare) following the manufacturer’s recommendations. Thrombin
digest and elution was then performed, such that, in all assays, LC8 was used as an untagged,
recombinant protein.
Generation of a purified anti-LC8 antibody. Immune serum against LC8 was generated by
immunization of Sprague-Dawley rats with rGST-LC8, according to a standard protocol
(Schimanski et al., 2006). rGST-LC8-specific antibodies were purified from serum by blotimmobolized antigen, as previously detailed (Park et al., 2014). In contrast to immune serum, the
purified antibody did not detect a non-specific band present in E. coli that co-migrated with
thrombin-digested LC8 (data not shown).
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Protein analysis. Immunoblot detections were performed using polyclonal antibodies directed
against CITFA2 (Brandenburg et al., 2007), CITFA6, CITFA7 (Nguyen et al., 2012), and TFIIB
(Schimanski et al., 2006). The PTP tag was detected with a monoclonal anti-ProtC antibody
(Roche), while HA-tagged proteins were detected with a rat monoclonal anti-HA antibody
(Roche). Extract preparation and tandem affinity purifications of PTP-tagged CITFA2, CITFA4,
and CITFA7 were conducted according to the standard protocol (Schimanski et al., 2005b). Crude
bacterial lysates of rCITFA2-PTH-expressing BL21 E. coli, used in protein pulldowns with rLC8,
were prepared as follows: after inducing protein expression with 1 mM IPTG IPTG for 30 min at
37°C, bacterial cultures were pelleted, and 0.2 g of the cell pellet was resuspended in 4 ml of
HisTALON xTractor buffer (Clontech). 250 units of Benzonase (Sigma), 400 ng lysozyme, and
250 µl of a protease inhibitor solution, prepared by resuspending 1 tablet of protease inhibitor
(Roche) in 1 ml H20, was then added. Following a 10 min incubation, with shaking, at 4°C, the
mixture was centrifuged at 3,200 g for 30 min at 4°C. The supernatant was taken and constitutes
the crude bacterial lysate. For the pulldowns, rCITFA2-PTH was purified from 100 µl of the crude
lysate using 20 µl equilibrated TALON metal affinity resin (Clontech), according to the
manufacturer’s specifications. A 40 µl binding reaction containing the CITFA2-PTH-conjugated
TALON resin, 100 mM KCl, 20 mM potassium glutamate, 20 mM HEPES-KOH (pH 7.7), 3 mM
MgCl2, 100 ng/µl BSA, 150 mM sucrose, 2.5 µl of the protease inhibitor solution, and 100 ng
rLC8 was incubated at 27°C for 1 hour, with shaking. The resin was washed 7 times with a buffer
containing 400 mM KCl), 20 mM potassium glutamate, 20 mM HEPES-KOH (pH 7.7), 3 mM
MgCl2, 10 ng/µl BSA,, 0.5 mM dithiothreitol (DTT), and 0.1% Tween-20. Proteins were eluted
using HisTALON Elution Buffer (Clontech), and investigated by immunoblotting. To analyze
rCITFA2-rLC8 interactions by sedimentation, 500 ng purified rLC8 was mixed with 200µl of
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rCITFA2-PTH-containing crude bacterial lysates, and incubated for 30 min at 27°C. The binding
reaction was then loaded onto a 4 ml 10-40% linear sucrose gradient, ultracentrifuged, and
fractionated from top to bottom, as previously described (Brandenburg et al., 2007). Coimmunoprecipitations (co-IPs) of CITFA2 were performed using trypanosome extract, as
previously described (Nguyen et al., 2007). UV-crosslinking and electrophoretic mobility shift
assays (EMSAs) of a radiolabeled BES promoter probe and purified CITFA, both visualized by
autoradiography, were conducted as previously detailed (Brandenburg et al., 2007). Secondary
structure analysis was carried out using PredictProtein (www.predictprotein.org/) (Rost et al.,
2004).
RNA analysis. To analyze the effect of LC8 silencing on transcription by RNA pol I, total
RNA was prepared by the hot-phenol method, as described previously (Park et al., 2014). For the
analysis of rRNA, total RNA was separated in Reliant precast 1.25% SeaKem Gold agarose RNA
gels (Lonza), and rRNA was detected by ethidium bromide staining. For semi-quantitative RTPCR analysis, total RNA was reverse transcribed with Superscript Reverse Transcriptase II
(Invitrogen) using an oligo(dT) primer. Semiquantitative PCR was performed using cycle numbers
that were empirically determined to be within the linear ampliﬁcation range for each primer pair:
5/-GATAAGCTTACGCGTTTCAACATTGAGAAGGAT

ATTGC-3/

and

5/ -

GATTCTAGACTCGAGTCTTTGACTCATCCGTGCTGG-3/ were used to amplify the LC8
coding sequence and 3/ UTR, while primers amplifying α-tubulin and VSG2 were published
previously (Nguyen et al., 2012).
Chromatin immunoprecipitation (ChIP). CITFA2-HA and CITFA3 promoter occupancy
were analyzed by ChIP assays, as described previously (Park et al., 2014), using monoclonal rat
anti-HA antibody (Roche) and purified polyclonal anti-CITFA3 antibody, respectively. Negative
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control precipitations were carried out using affinity beads not bound to antibody. Chromatin was
sonicated until fragments averaged 200-400 bp in length. The precipitated DNA was analyzed by
qPCR using consensus primers for the slightly varying copies of RRNA and BES promoters, and a
primer pair for the β-/α-tubulin intergenic region, which were specified previously (Nguyen et al.,
2012; Park et al., 2014). The percent IP was calculated relative to the input material and corrected
by subtracting the percent IP of the negative control ChIP. Each ChIP experiment was
independently carried out 3-4 times, and statistical analyses were performed using percent IP
averages. Comparisons between corrected percent precipitations of non-induced and induced cells
were performed using Student’s T-test. Prior to the application of the T-test, an F-test was
performed to assure that the assumption of equal variance between groups was not violated. If the
F-test indicated that the difference in variation was significant, then the T-test was performed with
the more conservative assumption of unequal variance. An unpaired, two-tailed test was used in
all cases.
Microscopy. To visualize changes in cell morphology and DNA content upon LC8 silencing,
BFs were incubated with 4,6-diamidino2-phenylindol (DAPI) at a ﬁnal concentration of 2 ng/µl
for 45 min and imaged using a Zeiss AxioVert 200 microscope and Zeiss Axiovision 4.6.3.0
software, as described previously (Park et al., 2014). For quantification of the percentage of cells
which were multiflagellated, multi-kinetoplastid, or multi-nucleated, cells were scored as
abnormal if they met any one of the following criteria: ≥3 kinetoplasts, ≥3 nuclei, ≥3 flagella, or
more nuclei than kinetoplasts. 150 cells were scored from both the non-induced and induced
populations.
Flow Cytometry. In order to assess changes in the size and DNA content of a large number
of cells upon LC8 silencing, flow cytometry experiments were performed. Non-induced and 1 day
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induced smLC8 cultures were stained with propidium iodide, and counted using an LSR II flow
cytometer (BD Biosciences), according to a previously described protocol (Li et al., 2009). 30,000
cells were counted in each experiment, in triplicate, for each induction state, and ungated data was
visualized using the FlowJo software package (Treestar Inc.).

II-3. Results
LC8 is essential for T. brucei viability, cytokinesis, and RNA pol I-mediated transcription. A
survey of kinetoplastid genome data bases revealed conservation of two distinct LC8 genes. One
encodes an LC8 protein that is closely related to both human DYNLL1 and DYNLL2 (~82%/88%
identity/similarity; accession number for the T. brucei gene is Tb927.11.1868 at
www.TritrypDB.org (Aslett et al., 2010) or www.GeneDB.org (Logan-Klumpler et al., 2012)) and
was previously termed DYNLL1 (Brandenburg et al., 2007). A second LC8 is also present, yet this
gene is more divergent from LC8s in other eukaryotes (~61%/85% identity/similarity to human
DYNLL1 and 2; Tb927.11.320; Figure II-S1). Since a phylogenetic analysis did not reveal that
these two LC8 proteins resemble the DYNLL1 and DYNLL2 dichotomy found in chordates
(Figure II-S1C in the supplemental material), we propose to rename Tb927.11.1868 as LC8 and
Tb927.11.320 as LC8dv (dv for divergent). Trypsin-derived peptides of these two proteins are
different except for a four amino acid-long peptide (Figure II-S1A). Since previous mass
spectrometric analyses of purified CITFA consistently identified LC8 but never LC8dv-derived
peptides (Brandenburg et al., 2007; Nguyen et al., 2012), it is highly unlikely that LC8dv is a
subunit of the transcription factor complex. We therefore concentrated our analysis on LC8.
To investigate the importance of LC8 to BFs, we reduced its expression by RNA interference
(RNAi), using a conditional gene silencing system which expressed double-stranded RNA
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(dsRNA) targeting both the LC8 coding and 3/ untranslated region (UTR) upon addition of
doxycycline (Wirtz et al., 1999). In three different clonal cell lines, derived from smBF cells and
termed smLC8, culture growth arrested within 1 day, and the majority of cells were lost by 2 days
of induction (Figure II-1A). By 3 days of induction, no living cells could be identified by
microscopic examination. RNA monitoring revealed that doxycycline induction resulted in a clear
decline of LC8 mRNA abundance after 1 day, while the levels of LC8dv and α-tubulin mRNA was
unaffected, confirming that the knockdown was specific to LC8 (Figure II-1B). To evaluate
whether this rapid death phenotype would allow us to detect effects on transcription by RNA pol
I, we measured levels of VSG mRNA derived from the active VSG2 gene and of rRNA. While the
VSG2 mRNA level dropped considerably after 1 day of induction, the rRNA level decreased only
modestly in the same experiment, possibly due to greater stability of rRNA (Figure II-1B).
Immunoblot monitoring of LC8-silenced cells showed a specific reduction in LC8 protein, while
CITFA6 and TFIIB, an RNA pol II-specific factor, were either increased or unchanged during this
short period (Figure II-1C), confirming the specificity of the knockdown. These data
demonstrated that LC8 is essential for trypanosome viability, and they indicated that LC8 is also
important, though perhaps indirectly, for transcription by RNA pol I.
Since smBF cells and their derivatives have a doubling time of approximately 7 hours in our
hands (Figure II-1A, -dox), propidium iodide staining, which allows for the quantification of the
DNA content of individual cells, revealed a rapidly-progressing second phenotype. After only 1
day of induction, the per-cell DNA content of induced cells had approximately tripled vs noninduced cells, as revealed by flow cytometry of propidium iodide stained cultures (Figure II-1D).
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Figure II-1. LC8 silencing has pleiotropic effects on BF trypanosomes. (A) Growth curve analysis
of a representative clonal smLC8 BF cell line in the absence (- dox) and presence (+ dox) of the
LC8 knockdown inducing compound doxycycline. (B) Total RNA prepared from non-induced (ni)
and 1 day induced cells was reverse transcribed with Oligo-dT and analyzed by semiquantitative
PCR using LC8, α-tubulin, and VSG2-specific oligonucleotides. rRNA was detected by ethidium
bromide staining of total RNA. (C) Whole cell lysates of non-induced and 1 or 2 day induced cells
were analyzed by immunoblotting using LC8, CITFA6 or, as a loading control, TFIIB-specific
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(Figure II-1 legend cont.) antibodies. (D) Flow cytometry analysis, without gating, of noninduced (blue) and 1 day induced cultures (red). Propidium iodide staining intensity (x-axis),
which measures DNA content per cell, and cell counts (y-axis) from one representative experiment
are shown. (E) Indirect fluorescence microscopy of non-induced and 1 day induced cells.
Representative single cells from each culture were imaged using both phase contrast and DAPI
fluorescence. Small and large areas of DAPI intensity represent kinetoplasts and nuclei,
respectively. Scale bar is 10 µm.
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Specifically, while non-induced cells demonstrated a curve with strong peaks representing cells
with normal 2C and 4C DNA content, induced cultures had smaller 2C and 4C peaks, with the
majority of cells displaying polyploidy (8C). This result was confirmed by DAPI fluorescence
microscopy, which demonstrated that the majority of cells in culture (64%, n = 150) had increased
in size, and were multi-flagellated, multi-kinetoplastid, and multi-nucleated (Figure II-1E), a
phenotype that was observed in only two out of 150 non-induced cells. The increase in size was
confirmed by flow cytometry of non-induced and LC8-silenced trypanosomes (Figure II-S2). This
phenotype is not likely due to the loss of LC8 from the CITFA complex, as previously published
knockdowns of other CITFA subunits failed to result in a similar phenotype (Brandenburg et al.,
2007; Nguyen et al., 2014; Nguyen et al., 2012; Park et al., 2014). It would be consistent, however,
with a role for LC8 in cell cycle progression, which has been reported previously in other
organisms (Asthana et al., 2012; Liu et al., 2003).
LC8 binds to the N-terminus of CITFA2. In order to investigate the CITFA-specific role of
LC8, we needed to determine LC8’s binding partner within the CITFA complex, since disrupting
this interaction would likely only interfere with LC8’s RNA pol I-related function. While LC8
binding sites are conserved from yeast to humans (Wickstead and Gull, 2007), a survey did not
unambiguously reveal such a site in CITFA subunit sequences (data not shown). We recently
discovered in a sedimentation analysis that the peaks of CITFA7 and CITFA2 in extract differed
slightly from each other, possibly indicating the existence of CITFA complexes with partially
different compositions (Nguyen et al., 2012). To compare the sedimentation profile of LC8 with
those of the other CITFA subunits, we tandem affinity-purified CITFA via PTP-tagged CITFA7
and sedimented the purified complex through a linear sucrose gradient (Figure II-2A).
Fractionating the gradient from top to bottom and analyzing the protein content of each fraction
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Figure II-2. LC8 binds to the N-terminus of CITFA2, promoting its dimerization. (A)
Sedimentation of tandem affinity-purified CITFA by ultracentrifugation in a 10-40% linear
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(Figure II-2 legend cont.) sucrose gradient. Fractions, taken from top to bottom, were separated
by SDS-PAGE, stained with SYPRO Ruby and immunoblotted for specific detection of CITFA2,
CITFA7, and LC8. CITFA7-P is so noted due to the presence of ProtC, which remains following
TEV protease cleavage. Arrows highlight the relative absence of CITFA2 and LC8 in fraction 12.
Taq DNA polymerase (95 kDa), IgG (150kDa), and apoferritin (AP) (444 kDa) were analyzed for
molecular mass comparison (arrowheads). (B) Pulldown of recombinant, full-length (amino acid
residues 1-422), wild-type CITFA2 with a C-terminal PTH tag, consisting of ProtC, a thrombin
cleavage site (TCS), and the terminal 6xHis tag, in the presence of recombinant LC8. Crude extract
(Inp), supernatant (S), and precipitate (P) were analyzed in relative amounts of 1:1:8 by
immunoblotting, using ProtC- and LC8-specific antibodies. A negative control pulldown was
conducted in the absence of CITFA2 (bottom panel). (C) Corresponding experiments with
CITFA2-PTH fragments which are specified by residue numbers. (D) Alignment of the N-terminal
CITFA2 sequences from Trypanosoma brucei brucei strain 427 (Tb427, accession numbers are
listed in Table II-S1), Trypanosoma congolense (Tcon), Trypanosoma vivax (Tv), Trypanosoma
cruzi (Tc), Trypanosoma grayi (Tgr), Trypanosoma rangeli (Tran), Leishmania tarentolae (Lta),
Leishmania mexicana (Lmx), Leishmania major (Lm), Leishmania infantum (Li), and Leishmania
donovani (Ldon). Positions with more than 50% identity or similarity are highlighted in black or
gray, respectively. The proposed LC8 binding site is marked below the alignment (asterisks), while
the two mutants used for further investigation, NDel and 3Amut, are indicated above. (E) Pulldown
assay of full length rCITFA2-PTH carrying the 3Amut mutation (r3Amut-PTH). (F) Sucrose
gradient sedimentation of rCITFA2-PTH alone, LC8 alone, or in combination, following coincubation (bottom two panels). Arrows indicate a co-sedimentation peak in fraction 10 that is not
present when either protein was analyzed on its own.
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by SDS-PAGE and SYPRO Ruby staining revealed a CITFA complex that peaked in fractions 1215 (Figure II-2A). The staining pattern and immunoblotting with specific antibodies, however,
showed that while CITFA7 and other CITFA subunits were present in all four peak fractions,
CITFA2 and LC8 were nearly absent from fraction 12, suggesting that CITFA2 may be the binding
partner of LC8.
To directly test this, we generated in E. coli recombinant LC8 with an N-terminal GST tag and
CITFA2 with a C-terminal composite PTH tag containing a ProtC epitope, a thrombin cleavage
site, and six histidine residues (6xHis). Incubating purified CITFA2-PTH, immobilized on beads,
with purified LC8, after removal of the GST tag, co-precipitated LC8 in a CITFA2-PTH-dependent
manner, strongly indicating a direct interaction between these two proteins (Figure II-2B). In
order to confirm this result, and better specify the site of interaction, we repeated this pulldown
experiment using recombinant protein portions of CITFA2. Precipitation of the N-terminal half of
CITFA2, comprising amino acids 1-208, effectively precipitated LC8 from solution, while
precipitation of the C-terminal half did not (Figure II-2C). We further divided the N-terminal half
of CITFA2, and again found that the most N-terminal portion, this time residues 1-101,
precipitated LC8, while the second quarter of CITFA2 failed to precipitate LC8. We then
attempted to identify the LC8 binding site within this reduced region of CITFA2 using motifs
validated in other organisms (Rapali et al., 2011b), as well as a report which used a directed
evolution approach to quantitatively determine the affinity preferences of the LC8 binding site
(Rapali et al., 2011a). In both of these publications, the LC8 binding site almost always contained
a central glutamine (Q), with threonine (T) or valine (V) in the -1 and +1 positions. Three amino
acids, threonine-glutamine-valine, at the N-terminus of CITFA2 (amino acids 6-8) were identified
as the likeliest site of interaction, and are almost completely conserved among kinetoplastid
41

CITFA2 sequences (Figure II-2D). In the course of this study two mutations of CITFA2 were
pursued: an N-terminal deletion of amino acids 2-10 (NDel) and a replacement of amino acids 68 with alanines (3Amut). Precipitation of full length recombinant 3Amut-PTH failed to precipitate
LC8 from solution, confirming that LC8 binds CITFA2 via this N-terminal sequence (Figure II2E).
LC8 binding promotes CITFA2 dimerization. In other systems it was shown that LC8,
acting as a dimer, binds to disordered regions of proteins, stabilizing their structure and allowing
for areas present in the binding partner, such as coiled-coil domains, to promote dimerization,
thereby resulting in the formation of a heterotetramer (Barbar and Nyarko, 2014, 2015; Rapali et
al., 2011b). While secondary structure prediction software identified the N-terminus of CITFA2
as unstructured, no domains known to promote protein dimerization were recognized (data not
shown). In order to investigate the possibility that LC8 binding induces dimerization of CITFA2,
we performed sucrose gradient sedimentation with recombinant CITFA2-PTH and LC8. CITFA2PTH, by itself, was found to peak in gradient fraction 7, which would be consistent with it existing
as a monomer of 50 kDa (Figure II-2F), while the 10 kDa LC8 was found at the top of the gradient.
When LC8 and CITFA2-PTH were allowed to interact before gradient sedimentation, however,
both proteins exhibited a peak in fractions 9-10, consistent in size with a complex containing a 120
kDa CITFA2/LC8 heterotetramer. Serendipitously, when CITFA2-PTH was expressed in E. coli,
immunoblots against the C-terminal ProtC tag detected its full length form and a truncated form
which is missing approximately 5 kDa (Figure II-2F, asterisks). This putative N-terminal
truncation was not shifted upon addition of LC8, indicating that LC8 cannot form a heterotetramer
with the truncated CITFA2. These results strongly indicate that LC8 promotes the dimerization of
CITFA2.
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The CITFA2-LC8 interaction is essential for cell viability and RNA pol I-mediated
transcription. In order to assess the importance of the CITFA2-LC8 interaction, we established
BF cell lines in which doxycycline triggers both silencing of endogenous CITFA2 and expression
of an RNAi-resistant CITFA2 transgene. In T. brucei, effective gene silencing via the RNAi
pathway requires strong expression of ~500 bp-long dsRNA (Shi et al., 2000). We recently showed
that targeting the heterologous PTP tag coding sequence effectively interfered with mRNAs
carrying the PTP sequence, while having no deleterious off target effect in BFs (Park et al., 2014).
The smPTP cell line, a derivative of the established smBF cell line for gene knockdowns (Wirtz
et al., 1999), constitutively expresses the tetracycline (TET) repressor and T7 RNA pol, and, upon
induction, PTP dsRNA from a TET-controlled T7 promoter (Park et al., 2014). To apply this
system to CITFA2, we replaced one CITFA2 allele in smPTP cells by hygromycin
phosphotransferase and inserted the PTP-CITFA2-PURO plasmid into the second CITFA2 allele
to obtain cell line smC2-PTP (Fig II-3A, left panel). As expected, induction of PTP dsRNA led to
a loss of cell viability over three days induction (Figure II-3A, middle panel), which matched
previously performed CITFA2 silencing experiments that targeted the CITFA2 coding sequence
(Brandenburg et al., 2007). Immunoblotting of whole cell lysates confirmed that CITFA2 was
exclusively expressed as a PTP fusion, and that depletion of PTP-CITFA2 was nearly complete
after 1 day of induction (Figure II-3A, right panel). We next generated three CITFA2 rescue
constructs which differed only in respect to the LC8 binding site (Figure II-3B). The constructs
contained the complete wild-type, 3Amut, or NDel coding region with an HA tag sequence at the
3/ end (CITFA2-HA), and were under the control of a TET-regulated T7 promoter (note that due
to SL trans splicing, trypanosomes can utilize T7 pol for the effective production of functional
mRNA (Stewart et al., 2010)). The constructs were transfected into smC2-PTP cells and targeted
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Figure II-3. Mutation of the LC8 binding site is lethal. (A) Left, schematic of the CITFA2 locus
(not to scale) in BF cell line smC2-PTP in which one allele has been replaced with a hygromycin
resistance cassette (HYG), while the remaining allele has been fused to the PTP tag sequence by
integration of pPTP-CITFA2-PURO, which harbors a puromycin resistance cassette (PURO).
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(Figure II-3 legend cont.) Small gray rectangles indicate gene flanks with essential RNA
processing signals. Doxycycline-induced expression of PTP dsRNA specifically targets PTPCITFA2 mRNA. Middle, smC2-PTP culture growth curve in the presence (+dox) and absence (dox) of doxycycline. Right, immunoblot monitoring of the CITFA2 knockdown using both antiCITFA2 and anti-PTP antibodies, with TFIIB serving as a loading control. Note that the absence
of a ~55 kDa band in anti-CITFA2 antibody probing confirms exclusive expression of PTP-tagged
CITFA2 in smC2-PTP cells. (B) Top, schematic depiction (not to scale) of the construct that
harbored the CITFA2-HA transgene and was targeted to the silent RRNA intergenic region to
conditionally express RNAi-resistant CITFA2-HA mRNA and rescue the PTP-CITFA2
knockdown. Bottom, culture growth curves of representative smC2-PTP cell lines whose PTPtargeted CITFA2 knockdown was rescued with wild-type (WT), 3Amut, or NDel CITFA2-HA
expression. (C) RNA analysis of the rescue cell lines after either no induction (ni) or two days of
doxycycline. (D) Immunoblotting of PTP-CITFA2 and CITFA2-HA proteins during a time course
of doxycyline-induced PTP-CITFA2 knockdown (KD) and CITFA2-HA expression, with TFIIB
serving as a loading control. Arrows indicate co-declines of 3Amut and NDel CITFA2-HA protein
with PTP-CITFA2 in the corresponding cell lines.
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to the ribosomal spacer region, a silent genomic locus commonly used for integration of exogenous
plasmid constructs. As expected, the expression of wild-type CITFA2-HA almost completely
rescued for the growth defect which resulted from PTP-CITFA2 silencing (Figure II-3B, left
panel). In contrast, neither 3Amut nor NDel were able to rescue for the knockdown (Figure II3B, middle and right panels). RNA analysis confirmed the reduction in PTP-CITFA2 mRNA in
all three cell lines, and the simultaneous expression of the HA-tagged transgenes (Figure II-3C).
Furthermore, and consistent with the failed rescue of the PTP-CITFA2 knockdown by both mutant
CITFA2-HA genes, RNA pol I-derived transcripts rRNA and VSG2 mRNA were strongly reduced
in induced cells, while such defects were absent in the wild-type rescue line (Figure II-3C).
Immunoblot monitoring confirmed the knockdown of PTP-CITFA2 after 24 hours of induction,
and the expression of the three different rescue transgenes within 8 hours (Figure II-3D). The
lethality of mutating the LC8 binding site in CITFA2 in conjunction with the specific decline of
rRNA and VSG2 transcripts strongly indicated that the interaction between LC8 and CITFA2 is
essential for RNA pol I-mediated transcription and BF viability in culture.
Our next goal was to determine the specific defect in transcription upon interfering with the
CITFA2-LC8 interaction. The 3Amut, and NDel rescue cell lines, however, were not informative
in this regard, as immunoblots revealed that while both 3Amut and NDel mutant proteins were
expressed upon induction, peak expression was transient, and protein levels fell sharply at 24 hours
(Figure II-3D, arrows). This cannot be due to a decline in transgene mRNA, as it was found to be
well expressed at 48 hours post induction (Figure II-3C). Given that the decline in mutant CITFA2
levels coincided with the RNAi-mediated decline of PTP-tagged CITFA2, we hypothesize that
wild-type CITFA2 might be stabilizing mutant CITFA2 through weak direct interaction. This
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would be consistent with the view that LC8 drives dimerization of proteins which already have a
propensity towards dimerization (Barbar and Nyarko, 2014).
Mutant CITFA2 does not bind promoter DNA or interact with other CITFA subunits. We
sought to obviate the problem of mutant instability by generating a cell line in which mutant
CITFA2-HA and wild-type CITFA2 were expressed simultaneously. We transfected our same
three CITFA2-HA transgene constructs into BF cells that contained two wild-type CITFA2 alleles,
generating cell lines C2-WT-HA, C2-NDel-HA, and C2-3Amut-HA. Immunoblot monitoring
revealed that both wild-type and NDel CITFA2-HA were able to achieve long-term, high level
expression in the presence of wild-type CITFA2, while 3Amut, though durably expressed, never
reached an equal protein level (Figure II-4A). This expression profile was consistent in 2-4 cell
lines obtained with each construct. The low expression of 3Amut could be due to a disruption in
the secondary structure of CITFA2 causing instability, as the three alanine residues would strongly
promote the formation of an α-helix (Pace and Scholtz, 1998) in a region predicted to form a βstrand.
Given that CITFA is a promoter-binding transcription factor, we sought to determine if the
well expressed NDel mutant was recruited to promoter DNA. ChIP using anti-HA antibody,
specific for the transgene-derived CITFA2-HA, revealed that while wild-type CITFA2-HA was
present at both RRNA and BES promoters, NDel CITFA2-HA was not (Figure II-4B). This lack
of promoter binding could be the result of either a loss of DNA-binding by a complete CITFA
complex, or a lack of assembly of the mutant CITFA2 into the CITFA complex. To differentiate
between these two possibilities, we immunoprecipitated both wild-type and NDel CITFA2-HA,
and analyzed for co-IP of other CITFA subunits (Figure II-4C). Precipitation of the wild-type
protein resulted in the co-IP of LC8, CITFA6, and CITFA7, verifying that the introduced CITFA247

Figure II-4. Mutation of the LC8 binding site prevents recruitment of CITFA2 to promoters and
its assembly into the CITFA complex. (A) Comparison of constitutive wild-type (WT), NDel, or
3Amut CITFA-HA expression in individual BF cell lines by immunoblotting, with TFIIB serving
as a loading control. (B) Anti-HA ChIP assays in cell lines constitutively expressing wild-type or
NDel CITFA2-HA. Precipitated DNA was analyzed using primer pairs which amplified the
consensus BES promoter (BES prom), the consensus RRNA promoter (RRNA prom), and the β-/αtubulin intergenic region. Error bars represent one standard deviation, with asterisks indicating a
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(Figure II-4 legend cont.) Student’s T-test P-value of < 0.05. (C) Anti-HA coimmunoprecipitation with the same cell lines. Blots monitoring wild-type (WT) or NDel CITFA2HA immunoprecipitation were probed to detect the co-immunoprecipitation of LC8, CITFA6,
CITFA7, and, as a loading control, TFIIB. Note that IgG light chain (IgG l.c.) was detected at the
top of the CITFA6 immunoblot. (D) Sucrose gradient sedimentation of whole cell extracts,
prepared from cell lines that constitutively express wild-type (WT), NDel, or 3Amut CITFA2-HA
cell lines, were analyzed by immunoblotting fractions 4-20 using either anti-HA or anti-CITFA6
immune serum.
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HA had assembled with other CITFA subunits. NDel CITFA2-HA, however, failed to co-IP any
of these proteins, showing that the lack of promoter binding by the mutant was due to a lack of
stable association with other CITFA subunits. To confirm this result, and further investigate the
assembly status of both wild-type and mutant CITFA2, we performed sucrose gradient
sedimentation of BF extract. While wild-type CITFA2-HA had its major sedimentation peak in
fractions 12-15, which coincided with the peak of CITFA6, both 3Amut and NDel peaked in
fractions 6-7, and lacked a peak in 12-15 (Figure II-4D). This result confirms that CITFA2 must
bind LC8 for CITFA complex assembly. Given that sedimentation in fractions 6-7 would be
consistent with a 50-kDa protein, it also appears likely that CITFA2 exists as a monomer in the
absence of LC8 binding in our extracts. Note that wild-type CITFA2-HA has a minor peak in
fractions 8-9, likely representing a CITFA2 dimer and/or a CITFA2-LC8 heterotetramer.
CITFA2 directly contacts BES promoter DNA and is required for promoter binding of
CITFA in vivo. CITFA2 was shown to be of crucial importance to the initiation of transcription
by RNA pol I from RRNA, BES and procyclin promoters, both in vivo and in vitro (Brandenburg
et al., 2007). However, its specific function in the complex has not been determined. Early UV
crosslinking of partially purified CITFA and radiolabeled BES promoter DNA resulted in a major
labeled protein band of ~50 kDa (Brandenburg et al., 2007), which is the approximate size of
CITFA subunits 1-3. Accordingly, depletion of CITFA1 in BFs caused a loss of CITFA3
occupancy of RRNA and BES promoters, indicating that CITFA1 is important for the transcription
factor’s ability to bind to RNA pol I promoters (Park et al., 2014). The BES promoter extends only
to position -67 relative to the transcription initiation site (TIS) and harbors two distinct sequence
elements (Pham et al., 1996; Vanhamme et al., 1995) both of which are required for efficient
binding of CITFA to the BES promoter (Brandenburg et al., 2007). The two elements are separated
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by 25 bp indicating that more than one CITFA subunit mediate DNA binding. Thus, to determine
a potential DNA-binding role of CITFA2, we first used the sucrose gradient fractions of the
purified CITFA complex (Figure II-2A), for a gel shift assay with an 82 bp-long radiolabeled BES
promoter probe. Consistent with CITFA2 and LC8’s near absence from fraction 12 and their
sedimentation peak in fraction 13 and 14, fraction 12 shifted the promoter only faintly (Figure II5A, arrow), while a strong shift signal was observed in fractions 13 and 14, indicating that CITFA2
and LC8 are important for the ability of CITFA to bind the BES promoter.
To better understand which CITFA subunits directly contact BES promoter DNA, we performed
UV crosslinking using tandem affinity-purified CITFA from BFs that expressed PTP-CITFA7
(Nguyen et al., 2012). Crosslinking this high purity eluate and a radiolabeled BES promoter
revealed two specific protein bands in the 50-60 kDa range and a third band of ~40 kDa (Figure
II-5, lane 3). Since the latter band was likely CITFA4, given that no other CITFA subunit is 40
kDa, we repeated the experiment with a BF cell line that expressed CITFA4-PTP. After tandem
affinity purification of a PTP-tagged protein, a ~4 kDa portion of the tag (ProtC) remains on the
purified protein. Accordingly, in the CITFA4-PTP purification, the 40 kDa band shifted up
(Figure II-5B, lane 2, CITFA4-P), unequivocally identifying CITFA4 as a direct contactor of
promoter DNA. Likewise, using purified CITFA containing a PTP-tagged CITFA2 resulted in a
shift of the uppermost crosslinked band, identifying CITFA2 as having direct DNA contact
(Figure II-5B, lane 4, P-CITFA2). Since we have been unable to verify functional PTP tagging of
CITFA1, we repeated this experiment with PTP-tagged CITFA3. A failure of tagged-CITFA3 to
increase the size of any of the three bands (data not shown) makes it likely that CITFA1 is the
third direct contactor of promoter DNA within the CITFA complex.
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Figure II-5. CITFA2 directly contacts the BES promoter and is required for CITFA to bind to
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(Figure II-5 legend cont.) RNA pol I promoters in vivo. (A) Sucrose gradient fractions of purified
CITFA, shown in Figure II-2A, were used in an EMSA with a radiolabeled BES promoter that
was visualized by autoradiography. Fraction 12, which contains minimal LC8 and CITFA and an
abundance of other CITFA subunits, barely binds to the probe (arrow), while fractions 13-14,
which contain an abundance of all CITFA subunits, effectively bound the promoter probe. (B) UV
crosslinking analysis using tandem affinity-purified CITFA with radiolabeled BES promoter.
After DNA digest, proteins were separated by SDS-PAGE and visualized by autoradiography. On
the right, tagged and untagged CITFA subunits are identified. As explained in the text, the band
that did not shift is putatively CITFA1 (put. CITFA1). (C) Anti-CITFA3 ChIP assay in a
smCITFA2 cell line which was either not induced or in which PTP-CITFA2 was silenced for 2
days. One and two asterisks represent P-values <0.05, <0.01, respectively.
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To confirm the importance of CITFA2 to CITFA promoter binding in vivo, we analyzed
CITFA occupancy at RRNA and BES promoters in non-induced BFs and in BFs in which CITFA2
was silenced for two days. Since CITFA2 depletion did not affect the abundance of CITFA3
(Figure II-5C, insert) and since absence of CITFA2 does not appear to disrupt the CITFA complex
(see Figure 2A, fraction 12; Nguyen et al. 2012), we performed ChIP using a purified, ChIP-grade
polyclonal anti-CITFA3 antibody (Park et al., 2014). Consistent with CITFA2 being a promoter
binding protein, CITFA3 occupancy of BES promoters was completely lost upon CITFA2
depletion (Figure II-5C). Although the CITFA3 occupancy of RRNA promoters was significantly
reduced in the same experiments, CITFA3 association with RRNA promoters remained substantial.
This might be due to structural differences between RRNA and BES promoters. In contrast to the
short BES promoter, the RRNA promoter extends to position -257 relative to the TIS, harboring
four distinct promoter domains (Janz and Clayton, 1994; Schimanski et al., 2004). Thus, it is
possible that additional factors present at the RRNA promoter interact with CITFA and stabilize it
in the absence of CITFA2. In either case, these data clearly demonstrate that CITFA2 is important
for CITFA binding to both RRNA and BES promoters.
LC8 depletion affects CITFA occupancy of RRNA and BES promoters. Finally, to verify that
the recruitment failure of the CITFA2 NDel mutant to RNA pol I promoters is due to a loss of the
CITFA2-LC8 interaction, we analyzed whether LC8 silencing affected CITFA occupancy of RRNA
and BES promoters. Using the same cell line as in Figure II-1, we found a highly significant
reduction in binding of CITFA3 to the BES promoter, despite the fact that LC8 silencing limited
the analysis to one day of induction (Figure II-6). According to our observation that CITFA2 is
less critical for CITFA3 occupancy of the RRNA promoter (see Figure II-5C), LC8 depletion
affected RRNA promoter precipitation only modestly (Figure II-6). These results are consistent
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Figure II-6. LC8 is required for recruitment of CITFA to the BES promoter. Anti-CITFA3 ChIP
in smLC8 BFs without induction (ni) and after 1 day of LC8 silencing. Precipitated DNA was
analyzed using the primer pairs previously noted. Three asterisks represent a P-value <0.001.
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with the CITFA2-LC8 interaction being crucial for CITFA function and they verify LC8’s
important role in multifunctional RNA pol I transcription in T. brucei.

II-4. Discussion
Here we have shown that LC8 has at least two essential functions in T. brucei, namely in cell cycle
progression and, as part of CITFA, in RNA pol I transcription, which was the focus of this
investigation. We found that LC8 directly interacts with the N-terminus of CITFA2, requiring a
conserved N-terminal TQV motif for binding. Sedimentation of recombinant CITFA2-LC8
complexes indicated that LC8 binding promotes the dimerization of CITFA2, resulting in a
CITFA2-LC8 heterotetramer. Silencing of endogenous CITFA2 in conjunction with the expression
of RNAi-resistant wild-type and mutant CITFA2 transgenes, revealed that the CITFA2-LC8
interaction is essential for trypanosome viability in culture, specifically affecting the abundance of
RNA pol I transcripts. Pursuing the specific defect in the RNA pol I system, we found that CITFA2
is unable to bind promoter DNA or assemble with other CITFA subunits to form a complete CITFA
complex in the absence of the CITFA2-LC8 interaction. Following up on a previous report which
suggested a role for CITFA2 in promoter binding by CITFA (Brandenburg et al., 2007), we found
that CITFA2, CITFA4 and, likely, CITFA1 directly contact promoter DNA. Accordingly, CITFA2
silencing led to a defect in both RRNA and BES promoter binding of CITFA3, a result which was
verified for the BES promoter by silencing LC8. These data suggest a model (Figure II-7) in which
trypanosome LC8, by forming a dimer as in other organisms (Barbar et al., 2001; Benashski et al.,
1997), binds to the N-termini of two CITFA2 molecules, promoting or stabilizing their
dimerization. Since CITFA2 and LC8 remain stably associated with the CITFA complex after
tandem affinity purification and sucrose gradient sedimentation, even at 400 mM KCl (Figure II-
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Figure II-7. Model of the CITFA2-LC8 interaction and function for BES promoter transcription.
Formation of a CITFA2-LC8 heterotetramer is a prerequisite for its assembly into the CITFA
complex. While a stable partial CITFA complex is formed without CITFA2-LC8, only a fully
assembled CITFA complex that includes CITFA2 and LC8 is able to bind promoter DNA. The
BES promoter, with its two sequence blocks essential for CITFA binding (yellow), is shown here
along with the TIS. Please note that, for ease of visualization and understanding, LC8’s site of
interaction with CITFA2 was not shown at its dimer interface, where it actually occurs. Promoterbound CITFA is able to, either directly or indirectly, recruit RNA pol I and enable transcription
initiation.
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2A; (Brandenburg et al., 2007; Nguyen et al., 2012); data not shown), it is likely that the full
assembly of CITFA occurs independent of DNA. Finally, by contacting DNA directly through its
CITFA2, CITFA4 and, likely, CITFA1 subunits, the transcription factor complex binds with high
affinity to both elements of the BES promoter which, in turn, leads to RNA pol I recruitment and
transcription initiation. Although we cannot exclude the possibility that CITFA2 dimerization
leads to dimerization of the whole CITFA complex, the sedimentation profile of purified CITFA
argues against this possibility. Consistent with an overall mass of CITFA of 323 kDa, which
assumes a CITFA2-LC8 heterotetramer and monomers for all other subunits, full CITFA
sedimented in-between the 150 and 444 kDa size markers (Figure II-2A).
Our data and model are consistent with the view that LC8, rather than functioning as a linker
between two different proteins, instead promotes homodimerization, thereby imparting new
function (Barbar, 2008; Barbar and Nyarko, 2014, 2015; King, 2008). Is LC8 essential for CITFA2
dimerization or does it rather stabilize a CITFA2 dimer by interacting with its predicted disordered
N-terminus? Sedimentation analysis of recombinant CITFA2 and LC8 proteins (Figure II-2F) and
of extracts containing NDel and 3Amut CITFA2-HA protein (Figure II-4D) suggested that in the
absence of LC8, CITFA2 cannot form a dimer. However, when endogenous, wild-type CITFA2
was depleted in trypanosomes, then NDel and 3Amut CITFA2 were co-lost (Figure II-3D)
whereas the same proteins could be constitutively expressed in the presence of wild-type CITFA2
(Figure II-4B). This stabilization of mutant CITFA2 by the wild-type protein suggests some
degree of CITFA2 interaction in the absence of LC8. This finding is consistent with the
demonstrated function of LC8 in structuring and stabilizing dimers of the human dynein
intermediate chain (Nyarko et al., 2004; Williams et al., 2007); reviewed in (Barbar, 2008; Barbar
and Nyarko, 2014), the Drosophila RNA-binding protein swallow (Kidane et al., 2013; Wang et
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al., 2004), the human motor protein myosin Va (Hodi et al., 2006; Wagner et al., 2006), and the
yeast nucleoporin Nup159 (Nyarko et al., 2013; Stelter et al., 2007).
Given that some of LC8’s non-dynein binding partners, such as the human transcriptional
repressor TRPS1 (Kaiser et al., 2003), estrogen receptor (Rayala et al., 2005; Rayala et al., 2006),
and the NF-κB inhibitor IκBα (Jung et al., 2008) are involved in transcriptional regulation, and
since proper B cell maturation was recently demonstrated to directly depend on the DYNLL1
expression level (Jurado et al., 2012), it is worth considering if LC8 might be regulating
multifunctional RNA pol I transcription in T. brucei. In accordance with this notion, our results
indicated that depletion of CITFA2 (Figure II-5C) or LC8 (Figure II-6) affected CITFA3
occupancy of the BES promoter more than that of the RRNA promoter, indicating that LC8 may
have a specific role in BES transcription. However, CITFA2 was shown in vitro and in vivo to be
essential for RNA pol I transcription initiating at RRNA, procyclin gene and BES promoters
(Brandenburg et al., 2007). In addition, the LC8 binding site within CITFA2 is at least partially
conserved among all kinetoplastids (Figure II-2D), including those which do not display antigenic
variation and are not known to utilize RNA pol I for pre-mRNA synthesis, suggesting that if LC8
does have a regulatory role for RNA pol I transcription, it is likely a general one. Nevertheless, the
CITFA2-LC8 heterotetramer appears to have a crucial role in activating the CITFA complex. As
previously determined, CITFA2 in BFs is expressed at about a fivefold lower level than CITFA7,
indicating that the majority of CITFA complexes in a trypanosome are inactive, requiring binding
of the CITFA2-LC8 heterotetramer for activation (Brandenburg et al., 2007; Nguyen et al., 2012).
Thus, it is possible that formation of a productive CITFA2-LC8 heterotetramer is quantitatively
controlled in the cell. It has been shown in other systems that phosphorylation of either LC8 or its
binding partner can alter their interaction, ranging from minor changes in kinetics to a complete
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elimination of binding (Benison et al., 2009; Gallego et al., 2013; Lei and Davis, 2003; Song et
al., 2008; Song et al., 2007). This regulatory phosphorylation occurs at S88 in human LC8, which
is conserved as S89 in the genus Trypanosoma (Figure II-S1B), allowing for such a regulation to
exist. Furthermore, phosphorylation of CITFA2 at amino acid T6, one of the conserved residues
in the LC8 binding motif, could also be used as a means to block LC8 binding, as is the case in
Nek9, a kinase involved in mitotic progression (Gallego et al., 2013).
Moreover, recent evidence suggests that CITFA is directly involved in the regulation of
monoallelic VSG expression, which takes place outside the nucleolus in the so-called expression
site body or ESB (Chaves et al., 1999; Navarro and Gull, 2001). ChIP assays consistently
demonstrated that CITFA occupancy of the active BES promoter was several times higher than
that of a silent BES promoter (Nguyen et al., 2014). Furthermore, the CITFA complex remained
localized to the nucleolus and the ESB after depletion of CITFA1, which caused CITFA to
dissociate from RRNA and BES promoters (Park et al., 2014). These results raised the possibility
that sequestration of CITFA to the nucleolus and the ESB may be the trypanosomes’ means to
restrict productive RNA pol I transcription to these compartments (Günzl et al., 2015). Since LC8
has been implicated in sub-nuclear and sub-cellular localization of many of its binding partners
(Barbar and Nyarko, 2014), sequestration or spatially controlled formation of CITFA2-LC8 may
be a mechanism for localizing CITFA function.
Although, an initial survey of CITFA sequences did not reveal a clear LC8 binding motif as
originally defined in humans and yeast (Lo et al., 2001), the reasonable conservation of the LC8
binding site within CITFA2 to the now more broadly defined consensus motifs (Rapali et al.,
2011a; Rapali et al., 2011b) suggests that it may be possible to bioinformatically identify other
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kinetoplastid proteins that interact with LC8, shedding light onto additional roles of LC8 in this
divergent group of organisms.
Furthermore, our results add T. brucei to the list of pathogens that rely on LC8 for viability.
LC8 silencing caused defects in both transcription and cytokinesis, and resulted in an extremely
rapid death phenotype of cultured BF T. brucei that is rarely observed in this system. Although, to
our knowledge, small molecule inhibition of LC8-ligand interactions have not been pursued so far,
this may be a worthwhile anti-pathogenic strategy since LC8 knockdown in adult animals appears
to not be lethal (Wang et al., 2014).
In summary, this work is the first investigation of LC8 in any kinetoplastid organism, and
reveals a novel use of LC8 in the basal process of transcription initiation by RNA pol I. It confirms
the results from studies in other organisms regarding LC8’s binding motif and its role in protein
dimerization, demonstrating that this function of LC8 is of ancient evolutionary origin.
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II-5. Supplemental

Table II-S1. Accession numbers of kinetoplastid CITFA2 genes
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Figure II-S1. Kinetoplastids harbor two distinct, conserved LC8 genes. (A) Clustal Omega
alignment of amino acid sequences (Sievers et al., 2011) deduced from TbLC8 (accession number
Tb927.11.18680) and TbLC8dv (Tb927.11.320) coding regions. Identical and similar positions are
indicated by asterisks and colons, respectively. Arginines and lysines, marking trypsin cleavage
sites, are highlighted in green. The short common trypsin-derived peptide is marked by red Xs. (B)
Multiple sequence alignment, carried out with the Clustal Omega server of the European
Bioinformatics Institute (http://www.ebi.ac.uk/Tools/services/web/toolform.ebi?tool=clustalo) at
default parameters, comprising DYNLL1 amino acid sequences from Homo sapiens (HsDYNLL1,
accession number NP_001032584), Mus musculus (MmDYNLL1, NP_001001185), Gallus gallus
(GgDYNLL1, XP_003642263), Xenopus tropicalis (XtDYNLL1, NP_001005077) and Danio
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(Figure II-S1 legend cont.) rerio (DrDYNLL1, NP_998189), of DYNLL2 from the same
organisms (HsDYNLL2, NP_542408; MmDYNLL2, NP_080832; GgDYNLL2, XP_004946822;
XtDYNLL2, NP_001165079; DrDYNLL2, NP_956393), LC8 sequences from Drosophila
melanogaster (DmLC8, NP_525075), Caenorhabditis elegans (CeDLC-1, NP_498422),
Schizosaccharomyces pombe (SpDLC2, NP_594368), Arabidopsis thaliana (AtLC8, CAB46031)
and from the kinetoplastids T. brucei (TbLC8), Trypanosoma vivax (TvLC8, TvY486_1100540 &
TvY486_1100570), Trypanosoma cruzi (TcLC8, TCDM_13942), Leishmania major (LmLC8,
LmjF.32.0230), Crithidia fasciculata (CfLC8, CfaC1_32_0390) and Bodo saltans (BsLC8,
BS21670.1..pep & BS74770.1..pep), and divergent LC8 sequences from the same kinetoplastid
organisms (TbLC8dv; TvLC8dv, TvY486_0034050; TcLC8dv, TcCLB.504109.24; LmLC8dv,
LmjF.25.0260; CfLC8dv, CfaC1_28_0460; BsLC8dv, BS22550.1..pep). Positions with more than
50% identity or similarity are highlighted in black or gray, respectively. (C) Phylogenetic Tree of
the shown sequence alignment using the BIONJ neighbor-joining algorithm (Gascuel, 1997) with
the Seaview version 4 software package (Gouy et al., 2010). Bootstrapping was performed with
1000 replicates with values representing percentages.
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Figure II-S2. LC8 silencing results in an increase in both cell size and DNA content. Ungated
count data from one of three replicate experiments comparing non-induced (left) to 1 day induced
(right) LC8 knockdown cells. The y-axis represents the per-cell DNA content, as measured by
propidium iodide staining, while the x-axis represents the forward scatter area, or size, of the cells.
Note the appearance of a third population of cells in the induced culture which exhibits an increase
in both size and DNA content. Blue represents areas of low count density, while green, yellow,
and red represent increasing densities of cells with a given value.
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Chapter III
A new strategy of RNA interference that targets heterologous
sequences reveals CITFA1 as an essential component of class I
transcription factor A in Trypanosoma brucei

Abstract
Conditional gene silencing by RNA interference in Trypanosoma brucei can be inconclusive
if knockdowns are inefficient or have off-target effects. To enable efficient, specific silencing of
single copy genes in mammalian-infective, bloodstream form trypanosomes, we developed a
system that targets the heterologous and functional Trypanosoma cruzi U2AF35 3/ UTR (Tc3) or,
alternatively, the sequence of the PTP tag which can be fused to any mRNA of interest. Two cell
lines were created, single marker (sm)Tc3 and smPTP, which conditionally express Tc3 and PTP
dsRNA, respectively. The system depends on manipulating both alleles of the gene of interest such
that cells exclusively express the target mRNA as a fusion to one of these heterologous sequences.
We have generated allele integration vectors in which the C-terminal part of a gene’s coding
sequence can be fused to either heterologous sequence in a single cloning step. We first tested this
system with CITFA7 which encodes a well-characterized subunit of the class I transcription factor
A (CITFA), an essential factor for transcription initiation by RNA polymerase I. Targeting either
Tc3 or PTP fused to the CITFA7 mRNA resulted in gene knockdowns that were as efficient and
specific as targeting the endogenous CITFA7 mRNA. Moreover, application of this system to
CITFA1, which could not be silenced by established methods, demonstrated that this gene encodes
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an essential CITFA subunit that mediates binding of the transcription factor complex to RNA
polymerase I promoters.

III-1. Introduction
Among kinetoplastid organisms, the tsetse borne, lethal human parasite Trypanosoma brucei
allows for specific gene silencing through the RNA interference (RNAi) pathway (Kolev et al.,
2011; Ngo et al., 1998). This system is based on strong, conditional expression of a ~500 bp-long
double-stranded (ds)RNA that targets a gene’s mRNA, and is available for both the insect-stage
procyclic form (PF) and the mammalian-infective bloodstream form (BF) of the parasite (Wirtz et
al., 1999). Given that direct transfection of dsRNA into cells is transient in nature and does not
reach all cells in a sample (Ngo et al., 1998), conditional dsRNA expression from genomeintegrated vectors is the system of choice for gene silencing experiments in trypanosomes. The
first step in developing such a system was the generation of trypanosomes expressing the bacterial
tetracycline (Tet) repressor (TetR) that controlled tetracycline-inducible promoters (Wirtz and
Clayton, 1995). Reproducible, tightly regulated Tet-inducible expression was originally
established in trypanosomes that express the heterologous T7 RNA polymerase (pol) as well as
TetR by a mutated T7 promoter (Wirtz et al., 1999). Two T. brucei brucei 427 cell lines were
generated that have been widely used for RNAi experiments: the PF cell line 29-13 harboring the
selectable NEO and HYG genes, which encode neomycin and hygromycin phosphotransferase,
respectively, and the “single marker” (NEO) BF cell line (Wirtz et al., 1999).
Several genome-integration vectors have been generated for Tet-inducible expression of genespecific dsRNA in T. brucei. The simplest vector type has opposing T7 promoters. Since gene

68

fragments can be cloned between the promoters in a single step, this type of vector, termed p2T7
(LaCount et al., 2000) or pZJM (Wang et al., 2000), enabled the generation of RNAi libraries and
a first successful forward genetic RNAi screen (Morris et al., 2002). However, the T7 promoters
of these vectors, which are each regulated by a single TetR binding site, the Tet operator, were
partially active even in the absence of tetracycline (Wang et al., 2000; Wirtz et al., 1999), which
could be lethal to transformed trypanosomes in some cases. A more tightly regulated vector has
been the stem-loop vector in which a target sequence is cloned in sense and antisense directions
around a stuffer fragment (Bastin et al., 2000; Shi et al., 2000). In the original vector, the stemloop cassette is expressed from the strong EP1 procyclin gene promoter under the control of two
Tet operators (Wirtz et al., 1999). Although it takes two to three cloning steps to produce a genespecific stem-loop construct, the tight regulation of its expression proved to be very useful in PFs
(Tschudi et al., 2003). Procyclin is the major cell surface antigen of PFs and procyclin genes are
highly expressed by virtue of a multifunctional RNA pol I which is recruited to the procyclin gene
promoter (Günzl et al., 2003). However, since procyclin is not expressed in BFs and the procyclin
promoter is several-fold less active in this life cycle stage (Biebinger et al., 1996), replacement of
the procyclin promoter by a T7 promoter made the “pT7-stl” stem-loop construct more suitable
for gene knockdowns in BFs; two Tet operators appear to be sufficient to minimize leakiness from
the strong T7 promoter (Brandenburg et al., 2007). Recently established vectors that made
conditional transgene expression in trypanosomes independent of T7 RNA pol revealed effective
gene knockdowns in PFs (Sunter et al., 2012). Other vector improvements simplified the cloning
procedure. The pQuadra system is based on a four component ligation assay and allows the
generation of a stem-loop vector in a single cloning step (Inoue et al., 2005) whereas other
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strategies made both dual T7 promoter and stem-loop construction compatible with the
recombination-based Gateway® cloning system (Kalidas et al., 2011; Lacomble et al., 2009).
In addition to different vector designs, the conditional gene silencing system in T. brucei has
benefitted from several modifications. Since high T7 RNA polymerase levels appear to be toxic
for trypanosomes, putting the expression of this enzyme under tetracycline control enhanced the
success rate in obtaining PF cell lines that exhibited an inducible phenotype (Alibu et al., 2005).
However, this modification did not generally improve the functionality of p2T7 constructs.
Historically, the preferred genome integration site of inducible vectors has been the
transcriptionally silent spacer of ribosomal RNA gene (RRNA) arrays. It appears that not all RRNA
loci provide equal conditions for regulated dsRNA expression and, thus, a standard procedure has
been to test several clonal cell lines to find the cells with the best knockdown efficiency. To avoid
this position effect, Alsford et al. marked a specific RRNA locus such that vectors could be
specifically and reproducibly targeted to this particular RRNA spacer, thereby reducing the
variability of gene silencing experiments (Alsford et al., 2005). In an independent approach,
Wickstead et al. found that targeting the p2T7 vector “p2T7-177” to a 177 bp-long,
transcriptionally silent repeat region of trypanosome minichromosomes improved regulation of
the T7 promoters (Wickstead et al., 2002). Nevertheless, despite these modifications and
improvements, the RNAi-mediated gene knockdowns have remained inefficient in some cases.
Furthermore, due to the need to express rather long dsRNA molecules, it is possible that siRNAs
are produced that affect trypanosome proliferation by targeting the wrong RNA, causing a socalled off-target effect.
We have been using conditional gene silencing to characterize the T. brucei class I transcription
factor A (CITFA) complex, which is indispensable for the multifunctional RNA pol I system in T.
70

brucei. This parasite uses RNA pol I to transcribe the RRNA array, as in all other eukaryotes, yet
also employs it to express its major cell surface proteins - procyclins in PFs and variant surface
glycoprotein (VSG) in BFs (Brandenburg et al., 2007; Nguyen et al., 2014; Nguyen et al., 2012).
The latter is expressed from a single VSG gene, drawn from a large repertoire, in one of fifteen 4060 kb-long BF telomeric expression sites (BESs) (Hertz-Fowler et al., 2008). While trypanosome
RRNA transcription is localized to the nucleolus, as in other eukaryotes, the active BES is
transcribed outside this compartment (Chaves et al., 1998) in the DNase I-resistant expression site
body, or ESB (Navarro and Gull, 2001). CITFA consists of the subunits CITFA1 to 7, which are
conserved only among kinetoplastid organisms, and the dynein light chain DYNLL1 (also known
as LC8). Data obtained thus far strongly indicate that CITFA is a promoter-binding transcription
initiation factor: CITFA stably bound the BES promoter in gel shift assays and required both
promoter elements for efficient binding, depletion or inhibition of CITFA resulted in a loss of
transcription within 121-146 bp of the transcription initiation site, CITFA7 silencing strongly
reduced promoter-proximal RNA pol I occupancy at RRNA repeats, and a genome-wide ChIP-seq
analysis found CITFA7 occupancy within a BES to be restricted to the promoter region
(Brandenburg et al., 2007; Nguyen et al., 2014; Nguyen et al., 2012). To analyze specific functions
of individual subunits we have attempted to silence the expression of each subunit gene. Our
previous results demonstrated that CITFA2 and CITFA7 are essential for RNA pol I transcription
and trypanosome viability (Brandenburg et al., 2007; Nguyen et al., 2012). We also found that
three of the eight subunits are required to maintain the integrity of the complex (TN Nguyen and
A Günzl, unpublished results). However, we have been unable to generate an unambiguous
CITFA1 knockdown. Although we targeted two different regions of the CITFA1 mRNA, the RNA
levels were not significantly affected (data not shown). To circumvent this setback, we set out to
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develop a generally applicable system in BFs for efficient and specific gene knockdowns that
targets a heterologous sequence fused to the mRNA of interest. We herein demonstrate that the 3/
gene flank of the Trypanosoma cruzi U2AF35 gene (here abbreviated as Tc3) is functional in T.
brucei, and that Tc3 can be specifically targeted when fused to a T. brucei mRNA. In addition, we
show that the sequence of the composite PTP tag, consisting of a protein C epitope (ProtC), a TEV
protease cleavage site, and tandem protein A domains (ProtA), is an equally good target for gene
silencing. Employing this system, we were able to demonstrate that CITFA1 is an indispensable
component of the CITFA complex and that it is required for CITFA to bind to the RRNA and BES
promoters.

III-2. Methods and Materials
DNAs. pT7-CITFA7-stl (Nguyen et al., 2012) and pCITFA7-PTP-BLA (Nguyen et al., 2014) were
described previously. For the generation of pT7-Tc3-stl, the entire 679 bp-long 3/ intergenic region
of the T. cruzi U2AF35 gene (accession number TcCLB.510943.60; note that this gene has been
annotated as U2AF26 instead of U2AF35), from position 703 to position 1,381 relative to the
translation initiation codon, was amplified from T. cruzi genomic DNA and inserted into the pT7stl vector (Brandenburg et al., 2007) in a sense-stuffer-antisense arrangement according to a
published protocol (Shi et al., 2000). A T924>C point mutation was introduced to remove an XbaI
restriction site which would have interfered with the stem-loop cloning strategy. pT7-PTP-stl was
generated analogously using the entire PTP coding sequence (498 bp) (Schimanski et al., 2005a).
The cloning strategy required the removal of two MluI restriction sites which was achieved by
introducing T153>C and T327>C point mutations.
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The tagging vector pCITFA7-HA-Tc3-BLA (Figure III-S1) has two cassettes, a C-terminal
tagging module and a selectable marker cassette. It is a direct derivative of pCITFA7-HA-BLA
(Nguyen et al., 2012) and was obtained by replacing the T. brucei RPA1 3/ gene flank with Tc3
using the vector’s XhoI and ClaI restriction sites. Furthermore, our tagging vectors are derived
from pBluescript II SK+ which has a T7 promoter that, after integration into an endogenous allele,
could lead to overexpression of downstream genes in T7 RNA polymerase-expressing sm BF and
29-13 PF cells. We therefore removed 27 bp from pCITFA7-HA-Tc3-BLA beginning precisely at
the T7 promoter and ending in the downstream KpnI restriction site. In the same way, we removed
the T7 promoter from pCITFA7-PTP-BLA and termed the corresponding plasmid pCITFA7-PTPBLAv2 (Figure III-S2). pCITFA1-HA-Tc3-BLA was obtained from pCITFA7-HA-Tc3-BLA by
replacing the CITFA7 sequence with 696 bp of the C-terminal CITFA1 coding region (position
700 to position 1395) using the ApaI and NotI restriction sites.
The following DNA oligonucleotides were used in semi-quantitative RT-PCR: 5/CCTACGGTGCAGCCATGCCGTTGG-3/ / 5/-TTCGGCACTGCCATATGCGAC-3/ (CITFA7
coding

sequence);

5/-CAATAACAGGAACAGCTGCACCAAG-3/

/

5/ -

GAGGAAACTCAAGTGCATTG-3/ (Tc3); 5/-GTAGACAACAAATTCAACAAAG-3/ / 5/ATTTAGCTTTTTAGCTTCTGC-3/ (PTP). Oligonucleotides for VSG221, TFIIB and CITFA2
amplification were previously described (Nguyen et al., 2012). Quantitative RT-PCR of CITFA1
mRNA

was

carried

out

either

with

oligonucleotide

pair

5 /-

ATCGGATGTTGAGTCGCTGCGTTG G-3/ / 5/-AAAGTCATTCCATGCCACTGGAACC-3/
(CITFA1 coding sequence) or pair 5/-AATACGCCAG GCAGATTGATGC-3/ / 5/TTAAGCGTAGTCAGGTACGTCGTAAGG -3/ (CITFA7 coding / HS). BES and RRNA
promoter consensus oligonucleotides and oligonucleotides specific to the TFIIB gene and the β73

/α- tubulin intergenic region, used in qPCR, were previously specified (Nguyen et al., 2012; Park
et al., 2011).
Cells. BFs were cultured in HMI-9 medium as specified previously (Park et al., 2011).
Transfections were done with 1-2 x 107 BF trypanosomes using the Amaxa Basic Parasite
Nucleofector kit (Lonza). Specifically, trypanosomes were pelleted at room temperature at 1,500
x g for 5 min and cell pellets were resuspended in 100 µl of Solution 1 containing 18% Supplement
1. After mixing DNA (5 µg PCR product or 10 µg of plasmid DNA) into the resuspension,
trypanosomes were electroporated using program X-001 on the Nucleofector 2b unit (Lonza). 500
µl of pre-warmed HMI-9 medium was added immediately to the transfected cells which were then
transferred to 50 ml of ~37°C warm medium. After allowing the cells to recover for 15 min at
37°C, the cell culture was distributed into two 24-well plates. Trypanosomes were cultivated
without antibiotic selection overnight after which additional medium containing selecting
antibiotics was added to each well. Transfectants typically reached a transferrable cell density six
to nine days later. Cells were cultured in 2.5 µg/ml G418, 1 µg/ml phleomycin and/or 2 µg/ml
blasticidin.
Cell lines C7HA-Tb3 and C7HA-Tc3 were obtained by transfecting wild-type BF 427 cells
with PshAI-linearized plasmids CITFA7-HA-BLA and CITFA7-HA-Tc3-BLA, respectively. The
basal BF cell lines for conditional expression of Tc3 or PTP dsRNA, smTc3 and smPTP, were
obtained by transfecting sm cells with the EcoRV-linearized vectors pT7-Tc3-stl and pT7-PTPstl, respectively. These vectors were targeted to the transcriptionally silent RRNA spacer.
smC7HA-Tc3 and smC7-PTP cell lines were generated by targeted integration of PshAI-linearized
plasmids CITFA7-HA-Tc3-BLA and CITFA7-PTP-BLAv2, respectively, into the CITFA7 locus
in the first step and by replacing in the second step the remaining CITFA7 wild-type allele with a
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PCR product in which 100 bp of CITFA7 gene flanks surrounded the hygromycin
phosphotransferase coding sequence. Cell line smC1HA-Tc3 was obtained analogously using the
MfeI-linearized plasmid CITFA1-HA-Tc3-BLA. Correct DNA integrations were analyzed by
PCR of genomic DNA with at least one oligonucleotide placed outside the cloned or amplified
sequence (data not shown).
For gene silencing experiments, dsRNA synthesis was induced with doxycycline, a more stable
derivative of tetracycline, at 2 µg/ml. Cells were counted and diluted to 2 x 105 cells/ml daily.
Antibodies and protein analysis. For the sedimentation analysis, extract was prepared from
non-induced BFs and from CITFA1-silenced BFs as specified previously (Park et al., 2011). 100
µl of extract was then loaded onto 4 ml 10-40% linear sucrose gradients, ultra-centrifuged and
fractionated exactly as has been described (Brandenburg et al., 2007). Immunoblots of HA- and
PTP-tagged proteins were probed with a rat monoclonal anti-HA antibody (Roche) and the mouse
monoclonal anti-ProtC antibody HPC4 (Roche), respectively. Immune sera against CITFA7,
TFIIB and U2A/ (also known as U2-40K) were described previously (Cross et al., 1993; Nguyen
et al., 2012; Schimanski et al., 2006). To obtain recombinant CITFA3 for antibody production, the
entire CITFA3 coding region was placed downstream of the glutathione S-transferase sequence in
pGEX-4T-2 vector (GE Healthcare). Recombinant GST-CITFA3 was expressed in Escherichia
coli strain BL21Star (DE3) and purified by glutathione affinity chromatography (GE Healthcare)
following the manufacturer’s recommendations. Generation of anti-CITFA3 immune serum was
achieved by immunization of female Sprague Dawley rats with purified GST-CITFA3 as detailed
previously (Schimanski et al., 2006). Polyclonal anti-GST-CITFA3 antibodies were purified from
rat immune serum through first pre-clearing the serum of antibodies that non-specifically interact
with trypanosome proteins. This was done by separating whole cell lysates of a total of 4.5 x 10 8
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wild-type PF trypanosomes in nine lanes on a 12% SDS-polyacrylamide gel. The gel was
transferred to a PVDF membrane and blocked in Tris-buffered saline (TBS), pH 7.5, containing
5% milk and 0.1% Tween20, for 2 hours. After washing twice in TBS the 50-55 kDa range of the
membrane which contained CITFA3 was removed and the remaining membrane was incubated
with 1 ml of antiserum and 9 ml of blocking solution at 4°C for 16 hours. 100 µg of recombinant
GST-CITFA3 was then run on four different SDS-PAGE gels, which were then transferred and
blocked as described above. The 70-80 kDa range of these four membranes, corresponding to size
of GST-CITFA3, was excised, cut into small strips, and incubated with the pre-cleared antiserum
and blocking solution mixture for 16 hours, at 4°C, with rotation. These membrane strips were
washed three times with TBS, and then rinsed briefly one time with water. Antibodies were eluted
by incubating the strips in 1 ml of 0.2 M glycine, pH 2.8, for 5 min. Eluted antibodies were then
immediately quenched by adding 1 M Tris-HCl, pH 8.0, until the solution pH reached 7.5, after
which bovine serum albumin was added to a final concentration of 1%. The purified antibody was
aliquoted and stored at -20°C until use.
RNA analysis. Total RNA was prepared by the hot phenol method as described previously
(Nguyen et al., 2007). For the analysis of ribosomal (r)RNA, total RNA was separated in Reliant
pre-cast 1.25% SeaKem Gold agarose RNA gels (Lonza), and rRNA was detected by ethidium
bromide staining. Relative amounts of SL RNA and U2 snRNA were determined by primer
extension of 10 µg of total RNA using the 5/-32P-end-labeled oligonucleotides SL-1394 and U2f
(Günzl et al., 1992) and Superscript reverse transcriptase II (Invitrogen) according to the
manufacturer’s specifications. Primer extension products were separated on denaturing 8%
polyacrylamide-50 % urea gels and detected by autoradiography. For PCR analyses, total RNA
was reverse transcribed with Superscript reverse transcriptase II and either oligonucleotide-dT or
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random hexanucleotides (Roche). Semi-quantitative PCR was performed using cycle numbers
which were empirically determined to be within the linear amplification range for each
oligonucleotide pair. Oligonucleotide pairs used in qPCR were verified for their specificity and
suitability by standard agarose gel electrophoresis. Additionally, for every round of qPCR
reactions a melt curve analysis was included to ensure the amplification of only a single product,
and linear regression analysis of a serial dilution of input material confirmed that the coefficient
of determination (r2) was within the 0.98 to 1.0 range.
Immunoﬂuorescence microscopy. BF microscopy was carried out as published previously
(Nguyen et al., 2012) except that coverslips with settled BF cells were incubated with a 1:100
dilution of the affinity-purified, polyclonal rat anti-CITFA3 antibody, and were then, after
washing, incubated with the 1:500 diluted anti-rat IgG antibody Alexa 488 (Invitrogen) and 4,6diamidino-2-phenylindol (DAPI) at a final concentration of 2 ng/µl. Imaging was performed using
a Zeiss AxioVert 200 microscope and Zeiss Axiovision 4.6.3.0 software. CITFA3 localizations
were captured using a FITC filter and a fixed exposure time of 6 s, while DAPI images were
captured using a DAPI filter and a variable exposure time, which averaged 0.5 s.
Chromatin immunoprecipitation (ChIP). Anti-CITFA3 ChIP assays, using the purified
polyclonal anti-CITFA3 antibody, were performed with smC1HA-Tc3 cells that were either not
induced or induced by doxycyline for 42 hour as recently described (Nguyen et al., 2014). In
negative controls, chromatin was immunoprecipitated with a non-specific rat immune serum. The
precipitated DNA was analyzed by qPCR using consensus oligonucleotides for the slightly varying
copies of RRNA and BES promoters and an oligonucleotide pair specific for the β-/α- tubulin
intergenic region. The percent immunoprecipitation (IP) was calculated relative to the input
material and corrected by subtracting the percent IP of the negative control assays.
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III-3. Results
System outline. Our aim was to generate a system in which the same heterologous sequence can
be functionally fused to any mRNA and provide a target for efficient and reproducible gene
knockdown. In a first step, we would generate a single marker (sm) BF cell line that conditionally
expresses dsRNA of a heterologous sequence (HS) without consequence on cell proliferation
(Figure III-1). This smHS cell line would carry NEO used to generate sm cells (Wirtz et al., 1999)
and the bleomycin resistance marker (BLE) as part of the stem-loop vector for conditional HS
dsRNA expression. For a specific gene knockdown, the smHS cell line would be used in two
consecutive transfections to enable specific knockdown of any single copy gene of interest,
denoted here as gene X. In the first transfection, site-specific integration of a PCR amplification
product of the hygromycin phosphotransferase coding region (HYG) surrounded by 5/ and 3/ flanks
of gene X would lead to the knockout of one wild-type X allele while, in the consecutive
transfection, targeted integration of plasmid X-HS-BLA (BLA stands for the selectable marker
gene blasticidin-S deaminase) into the X locus would fuse the HS to gene X. The corresponding
smX-HS cell line would exclusively express the X-HS fusion that can be targeted by doxycyclinemediated induction of HS dsRNA synthesis (Figure III-1).
The Trypanosoma cruzi U2AF35 3/ gene flank is functional in T. brucei. We speculated that a
Trypanosoma cruzi 3/ gene flank could provide a HS in the form of a functional 3/ UTR because
all trypanosomatids process their mRNAs by spliced leader (SL) trans splicing and
polyadenylation (Günzl, 2010), making it likely that a T. cruzi gene flank is able to direct these
RNA processing steps in T. brucei. At the same time, the T. cruzi intergenic sequences are
divergent from their T. brucei counterparts and are unlikely to give rise to siRNAs that target
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Figure III-1. Gene silencing system targeting a heterologous sequence (HS). The system is based
on a single marker BF cell line that has been stably transfected with a stem-loop construct (sm-HS
cell line) containing a doxycyline (dox)-inducible promoter for the expression of a heterologous
dsRNA. In the absence of further genetic manipulations, induction of this dsRNA expression has
no consequence on trypanosome proliferation. To enable a specific knockdown of any single copy
gene X, two further consecutive transfections of smHS cells are necessary: one to eliminate an X
allele by the hygromycin resistance marker (HYG), and one to integrate a plasmid into the
remaining X allele which will fuse the HS to the X mRNA sequence. Doxycycline-induced (+ dox)
expression of HS dsRNA will then target and destroy the X-HS mRNA hybrid.
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T. brucei mRNAs. After comparing known T. cruzi 3/ UTRs (Brandao and Jiang, 2009) we chose
to analyze the suitability of the 3/ UTR of the TcU2AF35 mRNA because its complete cDNA had
been characterized, and the 3/ UTR length of 390 nt appeared to be sufficiently large for an efficient
gene knockdown (Vazquez et al., 2003). Moreover, the complete intergenic region between
TcU2AF35 (accession number TcCLB.510943.60, www.genedb.org) and its downstream neighbor
TcCLB.510943.50, encoding putative delta-1-pyrroline-5-carboxylate dehydrogenase, is only 679
bp long and should harbor all necessary RNA processing signals. Finally, U2AF35 encodes an
essential RNA splicing factor that, in trypanosomes, is involved in the initial steps of the ubiquitous
SL trans splicing process (Vazquez et al., 2009), which suggested that the TcU2AF35 3/ UTR
could support a sufficient level of constitutive gene expression.
We first tested the functionality of the TcU2AF35 3/ gene flank (Tc3) in T. brucei with the
well-characterized CITFA7 gene. CITFA7 is an essential subunit of the CITFA complex and
CITFA7 silencing in BFs led to clear defects in RNA pol I transcription, e.g. a decrease of the
RNA pol I transcripts rRNA and VSG221 mRNA of the active VSG gene (Nguyen et al., 2012).
Moreover, CITFA7 can be functionally tagged at the C-terminus and there is no haploinsufficiency effect after deleting one CITFA7 allele either in BFs or PFs (Nguyen et al., 2012).
We generated two cell lines by targeting the integration of a plasmid to the endogenous CITFA7
gene (Figure III-2A). In both cases, the HA tag sequence was fused 3/ to the CITFA7 coding
region followed by the T. brucei (Tb)RPA1 3/ gene flank in the C7HA-Tb3 cell line or by the Tc3
gene flank in the C7HA-Tc3 cell line. RPA1 is the largest subunit of RNA pol I. The TbRPA1 3/
gene flank is present in all our C-terminal tagging constructs and has supported the expression of
a variety of factors such that the knockout of the remaining wild-type allele did not cause haplo-
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Figure III-2. The 3/ gene flank and UTR of T. cruzi (Tc)U2AF35 are functional in T. brucei. (A)
Schematic outline (not to scale) of the CITFA7 locus in control cell line C7HA-Tb3 and in cell
line C7HA-Tc3. In both cell lines the HA tag sequence was fused to the CITFA7 coding region by
targeted integration of the specified, linearized plasmid into one CITFA7 allele. The difference is
that in C7HA-Tb3 and C7HA-Tc3 cells the manipulated CITFA7 allele is under the control of the
T. brucei RPA1 (green) and the heterologous TcU2AF35 (red) 3/ gene flanks, respectively. The
CITFA7 coding region, and the HA tag and BLA sequences are indicated by open, blue and black
boxes, respectively. The smaller gray boxes surrounding BLA represent T. brucei gene flanks
providing RNA processing signals. (B) Immunoblot of C7HA-Tb3 and C7HA-Tc3 whole cell
lysates detecting CITFA7-HA with a monoclonal anti-HA antibody and, as a loading control, the
transcription factor TFIIB with an anti-TFIIB polyclonal immune serum. Note that, due to
phosphorylation, CITFA7 separates in multiple bands.
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insufficiency phenotypes (Schimanski et al., 2005a). Accordingly, CITFA7-HA was easily
detectable in C7HA-Tb3 cell lysates in multiple bands (Figure III-2B) that represent the various
[un]phosphorylated forms of CITFA7 (Nguyen et al., 2012). In C7HA-Tc3 cells, Tc3 supported
78% of the CITFA7-HA expression observed in C7HA-Tb3 cells (Figure III-2B). These results
showed that, in T. brucei, the heterologous Tc3 sequence directed the processing of functional
CITFA7-HA mRNA and the corresponding 3/ UTR supported an adequate level of CITFA7
expression.
Expression of Tc3 dsRNA does not affect BF trypanosome proliferation. Comparing the Tc3
sequence to the T. brucei brucei Lister 427 genome returned a single, siRNA-sized stretch of
identical sequence (27 bp) downstream of the non-syntenic gene Tb427.10.1000. Since this
sequence motif was found only in a fraction of the heterogenous Tb427.10.1000 3/ UTRs
(www.tritrypdb.org), we anticipated Tc3 dsRNA not to give rise to deleterious siRNAs. To test
this, we inserted a stem-loop construct of the Tc3 sequence into the pT7-stl vector that has a
tetracycline-inducible T7 promoter (Brandenburg et al., 2007). The vector, targeted to the
ribosomal spacer, was transfected into BF sm cells which express both the tetracycline repressor
and T7 RNA polymerase (Wirtz et al., 1999). Immediately after transfection, cells were cloned by
limiting dilution. Three of the resulting cell lines were evaluated for their knockdown competence
by transfecting them with the CITFA7-HA-Tc3-BLA construct and monitoring knockdown
efficiencies on the RNA and protein levels (see below, and data not shown). Based on these results,
one of the parent cell lines, termed smTc3, was chosen for all further experiments. As shown in
Figure III-3A, induction of Tc3 dsRNA synthesis by doxycycline did not affect proliferation of
smTc3 cells in culture, suggesting that no deleterious off-target effects occurred.
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Figure III-3. Proliferation of smTc3 and smPTP cells is not affected by heterologous dsRNA
expression. The smTc3 (A) and smPTP (B) cell lines are single marker BF cell lines in which
stem-loop constructs were integrated into the RRNA spacer for inducible expression of Tc3 and
PTP dsRNA, respectively. Addition of doxycycline to the medium did not inhibit cell proliferation
in either cell line while it induced strong expression of Tc3 or PTP RNA, as analyzed by semiquantitative PCR of random hexamer-derived cDNA (inserts).
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Generation of an alternative smPTP cell line. At this point, we considered testing a second
heterologous sequence in parallel. We decided on the large PTP tag because we have utilized it
repeatedly for tandem affinity purification (Schimanski et al., 2005a), indirect fluorescence
microscopy (Park et al., 2011), and chromatin immunoprecipitation experiments (Lee et al., 2010;
Park et al., 2011). The composite, heterologous PTP tag, designed for a modified tandem affinity
purification approach (Schimanski et al., 2005a), comprises 166 amino acids and consists of
human-derived ProtC (Stearns et al., 1988), a tobacco etch virus-derived protease cleavage site,
and a tandem ProtA domain of Staphylococcus aureus (Rigaut et al., 1999). Importantly, the PTP
tagging strategy has been based on integration of a PTP plasmid into an endogenous allele as
shown in Figure III-1. Hence, we wanted to know whether the PTP tag sequence could be used
as a target for efficient gene knockdowns as well. A bioinformatic analysis could not detect any
sequence match longer than 18 bp between the PTP sequence and the T. brucei brucei 427 genome
(data not shown). Analogously to cell line smTc3, we generated clonal smPTP cell lines that
conditionally express PTP dsRNA. To pick the most efficient line for subsequent experiments, we
determined PTP dsRNA levels before and after doxycycline induction by reverse transcription of
total RNA using random hexamers and semi-quantitative PCR of the PTP sequence (Figure III3B and data not shown). Induction of PTP dsRNA by doxycycline in the chosen smPTP cell line
did not affect trypanosome proliferation, again indicating that this heterologous dsRNA does not
target vitally important endogenous T. brucei RNAs (Figure III-3B).
The Tc3 3/ UTR and the PTP sequence are efficient knockdown targets. To test whether
targeting either of the two HSs by RNAi leads to efficient gene knockdowns, we fused both of
these sequences to the CITFA7 gene. As depicted in Figure III-1, this required two consecutive
transfections of smTc3 and of smPTP cells so that they exclusively expressed CITFA7-HA mRNA
84

with the Tc3 3/ UTR and CITFA7-PTP mRNA, respectively. In the first transfection of smTc3
cells, we integrated plasmid CITFA7-HA-Tc3-BLA into one of the two CITFA7 alleles and, in the
second step, we eliminated the remaining CITFA7 allele by transfecting a PCR product (Arhin et
al., 2004) that comprised the hygromycin phosphotransferase coding region surrounded by 100
bp-long CITFA7 gene flanks (Figure III-4A). Three independently derived, clonal smC7HA-Tc3RNAi cell lines exhibited nearly identical growth defects upon induction of Tc3 dsRNA synthesis.
As shown for one representative line in Figure III-4B, addition of doxycyline stopped culture
growth after 24 hours and reduced the number of surviving trypanosomes within the next 48 hours.
Since a very similar growth curve was obtained previously when CITFA7 mRNA was targeted
directly in smC7 cells (Nguyen et al., 2012), this result suggested that targeting of the Tc3 3/ UTR
resulted in effective depletion of CITFA7.
Analogously to smC7HA-Tc3 cells, we generated the cell line smC7-PTP in which integration of
plasmid pCITFA7-PTP-BLA fused the PTP sequence to the CITFA7 coding region in one CITFA7
allele, and the hygromycin resistance marker replaced the remaining wild-type allele (Figure III4C). Again, inducing the synthesis of PTP dsRNA stopped proliferation of smC7-PTP cells after
one day and led to cell death thereafter (Figure III-4D). Semi-quantitative RT-PCR analyses
showed that CITFA7-HA, CITFA7-PTP and CITFA7 mRNA were strongly reduced after 1 day
of induction in smC7HA-Tc3, smC7-PTP and smC7 cells, respectively (Figure III-4E). This
reduction was observed despite the fact that the level of the control TFIIB mRNA increased in
each of these experiments. As we have shown previously, silencing of CITFA subunit genes
rapidly decreases the levels of RNA pol I transcripts in induced cells, including ribosomal RNA,
the most abundant component in total RNA preparations, which in turn leads to relative increases
of RNA pol II and III transcripts (Brandenburg et al., 2007; Nguyen et al., 2012). As anticipated
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Figure III-4. Effective and specific CITFA7 silencing by targeting heterologous sequences.
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(Figure III-4 legend cont.) (A) Schematic outline (not to scale) of the CITFA7 locus in
smC7HA-Tc3 cells. One CITFA7 allele was replaced by the hygromycin resistance marker
(HYG, yellow box) and the second CITFA7 allele modified by targeted integration of plasmid
CITFA7-HA-Tc3-BLA. Coloring of boxes corresponds to the description in the legend of Figure
2A. (B) Culture growth of a representative smC7HA-Tc3 cell line in the presence and absence of
doxycyline. (C) Schematic outline (not to scale) of smC7-PTP cells in which integration of
plasmid CITFA7-PTP-BLA fused the PTP sequence (cyan box) to the 3/ end of the CITFA7
coding region. (D) Corresponding growth curve of a representative smC7-PTP cell line. (E)
Semi-quantitative PCR analysis of oligo dT-primed and reverse transcribed CITFA7-HA,
CITFA7-PTP, and CITFA7 mRNA in non-induced (n.i.) and one day induced trypanosomes of
cell lines smC7HA-Tc3, smC7-PTP, and smC7, respectively. TFIIB mRNA was analyzed in
parallel as a control. (F) Relative abundances of ribosomal RNA (rRNA) and of VSG221 and
TFIIB mRNA were determined by ethidium bromide staining and semi-quantitative RT-PCR,
respectively, in smC7HA-Tc3 and smC7-PTP cells that were non-induced or induced for one and
two days. (G) Immunoblot detecting CITFA7-HA with an anti-HA antibody in smC7HA-Tc3
cell lysates, CITFA7-PTP with an anti-ProtC antibody in smC7-PTP cell lysates, and wild-type
CITFA7 with a polyclonal immune serum in smC7 cell lysates. Detection of TFIIB on the same
blots served as a loading control. Cells were analyzed in their non-induced (n.i.) state or when
they were grown in the presence of doxycycline for one and two days.
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from these previous results, targeting the HSs that were fused to the CITFA7 mRNA led to a
decrease of rRNA and of VSG221 mRNA from the active VSG gene (Figure III-4F). In addition,
immunoblotting showed that the gene knockdowns led to a rapid loss of CITFA7 protein (Figure
III-4G). Together, these results clearly demonstrated that the HS-targeted CITFA7 gene
knockdowns were specific and efficient, affecting the abundance of RNA pol I transcripts in the
same way as did silencing of CITFA7 by dsRNA of endogenous sequence, as previously shown
(Nguyen et al., 2012).
Tc3 3/ UTR mediated efficient CITFA1 silencing. Next, we applied this gene knockdown system
to the CITFA1 gene, which we had not been able to silence efficiently thus far. Again, two
consecutive transfections of smTc3 cells generated cell line smC1HA-Tc3 in which, after the
knockout of one CITFA1 allele, targeted integration of plasmid CITFA1-HA-Tc3-BLA fused the
HA sequence and the Tc3 gene flank to the remaining CITFA1 allele (Figure III-5A). In the
absence of doxycyline smC1HA-Tc3 cells proliferated as fast as smTc3 cells, indicating that the
Tc3 3/ UTR supported sufficient CITFA1 expression from a single allele and that the C-terminal
HA tag did not impair the functionality of CITFA1 (Figure III-5B). Adding doxycyline to the
medium was then similarly deleterious to trypanosome proliferation and viability as in the CITFA7
knockdown: Trypanosome proliferation was affected one day after induction and trypanosome
numbers started to decline after two days of induction (Figure III-5B). RT-qPCR analysis
revealed that the Tc3-targeted knockdown reduced CITFA1 mRNA abundance relative to that of
TFIIB mRNA by ~80% (Figure III-5C). Interestingly, we obtained slightly different results
depending on which part of the cDNA was amplified. With oligonucleotides specific for the
CITFA1 coding region, the reduction of CITFA1 mRNA was on average 77% whereas the
reduction with an HS88

Figure III-5. Effective and specific CITFA1 silencing by targeting the TcU2AF35 3/ UTR. (A)
Schematic outline (not to scale) of the CITFA1 locus in smC1HA-Tc3 cells. (B) Culture growth
of a representative smC1HA-Tc3 cell line in the presence and absence of doxycyline. (C) RTqPCR analysis of CITFA1 mRNA in non-induced (n.i.) and one day induced trypanosomes. The
oligo dT-derived cDNA was either amplified in the CITFA1 coding region (cod. region) or in the
heterologous TcU2AF35 3/ UTR (heterologous seq.). CITFA1 mRNA abundance was normalized
with that of TFIIB and its level in non-induced cells was set to 100 in each of three independent
experiments. (D) Relative RNA abundances in total RNA preparations of non-induced cells and
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(Figure III-5 legend cont.) of cells induced for 1, 2, or 3 days were analyzed by ethidium bromide
staining (rRNA), semi-quantitative RT-PCR (VSG221, TFIIB and CITFA2 mRNA), or a primer
extension assay (SL RNA, U2 snRNA).
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specific oligonucleotide was 83%. Although this difference seems not that dramatic, we would
like to point out that we have made similar observations with other gene knockdowns.
Amplification of different parts of the reverse-transcribed mRNA revealed different knockdown
efficiencies, with the targeted region typically resulting in the greatest reduction of mRNA
abundance (AG laboratory, unpublished results). Further RNA analysis showed that, as expected,
CITFA1 silencing decreased the abundance of the major RNA pol I transcripts rRNA and VSG221
mRNA and, consequently, elevated the relative abundances of RNA pol II-synthesized TFIIB
mRNA, CITFA2 mRNA and SL RNA, as well as that of the RNA pol III transcript U2 snRNA
(Figure III-5D). Together, these results demonstrated that CITFA1 was efficiently and specifically
silenced by targeting the Tc3 3/ UTR, identified CITFA1 as the third CITFA subunit that is
essential for trypanosome viability in culture, and indicated that CITFA1 has an essential function
in trypanosome RNA pol I transcription.
CITFA1 is required for binding of the transcription factor complex to RNA pol I promoters.
The analysis of specific functions of individual CITFA subunits has been hampered by the fact
that amino acid sequences of CITFA subunits have not revealed functional motifs such as DNA
binding domains. In addition, procedures intended to break up the complex into smaller functional
units have failed thus far (data not shown). However, we recently found that depletion of CITFA7
from cells resulted in the concomitant, rapid loss of other CITFA subunits within 2 days of CITFA7
silencing, indicating that CITFA7 has a scaffold function and that the stability of CITFA subunits
in trypanosomes depends on the integrity of the transcription factor complex (TN Nguyen and A
Günzl, unpublished results). An immunoblot analysis of whole cell lysates showed that CITFA1HA was strongly depleted after 1 and 2 days of CITFA1 silencing (Figure III-6A). To assess the
abundance of other CITFA subunits in these samples we used previously established immune sera
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Figure III-6. CITFA1 is required for CITFA promoter binding in vivo.
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(Figure III-6 legend cont.) (A) Immunoblot detecting the indicated CITFA subunits in whole
cell lysates of non-induced cells (n.i.) and in cells in which CITFA1-HA was silenced for 1 or 2
days (boxed panel) on the same blot. Detection of the spliceosomal U2A/ protein served as a
loading control. (B) Sedimentation of extract by ultracentrifugation in a 10 to 40% linear sucrose
gradient. Fractions 5 to 20, taken from top to bottom, were analyzed by immunoblotting. Note
that the two CITFA1 blots were co-developed. For comparison, sedimentations of TEV protease
(29 kDa), Taq DNA polymerase (95 kDa), IgG (150 kDa, 6.6S), the TRF4-SNAPc-TFIIA
transcription factor complex (TST, 230 kDa), apoferritin (AP, 444 kDa, 17S), and thyroglobin
(TG, 660 kDa, 19S) were analyzed in parallel gradients (arrowheads). Fractions with CITFA3, 6
and 7 co-sedimentation peaks are indicated by red lettering and the shifted CITFA2 peaks by
asterisks. (C) Immunoblot using the purified, polyclonal anti-CITFA3 antibody for detection of
PTP-CITFA3 in PF PTPC3ee cells and untagged CITFA3 in PF and BF wild-type (WT) whole
cell lysates. Loading was controlled by the detection of the RNA pol II transcription factor
TFIIB. (D) Indirect immunofluorescence microscopy of CITFA3 in non-induced cells and cells
in which CITFA1 was silenced for 42 hours. Nucleolar areas are indicated by white arrows. For
the induced cells, an example was chosen in which the putative ESB was detected as an
additional spot outside the nucleolus, bar: 5 µm. (E) Anti-CITFA3 ChIP experiments with noninduced cells or with cells in which CITFA1 was silenced for one or two days. Occupancy by
CITFA3 was determined by qPCR at RRNA and BES promoters and, as a control, at the β-/αtubulin intergenic region (Tub). The percent precipitation was corrected by subtracting the
percent precipitation from negative control precipitations using a comparable, non-specific
immune serum. Each experiment including the negative control was carried out three times
independently and differences in occupancy were statistically analyzed by a two-tailed, student’s
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(Figure III-6 legend cont.) t-test assuming equal variance. Two asterisks indicate P-values that
are <0.01.
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against CITFA2, CITFA6 and CITFA7, and a newly generated polyclonal anti-CITFA3 antibody
(see Figure III-6). The results demonstrate that, besides a minor reduction of CITFA2 on day 2,
the CITFA subunits analyzed exhibited robust expression during the two-day-experiment
suggesting that CITFA1, in contrast to CITFA7, is not required for overall complex integrity. To
substantiate this notion, we analyzed the CITFA complex upon CITFA1 depletion by sucrose
gradient sedimentation in which fractions were taken from top to bottom of the gradient (Figure
III-6B). In non-induced cells the sedimentation profile was exactly as determined previously
(Brandenburg et al., 2007; Nguyen et al., 2012): CITFA1, 3, 6, and 7 exhibited sedimentation
peaks in fractions 13 and 14 while the less abundant CITFA2 peaked in fractions 14 and 15 shifting
part of the complex one fraction down the gradient. Loss of CITFA1 decreased the sedimentation
of CITFA2, 3, 6 and 7 by ~2 fractions (note that the sedimentation peak of the minor amount of
detectable CITFA1 remained in fraction 13). However, the CITFA subunits still co-sedimented
between the 6.6 S IgG marker (150 kDa) and the 230 kDa-large trypanosome TRF4-SNAPc-TFIIA
transcription factor complex (Schimanski et al., 2005a). Since the CITFA complex without
CITFA1 and without CITFA1 and 2 has a calculated mass of 221 kDa and 173 kDa, respectively,
this result strongly indicates that CITFA1 depletion did not affect the integrity of the CITFA
complex. Accordingly, a pull-down of CITFA3 in extract efficiently co-precipitated CITFA2, 6
and 7 in both non-induced and CITFA1-depleted cells (Figure III-S3).
The polyclonal anti-CITFA3 antibody was obtained by raising an immune serum in rats against
a recombinant GST-CITFA3 fusion protein that was expressed in Escherichia coli and purified by
glutathione affinity chromatography (data not shown), and by affinity purifying the antibody from
serum with immobilized antigen. While the calculated molecular weight of CITFA3 is 47 kDa, the
antibody recognized a single band of ~55 kDa in both BF and PF whole cell lysates (Figure III95

6C). This band is the correct band because in cell lysates of the PF line PTPC3ee, expressing
exclusively CITFA3 with an N-terminally fused PTP tag, the band shifted up by ~20 kDa, the size
of the tag. Hence, the polyclonal antibody detected CITFA3 with high specificity. We therefore
used this antibody for two further assays. Firstly, we analyzed CITFA3 localization in non-induced
cells and in cells in which CITFA1 was silenced for 42 hours because there was a possibility that
CITFA1 directs the CITFA complex to the nucleus or, within the nucleus, to the nucleolus and the
ESB. We analyzed 70 randomly selected non-induced cells and 83 CITFA1-silenced cells in detail.
In all cells CITFA3 exhibited subnuclear localization. In DAPI staining, the nucleolus becomes
clearly visible as a spherical area of low DNA density resulting in a fainter DAPI stain (Daniels et
al., 2012). In 93% of non-induced cells and in 86% of CITFA1-silenced cells, the CITFA3 signal
was confined to the nucleolus (Figure III-6D). We also detected an additional, smaller
extranucleolar spot in 11% and 6% of non-induced and induced cells, respectively (Figure III6D). This spot is likely the ESB, since we have shown previously that CITFA7 reliably colocalized
with RNA pol I in an extranucleolar compartment of similar size and signal intensity (Nguyen et
al., 2014; Nguyen et al., 2012). Since the vast majority of cells in this analysis exhibited CITFA3
localization in the nucleolus independent of the CITFA1 knockdown, it appears that CITFA1 is
not required for localizing the complex to the sites of RNA pol I transcription.
Secondly, we conducted an anti-CITFA3 ChIP assay in non-induced and CITFA1-silenced
cells (Figure III-6E). For the PCR analysis of precipitated DNA, we used consensus
oligonucleotide pairs that recognize either all copies of the RRNA promoter or all BES promoters
(Park et al., 2011). The antibody effectively precipitated RRNA promoter DNA whereas BES
promoter DNA was enriched 7.8 fold less than the RRNA promoter. This was expected because
we have recently obtained a similar result in anti-CITFA7 ChIPs due to the fact that CITFA
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predominantly binds the promoter of the active BES and occupies promoters of silent BESs to a
much lesser extent. This is in contrast to RRNA promoters which, according to a ChIP-seq analysis,
appear to be generally occupied by CITFA (Nguyen et al., 2014). Hence, in this assay, most if not
all RRNA promoters were precipitated while BES promoter enrichment was mainly restricted to
the active BES. Independent of the enrichment efficiency, CITFA1 silencing reduced CITFA3
occupancy of both promoter types. For the efficient RRNA precipitation, this reduction was highly
significant (Figure III-6E). Since we showed that CITFA1 has no role in the formation of a stable
CITFA complex or in localizing CITFA to the nucleolus, these results strongly indicate that
CITFA1 has a specific function in binding of the complex to RRNA and BES promoters.

III-4. Discussion
We have established a system in BF T. brucei for specific and efficient gene silencing that is based
on targeting a HS that is fused to the mRNA of a gene of interest. We have established two such
HSs, namely the 3/ UTR of the T. cruzi U2AF35 gene and the coding sequence of the large PTP
tag. The system is based on BF cell lines smTc3 and smPTP which inducibly express Tc3 and PTP
hairpin RNAs, respectively. Two consecutive transfections are required to fuse the HS to the gene
of interest in one allele and to eliminate the remaining allele. Although these transfections are time
consuming, this system comes with distinct benefits. Since doxycycline did not alter the rate of
proliferation of smTc3 and smPTP cell lines (Figure III-3) or affect trypanosome morphology as
observed by light microscopy, it can be inferred that Tc3 and PTP dsRNA-derived siRNAs do not
target genes that are important for trypanosome culture growth. Furthermore, since both of these
cell lines have the regulatable stem-loop vector already integrated, an RRNA-specific position
effect is highly unlikely. Moreover, the vectors pCITFA7-HA-Tc3-BLA (Figure III-S1) and
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pCITFA7-PTP-BLAv2 (Figure III-S2) offer a straightforward cloning strategy for fusing the HS
to the gene of interest. C-terminal coding sequences can be amplified and inserted into the ApaI
and NotI restriction sites in a single step. The only requirement for successful targeting of the
plasmid to an endogenous allele is a restriction site within the gene coding sequence that is
surrounded by at least 100 bp of coding sequence on either side and can be used to linearize the
plasmid. Since this system is based on targeting the same sequence independent of the gene of
interest, we anticipate that it can provide unambiguous gene silencing data in those cases where
targeting endogenous sequences was not successful or inefficient. Finally, it is likely that the
system can be implemented in PF 29-13 cells as well. However, the knockout of wild-type alleles
in 29-13 cells would have to be accomplished with the PURO marker instead of the HYG marker
as shown in Figure III-1, because 29-13 cells already harbor HYG.
The system also has its limitations, however. Firstly, it can only be applied to single copy genes
because it is obligatory to produce a cell line that exclusively expresses the mRNA of interest as a
HS fusion and no wild-type mRNA. Secondly, the system, as presented here, will not function if
the expression of both alleles is required for trypanosome viability and proliferation. It should be
noted, though, that we have so far generated many viable BF and PF cell lines which expressed
various essential nuclear proteins exclusively as PTP fusions from a single allele. This has included
RNA pol subunits, various transcription and RNA splicing factors, and kinases, suggesting that
haplo-insufficiency rarely affects trypanosome viability in culture (see for example references
(Badjatia et al., 2013; Lee et al., 2010; Li et al., 2008; Luz Ambrosio et al., 2009; Nguyen et al.,
2007). If haplo-insufficiency is a concern, it may be possible to integrate one HS plasmid into each
endogenous allele instead of knocking one allele out. For this, the blasticidin marker gene has to
be replaced with the puromycin marker which can be achieved by a single PCR amplification and
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cloning step, since either the selectable marker cassettes or the coding region can be excised by
restriction digests (Figures III-S1 and III-S2). Thirdly, the HS may negatively affect the
expression of the mRNA or the functionality of the resulting protein. If the tag interferes with the
function of the protein there are two options. The PTP tag can be fused to the N-terminus with our
published pN-PURO-PTP vector (Schimanski et al., 2005a). Although in the N-terminal PTP tag
the ProtA and ProtC domains have a different N- to C-terminal sequence order, the PTP dsRNA
produced in smPTP cells effectively silenced a CITFA2 gene in which the PTP tag sequence was
inserted after the initiation codon (JK Kirkham and A Günzl, unpublished data). Alternatively, Tc3
can be employed without the HA tag, which was used here to enable specific detection of the
protein translated from the fusion mRNA. In this case the 27 bp-long HA coding sequence needs
to be removed from pCITFA7-HA-Tc3-BLA. Furthermore, if the gene of interest produces a
mRNA whose regulation through its 3/ UTR is critical for cell viability, then replacing it either
with Tc3 or with the T. brucei RPA1 3/ UTR in pC-PTP-BLA may be deleterious. In this case
tagging the protein N-terminally with the PTP tag or replacing the RPA1 3/ gene flank with that of
the gene of interest in pC-PTP-BLA may be a solution.
Recently, a conditional gene knockout system has been established in T. brucei that employs
Cre recombinase and loxP sites (Kim et al., 2013a; Kim et al., 2013b). As with our approach, this
system requires the manipulation of both gene alleles, e.g. it also depends on two consecutive
transfection steps. This system offers instantaneous removal of the gene of interest in the genome
and an unambiguous assessment of gene essentiality. However, in contrast to our system, this
approach is irreversible, preventing the analysis of temporary gene knockdowns or the titration of
the gene silencing level.
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Finally, we have successfully employed this new gene silencing approach to evaluate
CITFA1’s role in the CITFA complex. We could unambiguously show that CITFA1 is essential
for BF viability in culture and, as expected, has a vital role in rRNA and VSG mRNA expression.
After CITFA2 and CITFA7, this is the third CITFA subunit whose knockdown led to rapid
trypanosome death in culture, underscoring the indispensability of this transcription initiation
factor for trypanosome viability. Furthermore, we showed that CITFA1 depletion strongly reduced
CITFA occupancy at RRNA and BES promoters. Since we could not detect mislocalization of
CITFA3 or the loss of CITFA subunits that are indicative of complex disruption as a consequence
of CITFA1 silencing, it appears that CITFA1 has a direct role in binding to promoter DNA. Most
interestingly, CITFA3 remained localized to the nucleolus/ESB after CITFA1 knockdown, which
suggests that subnuclear CITFA localization is not mediated by its binding to DNA. This finding
further supports a recently described model in which DNA-independent concentration and
confinement of CITFA to the nucleolus and ESB restricts maximal transcription initiation by RNA
pol I to these compartments (Nguyen et al., 2014).
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Figure III-S1. Plasmid CITFA7-HA-Tc3-BLA. (A) Plasmid map drawn to scale. The plasmid is
a derivative of pBluescript II SK+. Two gene cassettes were introduced in tandem. The first
cassette comprises the Trypanosoma brucei CITFA7 C-terminal coding region (white box) fused
to the HA tag (blue), followed by a stop codon and the Trypanosoma cruzi U2AF35 3/ gene flank
(Tc3; red). The second cassette harbors the coding region of blasticidin-S deaminase (BLA, black)
flanked by the intergenic region of the T. brucei heat shock protein 70 genes 2 and 3 (H23, gray)
(Lee, 1996) and the T. brucei β-/α-tubulin intergenic region (T, gray). Note that the vector was
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targeted for integration into the CITFA7 gene by linearizing it inside the CITFA7 sequence with
PshAI. To use this vector for other genes, the CITFA7 sequence needs to be replaced with the Cterminal coding sequence of a gene of interest using the KpnI/ApaI and NotI restriction sites. This
sequence must also have a linearization site which should be surrounded by a minimum of 100 bp
of gene sequence on either side. Furthermore, if the new sequence does not contain an NdeI
restriction site, as the CITFA7 sequence does, then, if desired, the BLA resistance marker may be
replaced using the NdeI and BstBI restriction sites. (B) Nucleotide sequence of the plasmid.
Highlighting of inserted sequences corresponds to the map. The CITFA7 sequence is italicized.
Important restriction sites and the stop codon following the HA sequence were highlighted in
yellow and pink, respectively.
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Figure III-S2. Plasmid CITFA7-PTP-BLAv2. (A) Plasmid map drawn to scale. The plasmid
corresponds to pCITFA7-HA-Tc3-BLA described above except for the tagging cassette in which
the CITFA7 sequence (white) is fused to the PTP tag sequence (cyan) via a NotI restriction site,
followed by a stop codon and the T. brucei RPA1 (accession number Tb927.8.5090 at
www.TriTrypDB.org) 3/ gene flank (gray). (B) Nucleotide sequence of the plasmid. The RPA1
sequence is presented in white lettering with dark gray highlighting to distinguish it from the H23
and T sequences.
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Figure III-S3. Anti-CITFA3 co-immunoprecipitation. CITFA3 was immunoprecipitated in
extract prepared from non-induced bloodstream form trypanosomes or from cells in which CITFA1
was silenced for 2 days. Extract, supernatant (SN) and immunoprecipitate (IP) were analyzed by
immunoblotting. x-Values indicate relative amounts loaded. A control (Ctrl) elution of protein G
bead-coupled antibodies was carried out to detect IgG contamination. CITFA2, CITFA6, CITFA7
and, as a negative control, TFIIB were detected with polyclonal immune sera on the same blot.
Asterisks indicate the CITFA2 band just above the IgG contamination. Although CITFA3 was
detected in a different gel that better separates proteins in the 50 kDa range, the CITFA3 signal in
the precipitate was not distinguishable from that of the IgG heavy chain. Nonetheless, this
experiment demonstrates that CITFA1 silencing did not affect the association of CITFA2,
CITFA6, and CITFA7 with CITFA3 indicating that the CITFA complex remained intact upon
CITFA1 depletion.
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Chapter IV
Transcription by the multifunctional RNA polymerase I in
Trypanosoma brucei functions independently of RPB7

Abstract
Trypanosoma brucei has a multifunctional RNA polymerase (pol) I that transcribes ribosomal gene
units (RRNA) and units encoding its major cell surface proteins variant surface glycoprotein (VSG)
and procyclin. Previous analysis of tandem affinity-purified, transcriptionally active RNA pol I
identified ten subunits including an apparently trypanosomatid-specific protein termed RPA31.
Another ortholog was identified in silico. No orthologs of the yeast subunit doublet RPA43/RPA14
have been identified yet. Instead, a recent report presented evidence that RPB7, the RNA pol II
paralog of RPA43, is an RNA pol I subunit and essential for RRNA and VSG transcription in
bloodstream form trypanosomes (Penate et al., 2009, EMBO Rep. 10:252-257). Revisiting this
attractive hypothesis, we were unable to detect a stable interaction between RPB7 and RNA pol I
in either reciprocal co-immunoprecipitation or tandem affinity purification. Furthermore,
immunodepletion of RPB7 from extract virtually abolished RNA pol II transcription in vitro but
had no effect on RRNA or VSG ES promoter transcription in the same reactions. Accordingly,
chromatin immunoprecipitation analysis revealed cross-linking of RPB7 to known RNA pol II
transcription units but not to the VSG ES promoter or to the 18S rRNA coding region. Interestingly,
RPB7 did crosslink to the RRNA promoter but so did the RNA pol II-specific subunit RPB9
suggesting that RNA pol II is recruited to this promoter. Overall, our data led to the conclusion
that RNA pol I transcription in T. brucei does not require the RNA pol II subunit RPB7.
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IV-1. Introduction
Trypanosoma brucei has a multifunctional RNA polymerase (pol) I that transcribes the large
ribosomal (RRNA) gene unit in all life cycle stages, and, uniquely, the telomeric expression site
encoding the active variant surface glycoprotein (VSG) gene in its bloodstream form (BF) as well
as gene units encoding procyclin in its procyclic form (PF). BFs evade the mammalian immune
response by antigenic variation of their cell surface coat consisting of ~10 million identical VSG
molecules expressed from a single gene. The variation occurs when parasites switch to the
expression of a different VSG gene drawn from a large VSG gene repertoire (recently reviewed in
(Horn and McCulloch, 2010)). Expression of the whole VSG coat from a single gene requires
extremely high expression levels and it has been determined that the transcription rate of the active
VSG gene is approximately 50 times higher than that of a β tubulin gene (Ehlers et al., 1987). Such
high rates are the hallmark of RNA pol I transcription which in general accounts for more than
50% of the transcriptional activity in a eukaryotic cell (Russell and Zomerdijk, 2005; White, 2008).
However, utilization of RNA pol I for protein coding gene expression requires a deviating mode
of gene expression. In the mouse, strong RRNA promoter-driven transcription of a reporter
construct, led to reporter enzyme activities which were 20-50fold lower than in a control
experiment with an RNA pol II promoter (Grummt and Skinner, 1985). Conversely, RRNA
promoter-driven expression of a selectable marker gene in T. brucei increased parasite resistance
around 30fold over RNA pol II-mediated expression of the same gene demonstrating that, in
trypanosomes, RNA pol I can efficiently synthesize functional mRNA (Rudenko et al., 1991;
Zomerdijk et al., 1991a). The opposite outcomes in these studies are most likely due to different
modes of mRNA capping. In the budding yeast Saccharomyces cerevisiae and higher eukaryotes,
RNA capping is co-transcriptional and specifically linked to RNA pol II because the capping
enzymes bind to the phosphorylated carboxy-terminal domain (CTD) of the largest RNA pol II
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subunit RPB1 (Bentley, 2005). Conversely, in trypanosomes and related organisms, proteincoding gene transcription is polycistronic and individual mRNAs are processed from precursors
by spliced leader (SL) trans splicing and polyadenylation. Since in trans splicing the capped SL,
comprising the 5/-terminal part of the small nuclear SL RNA, is transferred to the 5/ end of each
mRNA, this process constitutes a post-transcriptional capping mechanism that decouples capping
from RNA pol II transcription (Günzl, 2010).
Eukaryotic RNA pols I-III consist of twelve subunits which are either shared or paralogous
to each other. In addition, yeast RNA pol I contains two RNA pol I-specific subunits, RPA49 and
RPA34, which are not essential for yeast proliferation. The multifunctional nature of trypanosome
RNA pol I has spurred the investigation of this enzyme. While the largest two subunits, RPA1 and
RPA2, were discovered first (Jess et al., 1989; Schimanski et al., 2003; Smith et al., 1989), eight
of the remaining ten core subunits could be identified bioinformatically after the T. brucei genome
was completed (Kelly et al., 2005). The missing subunits were the orthologs of yeast RPA43 and
RPA14. Since these two subunits form a functional doublet in yeast and humans, it was proposed
that trypanosome RNA pol I may assemble the paralogous RNA pol II subunits RPB7
(GeneDB/TritrypDB accession number Tb11.01.6090) and RPB4 (Tb927.3.5270) instead (Kelly
et al., 2005), possibly to aid this polymerase in the synthesis of functional mRNA. This was an
attractive hypothesis because the respective genes were readily detected in trypanosomatid
genomes and because RPB4/7 analysis in other systems indicated specific functions of this protein
doublet in RNA synthesis such as binding of an RNA processing factor (Mitsuzawa et al., 2003),
direct RNA interaction (Újvári and Luse, 2005), and linking mRNA synthesis to mRNA decay
(Lotan et al., 2007). Moreover and most recently, the RPB4/7 doublet was characterized as a
potential “mRNA coordinator” in yeast that can be deposited on mRNA facilitating efficient
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translation and thereby linking expression outcomes from gene transcription to translation (HarelSharvit et al., 2010).
Based on co-immunoprecipitation assays, RPB7 expression silencing experiments, colocalization of RPB7 and the RNA pol I-specific subunit RPB6z (Tb11.03.0935), and in vitro
transcription assays in BFs, Penate et al. recently concluded in their publication title that “RNA pol
II subunit RPB7 is required for RNA pol I-mediated transcription in Trypanosoma brucei” (Peñate
et al., 2009). However, tandem affinity purification of trypanosome RNA pol I in two different
laboratories did not identify RPB7 as a co-purifying subunit (Nguyen et al., 2007; Nguyen et al.,
2006; Walgraffe et al., 2005). Moreover, isolation of RNA pol I from PF extract that was active in
both non-specific and promoter-dependent transcription assays did not reveal a protein band of
~20 kDa which is the apparent size of T. brucei RPB7 (Nguyen et al., 2007). This was of particular
concern because RPB7 and its RNA pol I and III paralogues RPA43 and RPC25 were shown in
yeast to be essential for promoter-dependent transcription initiation (Edwards et al., 1991;
Peyroche et al., 2000; Zaros and Thuriaux, 2004). We therefore revisited the role of T. brucei
RPB7 in RNA pol I transcription omitting RPB7 expression silencing which may affect gene
expression independently of RNA pol function or may rapidly lead to secondary defects through
a general shut-down of RNA pol II transcription.

IV-2. Methods

DNAs
For the generation of BF cell lines that exclusively expressed RPB7 or RPB9 with a Cterminal fusion of the composite PTP tag sequence, encoding tandem protein A (ProtA) domains,
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a tobacco etch virus (TEV) protease site and the protein C epitope (ProtC), plasmids RPB7-PTPNEO and RPB9-PTP-NEO were first integrated into endogenous alleles. The plasmids were
generated by inserting, respectively, 549 bp and 385 bp of the RPB7 and RPB9 (Tb11.02.5180) Cterminal coding regions into pC-PTP-NEO (Schimanski et al., 2005b) using ApaI and NotI
restriction sites. For pRPB9-PTP-NEO linearization, an AflII restriction site was engineered into
the RPB9 sequence creating a silent mutation in RPB9 codon 58. In a second round of stable
transfections, the remaining wild-type RPB7 and RPB9 alleles were knocked out by transfection
of 10 µg of a chimeric linear DNA in which 100 bp-long gene flanks were fused to the coding
region of the hygromycin phosphotransferase by standard PCR as described previously (Arhin et
al., 2004). pRPB7-HA-BLA was created by pasting the RPB7 target sequence from pRPB7-PTPNEO into the published plasmid pRPA31-HA-BLA (Nguyen et al., 2007). For transfections,
pRPB7-PTP-NEO/pRPB7-HA-BLA,

pRPB9-PTP-NEO,

and

pPTP-RPB6z-PURO

were

linearized with restriction enzymes PmeI, AflII, and BmgBI, respectively. pPURO-PTP-RPB6z
and transcription templates Rib-trm, VSG-trm, and SLins19 were described previously (Laufer et
al., 1999; Nguyen et al., 2007).
The following oligonucleotide pairs were used in semi-quantitative and quantitative (q)PCR
analyses of DNA obtained in chromatin immunoprecipitation (ChIP) assays: consensus VSG ES
promoter,
consensus

5/-TCTAAAAGAATCATATCC-3//5/-AAGCGTAGATGAGATTAAAGTC-3/;
RRNA

GTCTGAGAGCGGTCAGTTGC-3/;

promoter,
18S

5/-AATACAACACACAATAGG-3//5/rRNA

coding

region;

5/-

TCATCAAACTGTGCCGATTAC-3//5/-CTATTGAAGCAATATCGG-3/; SLRNA promoter, 5/CTACCGACACATTTCTGGC-3//5/-GCTGCTACTGGGAGCTTCTCATACC-3/; β-α tubulin
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intergenic

region,

5/-GCTGATTTCTGACAGATCTTCAAAC-3//5/-

GTGGATGCAGATAGCCTCACGCATG-3/.

Cells
PF and BF of Trypanosoma brucei brucei strain 427 were cultured as described previously
(Günzl et al., 2000; Hirumi and Hirumi, 1989). Transfected cells were cloned by limiting dilution
immediately after electroporation. BFs were selected with 2.5 µg/ml of G418, 1 µg/ml of
hygromycin, and 2 µg/ml of blasticidin whereas PFs were selected with increasing antibiotic
concentrations ranging from 15 to 40 µ/ml of G418 and from 10 to 20 µg/ml of hygromycin. DNA
integrations were confirmed in each clonal cell line by PCR of total DNA using oligonucleotides
that hybridize outside the cloned region. Protein tagging for each clonal cell line was confirmed
by immunoblotting.

Protein Analysis
Tandem affinity purification of PTP-tagged RPB7 (RPB7-PTP) was carried out exactly as
specified in the standard protocol (Schimanski et al., 2005b). Purified proteins were separated on
a 10–20 % SDS–polyacrylamide gradient gel and detected with Pierce Gelcode Coomassie blue
stain. The same protocol was used for the preparation of active RNA pol II, with the PTP tag fused
C-terminally to subunit RPB9. However, in this purification the enzyme was kept on the anti-ProtC
beads and not eluted. The beads were stored at -20°C until used in in vitro transcription assays.
Co-immunoprecipitation assays were carried out with 100 μl of crude cell extract
corresponding to 4 × 108 BF cells. PTP-RPB6z was precipitated with 40 μl settled volume of
human IgG beads (GE Healthcare) which bind the ProtA domains of the PTP tag. RPB7-HA was
precipitated with a rat monoclonal anti-HA antibody (Roche) that we bound to paramagnetic
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protein G beads (GE Healthcare) to avoid a non-specific interaction of this antibody with the ProtA
domains. After one hour on ice, the supernatant was taken off and the precipitate washed seven
times with 700 µl of TET100 buffer (100 mM NaCl, 20 mM Tris pH 8.0, 3 mM MgCl2, 0.1%
Tween 20). Precipitated PTP-RPB6z was eluted by resuspending the beads in 45 µl of TEV
protease buffer (150 mM KCl, 20 mM Tris pH 7.7, 3 mM 1M MgCl2, 0.5 mM EDTA, 1 mM
dithiothreitol [DTT], 0.1 % Tween 20) containing 40 units of AcTEV protease (Invitrogen) and by
an incubation of the protease digest at 28°C for 30 min. Eluted proteins were mixed with 15 µl of
4x standard SDS loading buffer and boiled for 10 min. Anti-RPB7-HA precipitates were directly
released into SDS loading buffer.
In immunoblots, PTP-tagged proteins were probed with the mouse monoclonal anti-ProtC
antibodyHPC4 (Roche) in the presence of 1 mM CaCl2 and HA-tagged proteins with a rat
monoclonal anti-HA antibody (Roche). Protein detection was achieved with peroxidase-labeled
anti-mouse or anti-rat IgG secondary antibody (Vector Laboratories) in combination with the BM
chemiluminescence blotting substrate (Roche) according to the manufacturer's protocol.
Previously published antisera were used to detect the two largest RNA pol I subunits RPA1 and
RPA2 (Schimanski et al., 2003) whereas for RPB1 detection a polyclonal anti-RPB1 immune
serum was raised in rat against an Eschericha coli-expressed GST fusion protein comprising RPB1
residues 1424 to 1766 according to a published procedure (Brandenburg et al., 2007).

Chromatin Immunoprecipitation
For each ChIP experiment, 1 x 108 bloodstream trypanosomes were fixed with formaldehyde
and washed as published (Lee et al., 2006). Cells were sonicated in a Bioruptor UCD-200
(Diagenode) for a total of 25 min (30 s on/30 s off) at 4 °C, with pulse setting on “high”. Following
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a 10-min centrifugation at 25,000g and 4 °C to pellet cell debris, the supernatant was pooled and
chromatin pre-cleared with antibody-free, bovine serum albumin-blocked ProtA Dynabeads
(Invitrogen) for 1 hour at 4 °C while rotating. For immunoprecipitation of PTP-tagged proteins,
0.75 ml of chromatin solution was incubated overnight at 4 °C with either a rabbit polyclonal antiProtA antibody (Sigma) or a nonspecific rabbit immune serum as negative control. Sodium
chloride was then added to a final concentration of 350 mM and the chromatin was captured with
ProtA Dynabeads for 40 min at 4 °C. Subsequent washing of the beads and DNA preparation
through RNase and proteinase K treatments were carried out as detailed previously (Lee et al.,
2010). In a final step, the DNA was purified using a MinElute kit (Qiagen) and eluted in 20 μl of
water.
The DNA was analyzed by standard qPCR assays using the SsoFast EvaGreen Supermix
(BioRad) on a CFX96 cycler (BioRad) according to the manufacturer’s recommendations.
Between two and five independent ChIP experiments were conducted for each cell line. For each
amplification and ChIP experiment, triplicate qPCR samples were analyzed using the Bio-Rad
CFX Manager software package. Each amplification product was analyzed for specificity by both
agarose gel electrophoresis and melt curve analysis. Standard curves for oligonucleotide pairs were
derived from input DNA dilution series and ranged in their r2 value from 0.98 to 1.0. Fold
enrichment values were calculated as the ratio between starting quantities of positive and control
precipitations.

In vitro transcription
The bloodstream in vitro transcription system will be described elsewhere in detail
(manuscript in preparation). Briefly, BF cells were harvested from 6 liter of culture that was grown
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to a cell density of 2 x 106 cells/ml. Cells were washed twice with Tryp wash solution (100 mM
NaCl, 3 mM MgCl2, 20 mM Tris–HCl, pH 7.5), equilibrated in transcription buffer (150 mM
sucrose, 20 mM potassium l-glutamate, 3 mM MgCl2, 20 mM HEPES–KOH, pH 7.7), and
resuspended in 1.5 times the packed cell volume of transcription buffer containing 1 mM DTT, 10
µg/ml leupeptin, and 10 µg/ml aprotinin. After adding 20 µl of phosphatase inhibitor cocktail
(Sigma) and ~200 µl settled volume of 800 µm low binding silica beads (OPS Diagnostics), cells
were broken by five cycles of shock freezing in liquid nitrogen, thawing and vortexing for 2 min
in a 4°C cold room. Broken cells were extracted by mixing the sample quickly with one tenth
volume of buffer C (1500 mM KCl, 20 mM HEPES-KOH pH 7.7, 3mM MgCl2) and by incubating
the mix for 20 min on ice. After centrifugation at 25,000g and 2 °C for 10 min, the extract was
separated from insoluble cell debris, diluted with 0.5 volumes of ice-cold transcription buffer,
concentrated ~5x in a centricon-10 centrifugal filter device (Millipore), aliquoted, shock-frozen in
liquid nitrogen, and stored at -80°C. For mock- or immuno-depletion of RPB7-PTP, 50 µl of BF
transcription extract was mixed with transcription buffer-equilibrated protein G beads or IgG beads
(settled volume of 30 µl), respectively, and incubated on ice for 1.5 hours. Beads were pelleted for
2 min. at 3000 g and 2 oC and extract was separated from beads, shock-frozen, and stored at -80
°C.
Standard transcription reactions were carried out in a volume of 20 μl containing 4 μl of cellfree extract, 20 mM potassium L-glutamate, 20 mM KCl, 3 mM MgCl2, 20 mM HEPES-KOH, pH
7.7, 20 mM creatine phosphate, 0.48 mg/ml of creatine kinase, 2.5% polyethylene glycol, 0.2 mM
EDTA, 0.5 mM EGTA, 4 mM DTT, 10 μg/ml leupeptin, 10 μg/ml aprotinin, 20 μg/ml RNA pol I
promoter template (Rib-trm or VSG-trm), 7.5 μg/ml SLins19 template, 12.5 μg/ml unrelated
plasmid DNA, 10 μg/ml leupeptin, and 10 μg/ml aprotinin. The reactions were pre-incubated on

115

ice for 10 min in the absence of nucleoside triphosphates (NTPs). After adding the NTPs to a final
concentration of 0.5 mM, the reaction was incubated for 1 h at 27°C and stopped by adding Trizol
solution (Invitrogen). Total RNA was prepared as described previously (Laufer et al., 1999).
Newly synthesized RNAs were detected by primer extension of 32P-end-labeled oligonucleotides
Tag-PE and SLtag which hybridize to unrelated oligonucleotide tags of VSG-trm/Rib-trm and
SLins19 RNAs, respectively. Primer extension products were resolved on 6% polyacrylamide50% urea gels and visualized by autoradiography. In RNA pol II reconstitution assays, tandem
affinity-purified RNA pol II, bound to anti-protein C matrix and equilibrated in transcription
buffer, was added back to the reactions. The amounts corresponded to 0.35% and 0.7% of a
standard PTP tandem affinity purification (Nguyen et al., 2007; Schimanski et al., 2005b).

Indirect immunofluorescence light microscopy
Immunolocalizations of procyclic cells were carried out as described previously (Luz
Ambrosio et al., 2009).

IV-3. Results and Discussion

Interaction of RPB7 with RNA polymerases I and II in extract
In a first step, we wanted to confirm an interaction between RPB7 and the RNA pol I subunit
RPB6z in a BF extract that was active in both accurate RNA pol I and II transcription (Laufer and
Günzl, 2001; Laufer et al., 1999). To avoid any cross-reactivity of polyclonal antisera, we
generated a cell line in which RPB6z was N-terminally tagged with the composite PTP tag (PTPRPB6z; (Schimanski et al., 2005b)) and RPB7 C-terminally with the HA tag (RPB7-HA). These
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proteins were then precipitated with antibodies directed against their tags. Since we have
previously shown that PTP-RPB6z is fully functional (Nguyen et al., 2007) and since BF and PF
cell lines which exclusively expressed C-terminally tagged RBP7 did not exhibit any growth defect
(data not shown), we concluded that tagging of these two subunits did not interfere with their
function. When we immunoprecipitated PTP-RPB6z from extract at low stringency conditions, the
RNA pol I subunits RPA1 and RPA2 were efficiently co-precipitated whereas RPB7-HA, RPB1
and a non-specific control were not (Figure IV-1A, left panels). Since there was the possibility
that only a small amount of RNA pol I was active and bound to RPB7, we increased the relative
amount of precipitate from 4x to 50x but still could not detect a signal above the background found
with the spliceosomal U2-40K protein (Figure IV-1A, lower left panels). Similarly, when we
precipitated RPB7-HA with a monoclonal anti-HA antibody, we saw efficient co-precipitation of
RPB1 but not of the RNA pol I subunits RPA1, RPA2 and PTP-RPB6z (Figure IV-1A, right
panels). Only when the precipitate was increased to 50x, we detected a faint PTP-RPB6z signal
but a band of similar strength was detected with the U2-40K control suggesting that this was the
background level due to the low stringency conditions applied. But even when the background
signal was not taken into account, densitometry revealed that RPB7 is bound to RNA pol I in
transcriptionally active extract to less than 1%.
In a different approach investigating the interaction of RPB7 with RNA pols I and II, we
tandem affinity-purified RPB7 complexes from extract prepared from PFs that exclusively
expressed RPB7 as a C-terminal PTP tag fusion. Although protein tags can change the affinities
of protein-protein interactions, the rationale here was that if RPB7 is an essential subunit for RNA
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Figure IV-1. RPB7 does not detectably interact with RNA pol I in transcriptionally active extract.
(A) Immunoblot analysis of PTP-RPB6z immunoprecipitation (PTP-RPB6z IP; left panels) and of
RPB7-HA immunoprecipitation (RPB7-HA IP, right panels). For each immunoprecipitation,
equivalent amounts of crude extract (Inp) and of supernatant (S) were analyzed and four or fifty
times the relative amount of the precipitate (P). Asterisks indicate IgG heavy and light chain
signals. Note the reduction in size of PTP-RPB6z to P-RPB6z upon TEV protease digest in the
PTP-RPB6z immunoprecipitation. (B) Immunoblot analysis of TbRPB7-PTP purification. Crude
extract (Inp), flow-through of the IgG sepharose column (FT-IgG), TEV protease eluate (TEV),
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(Figure IV-1 legend cont.) flow-through of the anti-protein C matrix (FT-ProtC), and final eluate
(Elu) were analyzed in relative amounts as indicated. Tagged RPB7 and endogenous RPB1 and
RPA1 were successively detected on the same blot. (C) RPB7 co-purified proteins. The complete
final eluate (Elu) of a standard RPB7-PTP purification was separated on a 10–20%
SDS/polyacrylamide gradient gel and stained with Coomassie blue. For comparison, small aliquots
of crude extract (Inp) and TEV protease eluate were co-analyzed. The band assignments on the
right were according to previous RNA pol II purifications (Das et al., 2006; Devaux et al., 2006;
Lee et al., 2009) and our own immunoblot results. RPB1 occurs in two bands, the upper one being
phosphorylated (ph. RPB1). The question mark indicates several co-purified bands which have not
been identified yet. The band pattern of RPB12 and RPB10 has not been determined yet.
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pol I transcription then it should interact in a similar manner with this enzyme as it does with RNA
pol II. The tandem affinity purification of RPB7-PTP by IgG chromatography and by anti-ProtC
affinity chromatography efficiently concentrated RPB7 complexes in the final eluate (Figure IV1B, top panel). RPB1 was enriched throughout the purification whereas RPA1 was only detected
in crude extract and the flow-through of the IgG column demonstrating that RPB7 is a bona fide
RNA pol II subunit but not assembled into a stable RNA pol I complex to a detectable extent
(Figure IV-1B, middle and bottom panels, respectively). Accordingly, when the final eluate was
separated by SDS-PAGE and stained with Coomassie blue, an RNA pol II-specific band pattern
(Das et al., 2006; Devaux et al., 2006) was detected and not bands characteristic for RNA pol I
(Figure IV-1C). We therefore concluded that in both BF and PF extracts that are active in RNA
pol I and II transcription, tagged RPB7 was quantitatively and stably associated with RNA pol II
but not with RNA pol I at our detection level.

3.2. Chromatin immunoprecipitation of RPB7
Although the RPB4/7 doublet can be deposited on mRNA (Harel-Sharvit et al., 2010), the
genome-wide occupancy profile of RPB7 in yeast was congruent with that of the RNA pol II
subunit RPB3 (Jasiak et al., 2008). Hence, If RPB7 is an essential component of RNA pol I, it
should be found with RPB6z at RNA pol I promoters in ChIP experiments because it is unlikely
that major amounts of inactive polymerase that lack RPB7 are recruited to these promoters. Since
we had previously shown that a polyclonal anti-ProtA antibody is of ChIP grade that can enrich
DNA-bound transcription factors more than 50fold over control precipitations with a non-specific
immune serum (Lee et al., 2010) and since we wanted to directly compare occupancies of RPB6z,
RPB7 and the essential, RNA pol II-specific subunit RPB9 with each other, we generated clonal
BF cell lines that exclusively expressed these three essential proteins as PTP fusions (data not
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shown). As expected, RPB6z was clearly enriched at VSG ES and RRNA promoters that recruit
RNA pol I (Figure IV-2). The weaker enrichment of RPB6z at VSG ES promoters in comparison
to RRNA promoters is most likely due to the fact that RRNA transcription is spread over several
repeat units whereas only one of fifteen VSG ESs is actively transcribed in an extranucleoloar
compartment (Navarro and Gull, 2001). RPB7 and RPB9 did not significantly cross-link to VSG
ES promoters. In contrast, occupancy of RPB7 was clearly established at RRNA promoters albeit
to a lesser extent than for RPB6z. Since the RRNA promoter was also occupied by RPB9 (Figure
IV-2), this finding suggests that RNA pol II is recruited to this site rather than RPB7 being a
subunit of RNA pol I. This notion was strengthened by high RPB6z occupancy and concomitant
absence of RPB7 and RPB9 in the 18S rRNA coding region downstream of the RRNA promoter.
The presence of RNA pol II at the RRNA promoter correlates well with the previously reported
finding that the most distal domain of the T. brucei RRNA promoter resembles the bipartite
upstream sequence element (USE) of the SLRNA promoter in opposite orientation and that this
ribosomal USE, as its SLRNA counterpart, bound the small nuclear RNA-activating protein
(SNAP)50 in vitro (Schimanski et al., 2004). Therefore, it is possible that binding of the SNAP
complex to the distal domain of the RRNA promoter nucleates an RNA pol II transcription preinitiation complex that recruits RNA pol II. This recruitment may be of functional significance
because it was recently shown in the human system that noncoding RNA, derived from the RRNA
promoter sequence, induces epigenetic regulation of RRNA transcription (Schmitz et al., 2010).
The absence or low occupancies observed with RPB7 and RPB9 at RNA pol I transcription
units cannot be due to inefficient cross-linking to DNA because both proteins were nearly 60fold
enriched at SLRNA promoters and clearly detectable in the β-/α- tubulin intergenic region (Figure
IV-2). In sum, these ChIP experiments demonstrated that RPB7 occupancy closely paralleled the
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Figure IV-2. ChIP analysis of RPB6z, RPB7 and RPB9. (A) Chromatin of clonal BF cells which
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(Figure IV-2 legend cont.) exclusively express either PTP-RPB6z, RPB7-PTP or RPB9-PTP was
precipitated with a rabbit polyclonal anti-ProtA antibody (IP) and analyzed by semi-quantitative
PCR. In negative control reactions, chromatin was precipitated with a non-specific rabbit immune
serum and for a positive PCR control, a small aliquot of DNA isolated from total chromatin (Inp)
was amplified. The occupancy of these subunits were determined for the consensus VSG ES and
RRNA promoters, the 18S rRNA coding region, the SL RNA promoter and the β-/α- tubulin
intergenic region. (B) Corresponding qPCR analysis shown as the fold enrichment over the
negative immunopreciptation. These results are based on at least two independent ChIP
experiments each of which was analyzed by three qPCR reactions. Note the different scales on the
y axes.
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occupancy of the RNA pol II subunit RPB9 at both RNA pol I and II transcription units whereas
it did not correlate with the occupancy of RPB6z at these sites. These findings do not support an
essential role of RPB7 in RNA pol I transcription.

RPB7 depletion from extracts specifically affects RNA pol II transcription
Previously, we have developed a homologous in vitro transcription system in procyclic T.
brucei that was active in RNA pol I transcription and in RNA pol II-mediated SLRNA transcription
(Laufer and Günzl, 2001; Laufer et al., 1999). However, to compare our results with those of
Penate et al. (Peñate et al., 2009), we needed to establish the system in BF extract. We have been
able to develop a small scale extract procedure that was applicable to BFs. We prepared extract
from cells that exclusively expressed RPB7-PTP and depleted the extract of ~90% of RPB7 using
PTP-binding IgG beads (Figure IV-3A). We then analyzed RNA pol I and II activity in assays in
which the SLRNA promoter template SLins19 was co-transcribed either with the VSG ES promoter
template VSG-trm or the RRNA promoter template Rib-trm. In previous work, we have
unambiguously shown that SLins19 transcription is mediated by RNA pol II and VSG-trm and
Rib-trm transcription by RNA pol I (Günzl et al., 2003). In comparison to mock-depleted extract,
RPB7 depletion virtually abolished SLRNA transcription whereas it had no effect on VSG-trm and
Rib-trm transcription (Figure IV-3B, compare lanes 1 and 2 and lanes 5 and 6). The defect on
SLRNA transcription was not a non-specific artifact because adding back tandem affinity-purified
and active RNA pol II (Das et al., 2006) partially restored transcriptional activity from the SLRNA
promoter in a dose-dependent manner (lanes 3 and 4, and lanes 7 and 8). We therefore concluded
that RPB7 cannot have an indispensable role in promoter-dependent transcription of RNA pol I.
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Figure IV-3. In vitro transcription analysis of RPB7-depleted extracts. (A) Immunoblot of BF
extract prepared from cells exclusively expressing RPB7-PTP that was either mock-depleted or
RPB7-depleted by means of ProtA-interacting IgG beads. Detection of U2-40k served as a loading
control. (B) Co-transcription reactions of the SLRNA promoter template SLins19 with the VSG
ES promoter template VSG-trm or the RRNA promoter template Rib-trm. Reactions were carried
out with either mock or RPB7-depleted (depl) extracts. Extracts were reconstituted with tandem
affinity-purified RNA pol II. Transcription signals were obtained through primer extension of
radio-labeled oligonucleotides that hybridize to unique tag insertions in the SLins19, VSG-trm and
Rib-trm RNAs. Primer extension signals were separated on a 6% polyacrylamide-50% urea gel
and visualized by autoradiography. On the right, signals for correctly initiated transcription from
VSG ES, RRNA and SLRNA promoters are indicated. Marker, MspI-digested pBR322.
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Penate et al. (Peñate et al., 2009) presented in vitro transcription results which indicated that
RPB7 is important for VSG ES promoter-dependent transcription. However, they used a G-less
cassette approach which did not discriminate between accurately initiated transcription and nonspecific read-through transcription raising the possibility that their transcription signals were
generated in a promoter-independent manner. On the other hand, they did show that VSG ES
promoter deletion in the template construct resulted in a loss of transcription signal, a finding
which cannot be resolved in the light of our results.

RPB7 does not detectably localize to the nucleolus.
RNA pol I has been localized either throughout the nucleolus (Navarro and Gull, 2001) or to
the nucleolar periphery (Landeira and Navarro, 2007; Peñate et al., 2009). However, in the latter
case the signal was clearly inside the spherical structure of low DNA density that marks the
nucleolus in a DAPI stain. Penate et al. showed a co-localization mask of RPB7 and RPA1, and
argued that in the nucleolar periphery, which is the site of RNA pol I transcription (Landeira and
Navarro, 2007), there is significant co-localization. However, their RPB7 localization did not
reveal a clear nucleolar or ESB signal and it is possible that the co-localization of RPB7 and RPA1
was derived from adjacent signals that could not be resolved in their analysis. To assess whether
RPB7 can be found in the nucleolus we transiently transfected procyclic cells that expressed
RPB7-PTP with a construct harboring a NOP10-GFP fusion gene (Ruan et al., 2007). NOP10 is a
component of small nucleolar ribonucleoprotein particles and localized in the central part of the
nucleolus (Boisvert et al., 2007). In the representative cell shown in Figure IV-4, DAPI staining
revealed a large and clear nucleolus. RPB7-PTP was found in most parts of the nucleus closely
following the perimeter of the nucleolus but not detectably extending into the nucleolus. As
expected, in the same cell NOP10-GFP was found in a central nucleolar position.
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Figure IV-4. Immunofluorescence light microscopy of procyclic trypanosomes showing
constitutively expressed RPB7-PTP in red, transiently expressed Nop10-GFP in green, and DNA
in blue. Scale bar is 6.5 µm.
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Importantly, the co-localization demonstrates a clear gap between Nop10 and RPB7 representing
the nucleolar periphery. The gap suggests that RPB7, in contrast to previous localizations of RNA
pol I, does not localize to the nucleolus in detectable amounts and is present only at the nucleolar
perimeter. This, however, is not surprising because RRNA repeats are tightly flanked by RNA pol
II transcribed loci, and in procyclic cells, an apparent RNA pol II transcription unit partially
overlaps with a procyclin gene unit (Liniger et al., 2001) suggesting that on DNA, RNA pol IIbased RPB7 should be present in close proximity to RNA pol I.

IV-4. Conclusion
In this study, we have revisited the role of RPB7 in T. brucei RNA pol I transcription. We did
not find detectable interactions of RPB7 with RNA pol I in reciprocal co-immunoprecipitations or
in tandem affinity purifications with RPB7 as bait. Moreover, RBP7 did not cross-link to RNA pol
I transcription units independent of the RNA pol II subunit RPB9, and immunodepletion of RPB7
from BF extracts did not affect VSG ES and RRNA promoter transcription whereas it did abolish
SLRNA transcription by RNA pol II. Unlike RNAi-mediated expression silencing of RPB7, these
approaches avoid potential secondary effects of an RNA pol II shut-down. While our data do not
exclude a potential role of RPB7 in VSG expression, they show that RPB7 is not a bona fide subunit
of RNA pol I and has no indispensable role in RNA pol I transcription in T. brucei.
It should be noted here that RPA31 could be the missing RNA pol I paralog of RPB7 because
it was essential for promoter-dependent RNA pol I transcription and found to be associated with
RNA pol I only in the presence of RPB6z (Nguyen et al., 2007; Nguyen et al., 2006), the subunit
ortholog that recruits RPA43 in yeast (Schimanski et al., 2006). Although RPA31 was described
as a “novel” subunit because its sequence is only conserved among trypanosomatids (Nguyen et
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al., 2007), recent characterizations of T. brucei TFIIB (Lee et al., 2009; Palenchar et al., 2006),
TFIIH (Peyroche et al., 2002) and, in particular, mediator (Lee et al., 2010) revealed that
trypanosomatid transcription factor sequences are extremely divergent to those of other eukaryotes
and, therefore, may not reveal the identity of a protein.
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IV-5. Response to “Role of RPB7 in RNA pol I transcription in Trypanosoma
brucei”
In their letter, Navarro et al. (Navarro et al., 2011) criticize our approaches and conclusion that
RPB7 is not required for RNA polymerase (pol) I transcription in Trypanosoma brucei (Park et
al., 2011). Our results are in sharp contrast to their previously published work which claimed that
RPB7 is essential for RNA pol I transcription (Peñate et al., 2009). We used several independent
criteria to evaluate the functional role of RPB7 in RNA pol I transcription, namely reciprocal coimmunoprecipitation (co-IP), tandem affinity purification (TAP), chromatin immunoprecipitation
(ChIP), in vitro transcription assays and indirect immunofluorescence (IF) microscopy. In no case
did we find evidence that RPB7 has an RNA pol II-independent function in RNA pol I transcription
or that this protein is stably associated with RNA pol I. We had hoped that the letter by Navarro et
al. would help to resolve the discrepancy between our two studies; instead we had to read some
rather far-fetched arguments why our results could be artifacts.
Navarro et al. describe RPB7 to be essential for RNA pol I transcription and, at the same time,
not to be a bona fide RNA pol subunit (Navarro et al., 2011). Conversely, though dissociable after
transcription initiation (Harel-Sharvit et al., 2010), RPB7 has been described as an essential RNA
pol II subunit that is required for promoter-dependent transcription initiation (Edwards et al., 1991)
and ChIP assays demonstrated that RPB7 occupancy is congruent to that of the non-dissociable
subunit RPB3 (Jasiak et al., 2008). Accordingly, we readily found T. brucei RPB7 as part of RNA
pol II complexes and cross-linked to RNA pol II transcription units while no such link to RNA pol
I was detectable (Park et al., 2011). Navarro et al. also state that they have “previously described
a low-affinity interaction of RPB7 with RPA1” (Navarro et al., 2011). The term “low affinity”,
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however, was not used in their original publication (Peñate et al., 2009) and their interpretation of
low affinity remains unclear.
The most obvious discrepancy between the two studies resides in the in vitro transcription
outcomes. In our assays, RPB7 depletion of extract nearly abolished RNA pol II transcription but
left RNA pol I transcription unaffected (Park et al., 2011) whereas a similar approach by Penate et
al. interfered with RNA pol I transcription (Peñate et al., 2009). It should be noted that our system
allows co-transcription of RNA pol I and II promoter templates and, due to primer extensionderived transcription signals, monitors accurate transcription initiation. In comparison, the
transcription signals provided by Penate et al. (Peñate et al., 2009) depended on a G-less cassette
that was introduced downstream of the transcription initiation site. Hence, there is no
discrimination between accurately initiated and non-specific read-through transcription. In
addition, individual reactions were not internally controlled. This is particularly bothersome
because their analysis was not quantitatively assessed, e.g. based on signal quantification of
repeated experiments.
According to Navarro et al. the lack of an effect on RNA pol I transcription in our assays could
stem from residual amounts of RPB7 left in the extract (Navarro et al., 2011). Since our extracts
were prepared from cells that exclusively expressed the essential RPB7 as a TAP tag fusion, this
would mean that the tandem protein A domains of tagged RPB7 were masked in the RNA pol I
complex but accessible in the RNA pol II complex. Having precipitated and purified more than 30
different TAP-tagged proteins (see for example (Brandenburg et al., 2007; Lee et al., 2010; Lee et
al., 2009)), we have not come across a single case in which the large tandem protein A domains of
the TAP tag were inaccessible to IgG beads or antibodies.
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Navarro et al. stated that in our co-IP analysis 25% of RPB7 interacted with RPB1 and only
1% of RPB7 interacted with RPA1 (Navarro et al., 2011). This is not true. In fact, we did not find
any interaction between RPB7 and the RNA pol I-specific subunit RPB6z in both reciprocal co-IP
and RPB7 TAP whereas in both assays RPB7 was stably associated with RNA pol II. We did,
however, acknowledge that, due to the ambiguousness of quantifying large amounts of
immunoprecipitate, we could not exclude the possibility that a very small amount of RPB7 (<1%)
was associated with RPB6z.
In regard to the amount of active RNA pol I in extracts, a study in yeast found that up to 98%
of RNA pol I was inactive. However, the inactivity was due to the dissociation of the transcription
factor RRN3 from RNA pol I and not to the lack of an RNA pol I subunit, e.g. the RNA pol I
paralog of RPB7 termed RPA43 (Milkereit and Tschochner, 1998).
Navarro et al. criticize our ChIP approach because we, like many others, compare the
enrichment of precipitated DNA over a negative control immunoprecipitation in which we use a
comparable, non-specific immune serum. While the suggested normalization to input amount is
valid, too, this kind of analysis promotes the usage of extremely low ratios of chromatin input and
antibody beads. More importantly, our ChIP analysis demonstrated that identically tagged RPB7,
RPB6z and RPB9 could be effectively and specifically cross-linked to chromatin. In all cases, we
found congruency of RPB7 and RPB9 (RNA pol II) occupancies that did not correlate with RPB6z
(RNA pol I) occupancy. In this regard, we find it inappropriate that Navarro et al. mention
unpublished data in their support which cannot be evaluated yet.
Concerning IF microscopy, we maintain that the co-localization mask provided by Penate et
al. (Peñate et al., 2009) cannot discriminate between adjacent signals and true co-localization.
Since they concluded that RPB7 is generally required for RNA pol I including transcription of
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ribosomal RNA genes, our approach to localize RPB7-PTP in nucleoli of transiently transfected
procyclics is valid.
Importantly, a major difference between our study and that of Penate et al. was that we used
functional protein tags (exclusive expression of essential, tagged proteins) and they used a
polyclonal anti-RPB7 antiserum. Since it is very likely that trypanosome RNA pol I requires an
RPA43 ortholog (Kuhn et al., 2007) representing an RPB7 paralog, Navarro et al. should make
sure that their antibody does not cross-react with an RNA pol I-specific protein, e.g. TbRPA31
(Nguyen et al., 2007), the protein we favor in retrospect to be the RNA pol I paralog of RPB7 (see
conclusion section in (Park et al., 2011)).
Finally, we are convinced that our data, in contrast to the title-based conclusion of Penate et
al. (Peñate et al., 2009), demonstrate that RPB7 has no essential role in T. brucei RNA pol I
transcription; it does not replace the function of an RPA43 ortholog. As we state in our publication,
we cannot rule out a post-transcriptional or RNA pol II-based role of RPB7 in the expression of
RNA pol I-synthesized transcripts because this was not the aim of our analysis.
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Chapter V
Mono-allelic VSG expression by RNA polymerase I in Trypanosoma
brucei: expression site control from both ends? (Review)

Abstract
Trypanosoma brucei is a vector borne, lethal protistan parasite of humans and livestock in subSaharan Africa. Antigenic Variation of its cell surface coat enables the parasite to evade adaptive
immune responses and to live freely in the blood of its mammalian hosts. The coat consists of ten
million copies of variant surface glycoprotein (VSG) that is expressed from a single VSG gene,
drawn from a large repertoire and located near the telomere at one of fifteen so-called bloodstream
expression sites (BESs). Thus, antigenic variation is achieved by switching to the expression of a
different VSG gene. A BES is a tandem array of expression site-associated genes and a terminal
VSG gene. It is polycistronically transcribed by a multifunctional RNA polymerase I (RNAPI)
from a short promoter that is located 45-60 kb upstream of the VSG gene. The mechanism(s)
restricting VSG expression to a single BES are not well understood. There is convincing evidence
that epigenetic silencing and transcription attenuation play important roles. Furthermore, recent
data indicated that there is regulation at the level of transcription initiation and that, surprisingly,
the VSG mRNA appears to have a role in restricting VSG expression to a single gene. Here, we
review BES expression regulation and propose a model in which telomere-directed, epigenetic
BES silencing is opposed by BES promoter-directed, activated RNAPI transcription.
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V-1. Introduction
The tsetse borne, unicellular parasite Trypanosoma brucei, which belongs to the phylogenetic
order Kinetoplastida, is the only known organism that has evolved a multifunctional RNA
polymerase I (RNAPI) system. This system is used to transcribe ribosomal gene units (RRNA) in
the nucleolus, as in all eukaryotes, yet also to transcribe gene units that encode the parasite’s major
cell surface antigens (Günzl et al., 2003; Kooter and Borst, 1984). Trypanosomes have a unique
mode of protein coding gene expression that allows them to utilize other RNA polymerases than
RNAPII for the production of functional mRNA. In their genome, protein coding genes are
arranged in long tandem arrays which are polycistronically transcribed. The precursor RNA is
processed by spliced leader (SL) trans splicing and polyadenylation, resulting in mature,
monocistronic mRNAs (Günzl, 2010; Michaeli, 2011; Preußer et al., 2012). Since in trans splicing
the same capped leader sequence, derived from the SL RNA, is spliced onto the 5/ end of each
mRNA, this process represents a post-transcriptional mode of capping that is decoupled from
RNAPII transcription. Consequently, trypanosomes, in contrast to mammals (Grummt and
Skinner, 1985), are able to use RNAPI to effectively and specifically express endogenous gene
units that encode their major cell surface antigens (Rudenko et al., 1991; Zomerdijk et al., 1991a).
This antigen, in mammalian-infective metacyclic and bloodstream form (BF) trypanosomes, is
known as the variant surface glycoprotein (VSG), while the major cell surface antigen in insectstage procyclic form trypanosomes is procyclin.
T. brucei causes Human and Animal African Trypanosomiasis (also known as Sleeping
Sickness and Nagana, respectively) throughout sub-Saharan Africa (Fevre et al., 2006). The
parasite lives freely in the bloodstream of its mammalian host, evading the immune system by
antigenic variation of its cell surface coat. The coat consists of ten million copies of the same VSG,
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shielding invariant membrane proteins from immune recognition (Schwede et al., 2011). T. brucei
possesses roughly 2500 different VSG genes and pseudogenes (Cross et al., 2014), and periodic
switching to the expression of an alternative VSG gene leads to antigenic variation. VSG genes are
located in subtelomeric regions of 11 megabase, 5 intermediate-sized and ~100 minichromosomes
covering, in total, ~30% of the genome (Ersfeld, 2011; Horn, 2014). However, the active VSG
gene is invariably located next to the telomere within an expression site, with the coding region
ending ~200-1800 bp upstream of the telomeric repeats. Metacyclic trypanosomes express a single
VSG monocistronically from one of five metacyclic expression sites in which the RNAPI promoter
is located ~1-4 kb upstream of the coding region (Cross et al., 2014; Ginger et al., 2002; Kolev et
al., 2012). Conversely, BFs express the active VSG from one of fifteen polycistronic “bloodstream
expression sites” (BESs) which comprise a tandem array of typically 8-9 expression-site associated
genes (ESAGs) and a terminal VSG gene (Figure V-1) (Hertz-Fowler et al., 2008). ESAGs appear
to be important for the successful infection of the mammalian host since they encode a variant
heterodimeric transferrin receptor (ESAG6 and ESAG7), whose varying affinity for transferrins
of different host species is thought to expand the parasite’s host range (Bitter et al., 1998). These
also encode adenylate cyclases (ESAG4) that inhibit the innate immune system upon trypanosome
lysis (Salmon et al., 2012).
The BES promoter resides 45-60 kb upstream of the telomere (Zomerdijk et al., 1990). It
extends only 67 bp upstream of the transcription initiation site and comprises two short sequence
elements (Pham et al., 1996; Vanhamme et al., 1995). Both elements are required for efficient
binding of the multi-subunit class I transcription factor A (CITFA) which is essential for RNAPI
transcription in the trypanosome (Brandenburg et al., 2007). The active BES is transcribed
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Figure V-1. Schematic outline of BES5 and interacting proteins
Depiction of BES5 (to scale) as a representative BES according to the published sequence (HertzFowler et al., 2008). The diagram includes ESAGs (labeled 1, 2, 4-8 and 12), a VSG pseudogene
(Ψ), 70 bp repeats preceding the terminal VSG gene, and the telomeric repeats (T). Note that some
BESs have an additional promoter and an ESAG10 gene ~14 kb upstream of the depicted promoter
(not shown). The green arrow and red X represent the promoter when the BES is in the active state
and silent state, respectively. Activating factors that are predominantly associated with the active
BES are indicated above the diagram in green whereas factors which are implied in BES silencing
are listed below the diagram in red. Filled and empty arrowheads indicate positive and negative
ChIP results, respectively. Histone H1 and SPT16 associate predominately with silent sites
whereas TbISWI and NLP were shown to interact equally with expression sites in both states.
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outside the nucleolus (Chaves et al., 1998), apparently in a small compartment termed the
expression site body (ESB) (Navarro and Gull, 2001). In BFs the switch to the expression of
another VSG occurs by two principal ways: either the active BES is silenced while one of the silent
BESs is activated, or a DNA recombination event replaces the VSG gene in the active BES with a
VSG gene from the repertoire.
Antigenic variation and mono-allelic VSG expression in T. brucei have been a research focus
for decades. Several factors involved in BES silencing have been identified (see below) and BES
silencing has been linked to DNA replication/ORC1 (Benmerzouga et al., 2013; Tiengwe et al.,
2012), chromosome maintenance (Kim et al., 2013b), and association of BESs with the nuclear
lamina (DuBois et al., 2012). In addition, cohesin plays a critical role in maintaining the activated
state of the BES during the cell cycle (Landeira et al., 2009). Recently, excellent and detailed
reviews have addressed antigenic variation in trypanosomes and the biology of BES silencing
(Alsford et al., 2012; Glover et al., 2013; Horn, 2014; Horn and McCulloch, 2010; Rudenko, 2010).
Here we focus on the most recent findings of factors that appear to be directly involved in BES
regulation, and propose a model in which BES-specific telomeric silencing is opposed by a
mechanism that activates transcription initiation at the promoter of the active BES.

V-2. Telomeric Silencing
The active VSG gene, independent of whether it resides in metacyclic or bloodstream
expression sites, is invariably located near the telomere, indicating that the telomere has an
essential function in regulating VSG expression. Accordingly, repression of RNAPI-mediated
transcription by the telomere was directly demonstrated by integrating a plasmid with seeds for de
novo telomere formation either at BESs or, internally, at RRNA loci (Glover and Horn, 2006). At
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the latter, tight repression extended only 2 kb upstream of telomeric repeats whereas, at inactive
BESs, repression reached at least 5 kb in these experiments. The more extended repression of silent
BESs was consistent with previous findings in which integration of RNAPI promoter-driven
reporter cassettes at different positions of a silent BES were repressed, even when placed 14 kb
upstream of the telomere (Horn and Cross, 1997). Several lines of evidence suggest that the
pronounced silencing of BESs is dependent on the telomere. Depletion of the telomeric protein
RAP1 led to de-repression of silent BESs, co-expression of multiple BES-encoded VSG genes, and
the formation of additional extranucleolar RNAPI foci (Yang et al., 2009). Furthermore, depletion
of the disruptor of telomeric silencing B (DOT1B), which methylates lysine 76 of trypanosome
histone H3 (Janzen et al., 2006), similarly led to de-repression of silent BESs (Figueiredo et al.,
2008). Direct evidence for repression of a BES from the telomere stems from a recent study in
which induced expression of a VSG transgene, inserted into one of the RRNA loci, surprisingly led
to a short-term, reversible attenuation of the active BES, indicating that VSG mRNA plays a direct
role in the regulation of mono-allelic VSG expression (Batram et al., 2014). Interestingly, a time
course experiment showed that this silencing of the active BES spread from the telomere towards
the BES promoter in a DOT1B-dependent manner (Batram et al., 2014). Together, these data
strongly indicated that BES silencing is directed by the telomere. Furthermore, it is likely that the
VSG gene on silent BESs is protected from RNAPI transcription by more than one mechanism
because DOT1B knockout cells could still shut down the active VSG gene upon ectopic VSG
expression but were unable to attenuate expression of the remainder of the active BES (Batram et
al., 2014).
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V-3. BES transcription attenuation
Inactive BESs are completely silent only in regard to their telomere-proximal regions,
including the terminal VSG gene. VSG mRNA from inactive BESs is 104 to 105-fold less abundant
than that from the active BES (Figueiredo et al., 2008; Yang et al., 2009). Despite this strong
difference, several observations have shown that transcription does initiate at silent BESs at a
clearly detectable level. The first evidence came from a study in which insertion of a selectable
marker gene 1 kb downstream of a “silent” BES promoter led to resistant parasites (Navarro and
Cross, 1996). BES sequences are highly similar, especially at the promoter and in the proximal
downstream region, differing from each other only by a few single nucleotide polymorphisms.
However, the first genes within BESs are ESAG7 and ESAG6 which encode the heteromeric
transferrin receptor and harbor short hypervariable regions that distinguish them from each other
(Zomerdijk et al., 1991b). Analysis of ESAG6 cDNA sequences, which on BESs are located ~5 kb
downstream from the promoter, revealed that 20% of the ESAG6 mRNA in BFs was derived from
various silent BESs whereas 80% stemmed from the active BES, demonstrating that, even in the
absence of selective pressure, productive transcription did occur in the promoter-proximal domain
of inactive BESs (Ansorge et al., 1999). Subsequently, a vast cDNA clone analysis along whole
BESs showed that silent BESs contributed much more to the promoter-proximal cDNA pool than
to pools of promoter-distant cDNAs, revealing that transcription that initiated at silent BESs was
attenuated along the BES (Vanhamme et al., 2000). Recently, this approach was repeated with
single cells, confirming that silent BESs are transcribed in their promoter-proximal region and that
transcription was attenuated further downstream within a single trypanosome (Kassem et al.,
2014). Finally, the demonstration that BES silencing spreads gradually from telomere to promoter
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and BES reactivation occurs gradually in the opposite direction (Batram et al., 2014) strongly
supports the notion that transcription is attenuated at silent BESs.

V-4. Regulation of BES transcription Initiation
Although the promoters of inactive BESs are not “silent”, there is now convincing evidence
that there is substantial regulation at BES promoters. Consistently, promoter-proximal RNA levels
were found to be much higher from the active versus silent BESs. Thus, when the neomycin
phosphotransferase gene (NEO) was inserted 1 kb downstream of the promoter of an inactive BES,
it conferred parasite resistance to a low concentration of the drug G418 (1 µg/ml) while the same
gene, when inserted at the identical position of an active BES, boosted resistance at least 100-fold
(Navarro and Cross, 1996). The finding that in BFs 80% of ESAG6 mRNA stemmed from the
active BES suggested that there is at least a 50-fold stronger ESAG6 expression from the active
BES than from the average silent BES. When Yang et al. (2009) introduced a luciferase gene
immediately downstream of the active or a silent BES promoter, the active BES produced 15004000-fold more light units than the silent BES.
More direct evidence for BES regulation at the level of transcription initiation came from the
analysis of CITFA. CITFA consists of seven subunits, CITFA1-7, which are conserved only
among kinetoplastid organisms, and the dynein light chain DYNLL1 (also known as LC8).
Silencing of CITFA1, CITFA2 and CITFA7 was lethal to BFs grown in culture and strongly and
specifically reduced the abundance of rRNA and VSG mRNA (Brandenburg et al., 2007; Nguyen
et al., 2012; Park et al., 2014). Accordingly, depletion of CITFA2 from extract virtually abolished
RNAPI transcription in vitro, as assayed by ~100 bp-long primer extension products, and the
purified CITFA complex produced a specific gel shift with the BES promoter (Brandenburg et al.,
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2007). Moreover, a ChIP-seq analysis indicated that within a BES, CITFA7 occupancy was
restricted to the promoter region (Nguyen et al., 2014). Together, these findings identified CITFA
as a basal and general transcription initiation factor for RNAPI transcription in trypanosomes.
Interestingly, marking the active BES and a silent BES ~500 bp downstream of the
transcription initiation site (Figueiredo et al., 2008) revealed that CITFA2 and CITFA7
predominantly occupied the promoter of the active BES relative to that of the marked silent BES,
a phenotype that was maintained after consecutive in situ switches between the two marked sites
(Nguyen et al., 2014). In accordance with CITFA’s role as an RNAPI transcription initiation factor,
higher CITFA occupancy at the active versus the silent BES promoter correlated with a ~70-fold
higher abundance of promoter-proximal, unspliced RNA and a ~17-fold higher occupancy of the
RNAPI-specific subunit RPB6z at the marker gene (Nguyen et al., 2014). Finally, CITFA7
silencing led to a strong reduction of RNAPI occupancy and of promoter-proximal RNA levels,
which directly demonstrated that CITFA binding to the promoter is required for high transcription
rates in vivo (Nguyen et al., 2014). These data unequivocally showed that mono-allelic BES
expression entails a mechanism that functions at the BES promoter, apparently limiting access of
CITFA to silent BES promoters and/or ensuring maximal promoter occupancy of CITFA at the
active BES.
It should be noted that this mechanism is not an “all or nothing”-mechanism because, in these
experiments, the marked silent BES promoter was consistently occupied by CITFA above the level
of negative control experiments. This finding is in accordance with promoter-proximal
transcription occurring at silent BESs (see above) and it likely explains why hypersensitive DNase
I sites in the promoter region, indicative of a bound transcription factor, were not restricted to the
active BES but were also detected at a silent BES (Navarro and Cross, 1998). It appears that
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trypanosomes cannot completely shut down transcription initiation from silent BESs.
Alternatively, low level transcription of the promoter-proximal part of silent BESs might serve a
biological function. For instance, co-expression of different forms of the heteromeric transferrin
receptor, e.g. ESAG6 and ESAG7, could ensure initial survival in different mammalian hosts.

V-5. Factors involved in BES transcription regulation
There is strong evidence that inactive BESs are silenced epigenetically. Thus, while silent
BESs have a nucleosomal structure, the active BES is largely depleted of nucleosomes (Figueiredo
and Cross, 2010; Stanne and Rudenko, 2010). Direct evidence that nucleosomes are important for
BES promoter silencing stems from depleting histone H3, which rapidly led to a ~11-fold derepression of a GFP gene introduced downstream of the promoter of a silent BES (Alsford and
Horn, 2012). In addition, CAF-1b, a replication-dependent histone chaperone, and the replicationindependent chaperone ASF1A, were shown to be important for the inheritance and maintenance
of the silenced state of BESs (Alsford and Horn, 2012). Interestingly, silencing the gene of either
chaperone led to apparent nucleosome depletion and a de-repression of the promoter-proximal
BES region. However, it did not affect expression of the corresponding VSG gene suggesting that
nucleosomal structure is particularly important for the regulation of BES promoter activity.
Several chromatin remodeling and modifying proteins have been implicated in BES repression
so far. The first epigenetic factor found to play a role in BES regulation was the chromatin
remodeler TbISWI (Hughes et al., 2007). Depletion of this factor increased the mRNA abundance
of a reporter gene inserted promoter-proximally into a silent BES up to 60-fold, whereas only a
fivefold increase of the corresponding silent VSG mRNA was observed. TbISWI was found to
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occupy the entire length of both silent and active BESs, but was not enriched at BES promoters
(Stanne et al., 2011). Although the specific function of TbISWI remains to be determined, these
results suggest that TbISWI controls RNAPI transcription elongation rather than initiation.
Similar de-repression of a promoter-proximal reporter gene was observed when the histone
deacetylase DAC3 (Wang et al., 2010), the linker histone H1 (Pena et al., 2014; Povelones et al.,
2012), or the nucleoplasmin-like protein NLP (Narayanan et al., 2011) was depleted. The function
of DAC3 appears to be promoter-specific since expression of the VSG gene in the marked BES
was unaffected at both the mRNA and the protein level (Wang et al., 2010). However, direct
association of DAC3 with BESs has not been demonstrated yet and it remains a possibility that
DAC3’s control of BES silencing is indirect.
The role of histone H1 in BES promoter repression has been more deeply investigated. Histone
H1 is important for chromatin architecture and generally functions in chromatin condensation and
transcription repression (Happel and Doenecke, 2009). Accordingly, co-silencing of the T. brucei
H1 multigene family opened up chromatin globally with the strongest effect on silent BES
promoters (Pena et al., 2014). Metabolic labeling of nascent RNA then showed that histone H1
depletion resulted in an approximately six-fold higher promoter-proximal transcription rate at a
silent BES, indicating that relaxation of the nucleosome structure in the promoter region led to an
increase of the transcription initiation rate at the silent BES (Pena et al., 2014).
NLP is a ubiquitous nuclear protein and, accordingly, was found to be associated with all
genomic loci analyzed, including the active and silent BESs (Narayanan et al., 2011). Despite this
apparent general association with genomic DNA, NLP seems to be particularly important for BES
promoter regulation. Depletion of NLP de-repressed a silent BES 45-65-fold, as measured by
fluorescence derived from a promoter-proximal GFP gene. Moreover, NLP silencing also reduced
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promoter-proximal gene expression from the active BES about threefold (Narayanan et al., 2011).
While it was speculated that NLP may have a dual function in BES silencing and in promoting
processive transcription at the active BES (Narayanan et al., 2011), it is equally possible that loss
of NLP enabled competition between silent and the active BES for the RNAPI transcription
machinery. However, the specific function of NLP in BES regulation remains to be determined.
SPT16 is a subunit of the trypanosome FACT (“facilitates chromatin transcription”) complex
(Patrick et al., 2008) and appears to have a direct role in BES promoter silencing because it was
found highly enriched at a silent BES promoter (Denninger et al., 2010). Accordingly, SPT16
silencing increased promoter-proximal GFP expression from a silent BES up to 25-fold, yet derepression did not extend to the VSG genes of silent BESs. However, the de-repression effect was
strongly correlated with an arrest in the G2/early M cell cycle phase, raising the possibility that
SPT16 does not generally facilitate BES repression in the bloodstream trypanosome. Moreover,
SPT16 depletion strongly reduced VSG expression from the active BES, suggesting a separate
BES-related function of SPT16 in facilitating processive RNAPI transcription. Overall, the
specific function of FACT in the multifunctional RNAPI system remains unclear. While SPT16
has been co-purified with RNAPII of the related organism Leishmania major (Martinez-Calvillo
et al., 2007), its association with T. brucei RNAPI remains to be shown.
The epigenetic factors discussed so far, including RAP1 and DOT1B (see section 2, Telomeric
silencing, above), function in BES silencing. The only such factor found to be important for
efficient transcription of the active BES is the high mobility group protein TDP1, which belongs
to a family of architectural chromatin proteins (Narayanan and Rudenko, 2013). Interestingly,
TDP1 exhibited an inverse occupancy pattern to the core histone H3 at RNAPI-transcribed loci
and was up to fivefold more abundant at the active BES promoter relative to a silent BES promoter.
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Accordingly, TDP1 depletion decreased the abundance of pre-rRNA and VSG mRNA from the
active BES. In addition, TDP1, a nuclear protein, exhibited predominant localization to the
nucleolus and the ESB, and its DNA association was found throughout the active BES and RRNA
gene units. Thus, it appears that TDP1 facilitates high rates of processive RNAPI transcription
required for trypanosome survival (Narayanan and Rudenko, 2013).

V-6. A model of BES regulation
It is difficult to integrate the data from BES de-repression studies because, for most factors,
specific functions in BES silencing have not been determined yet. Nevertheless, recent data
strongly indicated that BES regulation occurs at both ends of expression sites. RAP1 and DOT1B
depletion studies have clearly shown that BESs are silenced by a telomere-directed mechanism.
Moreover, the demonstration that BES silencing spreads from the telomere towards the promoter
(Batram et al., 2014) strongly supports a telomere-directed BES silencing mechanism. However,
it is unlikely that this is the only mechanism regulating mono-allelic BES expression. If this was
the case one would expect full activation of promoter-proximal transcription once telomeric
silencing retreats beyond the promoter region, which should result in a leveling of the transcription
rate between active and silent BESs (given the extremely high expression level of the active BES,
it is unlikely that a trypanosome can support full activation of all fifteen BESs). However, in all
cases reported, de-repression of silent BESs is, at best, moderate with the promoter-proximal
expression level remaining manifold below that of the active BES. Furthermore, RAP1 silencing
did not strongly affect promoter-proximal transcription of de-repressed BESs and had only a minor
influence on the high expression level of the active BES (Yang et al., 2009). Similarly, DOT1B
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silencing did not affect expression of the active BES at all (Figueiredo et al., 2008). These results
strongly argue for the presence of a separate mechanism involved in BES regulation.
Transcription attenuation has been proposed to be that mechanism and, as discussed, there is
clear evidence that it does occur on silent BESs (Kassem et al., 2014; Vanhamme et al., 2000).
Moreover, some data suggested that transcription attenuation is caused by inefficient transcript
processing (Vanhamme et al., 2000) rather than by repressive chromatin. However, recent data do
not support this scenario. The finding that RAP1 silencing caused gradual BES de-repression with
the greatest effect on telomere-proximal genes, strongly indicated that transcription elongation on
silent BESs is “antagonized” by telomere-directed spreading of repressive chromatin (Yang et al.,
2009). Furthermore, upon removal of the apparent transcription elongation barrier, e.g.
pronounced telomeric silencing, by RAP1 (Yang et al., 2009) or DOT1B (Figueiredo et al., 2008)
depletion, promoter-proximal expression remained magnitudes below that of the active site,
making it unlikely that transcription attenuation accounts for the strong difference in promoterproximal transcription observed between active and silent BESs. Hence, transcription attenuation
appears to be a consequence of epigenetic silencing rather than a regulatory mechanism, and seems
to be in place to prevent the low level of transcription that does initiate at silent BESs from reaching
the distally located VSG gene.
Based on the RAP1 silencing results on BES de-repression, Yang et al. (2009) suggested that
there has to be a mechanism functioning on the BES promoter that could explain the striking
difference in promoter-proximal expression levels between the active and de-repressed/silent
BESs. The strongest support for this idea stems from the demonstration that CITFA, which is
absolutely required for RNAPI transcription, is predominantly associated with the active BES
promoter, versus a silent site, strongly indicating that there is a mechanism in place that allows
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CITFA to preferentially interact with the active BES. In addition, the fact that depletion of several
epigenetic factors increased promoter-proximal transcription with no or very little effect on the
downstream VSG gene further supports the notion of a promoter-dependent regulatory mechanism.
Taking these data into account, we propose a model in which BESs are regulated by two
opposing forces, namely telomere-directed epigenetic silencing acting on silent BESs and
activated transcription initiation at the active BES (Figure V-2). In this model, the active BES
promoter has unrestricted access to CITFA and RNAPI, allowing it to achieve the high
transcription rate necessary for productive VSG expression. In addition, productive RNAPI
transcription at the active BES is ensured by the presence of TDP1. At the same time, telomeric
silencing at the active BES is impaired or pushed back so far that RNAPI transcription can extend
productively past the VSG gene. In contrast, in this model, silent BES promoters are unable to
recruit CITFA and RNAPI in sufficient amounts to allow for high transcription rates. In addition,
a telomere-directed repressive epigenetic gradient spreading from the telomere into the BES causes
transcription attenuation to prevent the low level of transcription, initiating at inactive BESs, from
reaching the VSG gene.
How are BES promoters differentially regulated? An obvious mechanism that could prevent
CITFA from interacting with silent BES promoters and from recruiting RNAPI is a repressive
chromatin structure at the promoter. The epigenetic factors whose depletion led to promoterproximal BES de-repression, e.g. DAC3, histone H1 and NLP, may be important to build up a
repressive chromatin structure at the promoter. If this is correct, depletion of these factors should
lead to higher CITFA and RNAPI occupancies at de-repressed promoters. An alternative idea for
the low promoter activity at “silent BESs” has been put forward in studies of CITFA. CITFA was
found to be concentrated in both the nucleolus and the ESB (Nguyen et al., 2014), and it retained
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Figure V-2. Model of BES regulation in T. brucei
In the model of BES regulation, two opposing forces antagonize each other. The active BES is
characterized by high transcription initiation rates and the lack of telomere-dependent epigenetic
silencing, allowing unrestricted transcription elongation past the terminal VSG gene (green arrow).
High processive transcription rates are facilitated by CITFA and TDP1. In silent BESs, low level
RNAPI transcription initiation is opposed by BES-specific telomeric silencing that spreads
towards the BES promoter causing transcription attenuation. This silencing depends on a
nucleosomal structure, DOT1B and RAP1. RAP1 was shown to bind to telomeric repeats but the
association of DOT1B with BESs remains to be determined (dotted line). Epigenetic factors may
work together to build up a repressive chromatin structure at the promoter of silent BESs,
preventing efficient binding of CITFA to its cognate DNA sequence elements. Alternatively,
CITFA sequestration may limit the availability of the initiation factor for inactive BESs (not
shown).
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this localization even when its promoter-binding capability was impaired by depletion of the
essential subunit CITFA1 (Park et al., 2014). It was therefore suggested that sequestration of
CITFA into the nucleolus and the ESB could restrict maximal RNAPI transcription to these
compartments. This idea is in line with a previous study in which BFs were forced to co-express
two BESs simultaneously by antibiotic selection. The two marked BESs were consistently detected
in close spatial proximity (Chaves et al., 1999), as if they were competing for an essential
expression factor. Furthermore, it may explain why de-repressed BES promoters remain much less
active than the promoter from the active BES.
Finally, this model of two opposing forces is supported by the monitoring of the shutdown/reactivation of the active BES upon ectopic expression of VSG mRNA (Batram et al., 2014).
In these experiments the active BES was gradually inactivated from the telomere towards the
promoter, most likely by an active, telomere-directed process of repressive chromatin spreading,
whereas the reactivation of the same BES occurred in the reverse direction, possibly by removal
of nucleosomes by the transcription machinery. An important question emanating from this study
is how does the ectopically expressed VSG mRNA cross-talk to the active BES? Although this
question is beyond the scope of this article, it is tempting to speculate that the VSG mRNA
sequestered an important factor for RNAPI transcription, allowing repressive chromatin to spread
onto, and silence, the active BES.

V-7. Conclusion
Mono-allelic VSG expression in T. brucei differs from other allelic exclusion systems, such as
var gene expression in Plasmodium falciparum (Guizetti and Scherf, 2013; Kirkman and Deitsch,
2012) or olfactory receptor expression in mammals (Magklara and Lomvardas, 2013) by the fact
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that the active VSG gene must be transcribed at an extremely high rate to enable rapidly
proliferating trypanosomes to completely cover themselves with VSG. The careful measurement
of RNA abundances and half lives indicated that the active VSG gene is transcribed at a 50-fold
higher rate than a β-tubulin gene (Ehlers et al., 1987). At the same time, T. brucei must ensure that
VSG genes on other BESs are not expressed. The parasite achieves this balancing act apparently
by restricting full RNAPI transcription initiation to the active BES and by shielding VSG genes on
silent BESs by a telomere-dependent silencing mechanism that causes attenuation of RNAPI
transcription.
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Chapter VI
Discussion and future directions

VI-1. Gene silencing by targeting heterologous sequences is a new and flexible
tool for studying T. brucei
Previous work on CITFA revealed that it was a promoter-binding factor required for all
transcription by RNA pol I in T. brucei (Brandenburg et al., 2007). CITFA was shown to consist
of 8 subunits, CITFAs 1-7 (Brandenburg et al., 2007; Nguyen et al., 2012), conserved only among
kinetoplastids, and a dynein light chain LC8 that is conserved among eukaryotes (Wickstead and
Gull, 2007). CITFA was previously shown to co-localize to the sites where transcription by RNA
pol I occurs, and was also shown to be present at RRNA and BES promoter (Brandenburg et al.,
2007; Nguyen et al., 2012). For an overview of transcriptional regulators known to bind to active
and silent BESs, including CITFA, please see Figure V-2 on page 139. While CITFA2 and
CITFA7 were previously shown to be essential for transcription by RNA pol I, the specific role of
CITFA subunits in transcription was unclear. Furthermore, while it had been demonstrated that
CITFA was localized to the nucleolus and the expression site body, or ESB, where VSG
transcription takes place, its means of restriction to these compartments was unknown. While
pursuing the above, we attempted to silence CITFA1 by producing double stranded RNA (dsRNA)
targeting CITFA1’s coding sequence and 3/ untranslated region (UTR), which failed, even though
this approach had been successfully used in our lab with other genes.
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As detailed in Chapter II and Chapter III, we were able to solve this problem, and
investigate the role of CITFA1, by developing a new system for gene silencing that relied on
targeting heterologous sequences. We demonstrated that it was possible to specifically silence
CITFA7 and CITFA1 using two different fused heterologous sequences (Park et al., 2014), one
being a tandem affinity tag while the other was a 3/ UTR from another member of the genus,
Trypanosoma cruzi. The phenotype produced upon CITFA7 silencing was in accordance with a
previously published silencing of CITFA7 that targeted its coding sequence (Nguyen et al., 2012),
showing that our approach was valid. The lack of a phenotype upon replacing CITFA7’s
endogenous 3/ UTR with one from T. cruzi suggests that the genomic elements required for RNA
processing are shared between these two species. The main purpose of this work, however, was to
develop a tool for specific gene silencing that was less reliant on targeting endogenous sequences,
and there are numerous advantages to using this approach. Firstly, some genes, as was shown in
Chapter III, were unaffected when dsRNA targeting their coding sequences or UTRs were
expressed. Only though fusion of a targetable heterologous sequence could silencing be achieved.
Secondly, gene silencing by production of dsRNA has traditionally required expression of a 500
bp long targeting sequence (Shi et al., 2000). This makes targeting smaller proteins or genes with
shorter UTRs difficult, as they may not have the required sequence length for decisive silencing.
Thirdly, due to the length of the dsRNA, the cells likely produce many different siRNAs,
increasing the chance for a deleterious off target effect. However, as tested, induced expression of
the two heterologous dsRNAs did not affect cell proliferation, eliminating such a possibility in this
approach. Finally, our heterologous sequence targeting approach allows for genes with a high
degree of similarity to be specifically and individually silenced. In the extreme case, it would even
be possible to silence only one allele of a given gene, in order to study the effects of gene dosage.
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Likewise, this method will allow for homologues of T. brucei proteins found in related species to
be investigated for functional equivalency in T. brucei. Tagging an endogenous gene and targeting
it for knockdown via a fused PTP tag or T. cruzi 3/ UTR, would allow for rescue studies to be
performed with homologues from other kinetoplastids, or, as was demonstrated in Chapter II,
mutants which vary only slightly from their wild-type counterparts. The importance of the
phosphorylation sites in CITFA7 (Nguyen et al., 2012), for example, could be studied by
attempting to rescue for the knockdown of the wild type protein with a mutant in which
phosphorylated residues are mutated to comparable amino acids which cannot accept a
phosphorylation. In short, the ability to specifically knock down target genes, regardless of their
sequence length or homology, is a powerful tool that could enhance almost any genetic studies of
protein function.

VI-2. CITFA1 is required for transcription but not CITFA complex assembly
Once we had established this new method for gene silencing, we were able to return to our original
interest in determining the specific function of individual CITFA subunits. We were able to
demonstrate that silencing CITFA1 was lethal to bloodstream form (BF) trypanosomes, which
emphasizes the essential nature of this complex, as CITFA2 and CITFA7 silencing were similarly
lethal (Brandenburg et al., 2007; Nguyen et al., 2012). The loss of RNA pol I-synthesized
transcripts upon CITFA1 silencing confirmed CITFA’s role as a RNA pol I transcription factor.
CITFA1 silencing also resulted in a loss of CITFA from the RRNA and BES promoters, indicating
that CITFA1 has a role in DNA binding. Interestingly, however, a loss of CITFA1 protein was not
accompanied by a loss of other CITFA subunits or a change in CITFA’s localization. This reveals
that the CITFA complex does not rely on CITFA1 for assembly, and suggest that CITFA is able
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to localize to the ESB in the absence of DNA binding. Given that little is known about the nature
of the ESB, beyond that it includes RNA pol I, CITFA, the active BES, and resulting VSG mRNA
(Navarro and Gull, 2001), it may be possible to use DNA-disassociated CITFA, induced by
CITFA1 silencing, to investigate the proteins that are likely binding to and anchoring CITFA in
the ESB.
Though CITFA1 was shown to be important for CITFA to bind RNA pol I promoters, and
is likely a direct DNA contactor, this has yet to be conclusively shown. Tagging and purifying
CITFA1 would allow for UV crosslinking studies to be performed side-by-side with CITFA
purified by either a tagged CITFA2, CITFA4, or CITFA7. A shift in the lower of the two ~50 kDa
bands observable when purified CITFA is subjected to UV crosslinking (Figure II-5B) would
agree with other data, and would indicate that CITFA1, in addition to the already proven CITFA2
and CITFA4, is a direct DNA contactor.

VI-3. The CITFA2-LC8 interaction is essential for RNA pol I-mediated
transcription in T. brucei
In addition to our general interest in determining the specific functions of individual CITFA
subunits, we decided to investigate LC8 because of its role in transcription in other organisms,
reviewed by Rapali et al., (2011b). LC8 silencing caused a severe defect in mitotic progression,
resulting in cells which were multinucleated yet had failed to divide. This agrees with work
performed in HeLa cells, which also showed a mitotic block upon LC8 silencing (Asthana et al.,
2012). In addition to this phenotype, a drop in RNA pol I-synthesized transcripts was noted, with
the drop in VSG mRNA being more pronounced than the effect upon RRNA. Given the severity of
the apparent cytokinesis defects, pursuit of the role of LC8 in RNA pol I-mediated transcription
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required identifying, and disrupting, LC8’s interaction with the CITFA complex. We determined
that LC8 interacted with a conserved 3-amino acid strength, TQV, at the N-terminus of CITFA2,
and that this interaction promoted dimerization of CITFA2. Mutation or removal of this sequence
eliminated the interaction between CITFA2 and LC8 both in vitro and in vivo. We were also able
to show that this interaction is essential for trypanosome viability, and that disrupting it
dramatically reduced RRNA and VSG mRNA levels. Furthermore, we showed that without this
interaction, CITFA2 is unable to assemble into the CITFA complex or bind RNA pol I promoters.
Lastly, we identified CITFAs 2, 4, and, likely, 1 as direct DNA contactors, and showed that without
CITFA2, the remaining CITFA complex, though stable, was unable to bind promoter DNA or
initiate transcription by RNA pol I. For a model summarizing these interactions between CITFA2
and LC8, and the assembly of the CITFA complex, please see Figure II-7, page 59. These data
represent a massive step forward in understanding the roles of individual CITFA subunits, and is
the first demonstration of LC8 being required for basal transcription. It also shows that LC8’s
function as a dimerizing ‘hub’ protein is of ancient evolutionary origin.

VI-4. Does LC8 have additional function in CITFA or in RNA pol I-mediated
transcription?
Our data are consistent with the view that LC8, rather than functioning as a linker between two
different proteins, instead promotes homodimerization, thereby imparting new function (Barbar,
2008; Barbar and Nyarko, 2014, 2015; King, 2008). It would be interesting to determine, however,
if this was LC8’s only role in the CITFA complex, as our work is far from conclusive in this regard.
This could be tested by substituting the N-terminus of CITFA2 with sequences known to induce
dimerization, such as coiled coil domains. If an N-terminal deletion CITFA2 mutant with the
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addition of such domains was able to rescue for the knockdown of wild-type CITFA2, then it
would be likely that LC8’s only function in binding CITFA2 is to promote its dimerization. It
would be interesting to test in these cells if LC8 was still present in CITFA that contained the
mutant CITFA2. If LC8 were still present, it would indicate that LC8 may be interacting with other
members of the complex. Though not as conserved as the LC8 site in CITFA2 (VGTQV), other
CITFA subunits have sites which would be of almost comparable LC8 binding strength, according
to binding strength assessments offered by Rapali et al. (2011a). CITFA5, both a and b
homologues, contain a sequence, RVTQV, which is not conserved with other kinetoplastids. Given
that CITFA5b amino acid sequence has 72% identity to CITFA5a, and that both have been
identified by mass spectrometry in tandem affinity-purified CITFA eluates, it is tempting to
speculate that these subunits are dimerized by LC8. Our lab has also performed experiments
investigating a possible LC8 binding site in CITFA7, AGVQV, which is fairly well conserved in
trypanosomatids, though not in Leishmania spp (data not shown). Unpublished data showed that
CITFA7 and LC8 interacted in a yeast-two-hybrid assay and mutating this putative binding site in
CITFA7 increased the expression from silent BESs in BF trypanosomes (Tu N Nguyen, Bao N
Nguyen & A Günzl, unpublished), raising the possibility that a CITFA7-LC8 heterotetramer is
responsible for localizing the CITFA complex to nucleolus and ESB. While it may seem unlikely
for LC8 to be involved in more than one element of the same complex, it has been demonstrated
with the estrogen receptor and KIBRA that LC8 is involved at multiple points in the activation of
the estrogen response pathway (Rayala et al., 2005; Rayala et al., 2006).
It is possible that LC8 has additional effects upon the CITFA complex, or that it affords the
cell an additional point of regulation to control the expression of either RRNA or VSG mRNA. The
conservation of the TQV sequence in CITFA2 that binds LC8 with other, non-VSG expressing
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kinetoplastids, supports the idea that LC8 is not playing a role in only VSG expression, though this
may not be the case. The amino acids surrounding the TQV-motif are not entirely conserved, and
are within close enough proximity to affect the CITFA2-LC8 interaction (Rapali et al., 2011a). It
would be interesting, therefore, to express a CITFA2 sequence from a related kinetoplastid in T.
brucei, either as an entire unit, or as a chimera, with just the N-terminal portion fused to an Nterminally truncated T. brucei CITFA2, in order to determine if the CITFA2s present in related
organisms were able to interact with LC8 or rescue the knockdown of endogenous CITFA2.
It has been shown in other organisms that phosphorylation of either LC8 or its binding partner
can alter their interaction (Benison et al., 2009; Gallego et al., 2013; Lei and Davis, 2003; Song et
al., 2008; Song et al., 2007). This regulatory phosphorylation occurs at S88 in human LC8, which
is conserved as S89 in the genus Trypanosoma (Figure II-S1B), allowing for such a regulation to
exist. Furthermore, phosphorylation of CITFA2 at amino acid T6, one of the conserved residues
in the LC8 binding motif, could also be used as a means to block LC8 binding, as is the case in
Nek9, a kinase involved in mitotic progression (Gallego et al., 2013). The phosphorylation state
of CITFA2 and LC8 in T. brucei are, however, unknown. Before an investigation of the importance
of phosphorylation of these proteins is performed, it will be necessary to determine whether these
sites are phosphorylated in trypanosomes.
It should be noted that the above hypotheses regarding the function of LC8 in T. brucei are, in
part, made possible by the work presented in Chapter II. Previous to this work, nothing was
known regarding LC8 binding partners or binding site preferences in T. brucei. While the high
degree of identity between human and trypanosome LC8 made it likely that characteristics were
shared, the early divergence of kinetoplastids from other eukaryotic lineages made this uncertain.
Our work, though only detailing one LC8 interaction, demonstrates that LC8 appears to bind
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motifs similar to those detailed in other organisms, and that its role in promoting or stabilizing
dimerization is the same. This means that the vast array of studies detailing LC8’s binding
preferences can now be tentatively used to predict potential LC8 binding partners in kinetoplastid
organisms. Once additional studies on LC8 in these organisms have been performed, if they are
also consistent with the non-kinetoplastid literature, it will allow for rapid progress in our
understanding of LC8 in these organisms by allowing use of predictive bioinformatics.

VI-5. Does LC8 have functions in T. brucei outside of dynein and CITFA?
In addition to the above means of investigating LC8 function, it would likely be informative
to tandem affinity-purify LC8 and characterize LC8-containing protein complexes by sucrose
gradient sedimentation and mass spectrometry. However, it is currently unclear whether LC8 can
be functionally tagged. This approach may even allow for the binding preferences of LC8 in T.
brucei to be further established by sequence analysis in silico, if enough co-purifying proteins have
recognizable LC8 binding motifs.

VI-6. CITFA and the ESB
The work contained in Chapter II demonstrated that, upon CITFA2 silencing, CITFA3 is
stable, but is lost from RNA pol I promoters. LC8 silencing produced a similar effect, with CITFA6
also being shown to be stable in this case. CITFA2, therefore, represents the second CITFA
subunit, with the first being CITFA1, to reveal that binding DNA is not required for CITFA
assembly. This concept is intriguing, as it suggests a CITFA complex that assembles and localizes
to sites of RNA pol I-mediated transcription independent of DNA and independent of RNA pol I,
as an RNA pol I subunit has never co-precipitated or co-purified with CITFA. How then is CITFA
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localizing to the nucleolus and ESB so effectively? One way to approach this question would be
to tandem affinity purify the CITFA complex after CITFA1 silencing, and subject the purified
material to mass spectrometry. This may enhance the likelihood of identifying the proteins
responsible for CITFA’s localization, as it would ensure that CITFA is not interacting with DNA.
While there is no evidence that CITFA interacts with RNA, it is possible that a CITFA-RNA
interaction mediates its localization. While it was previously demonstrated that the accumulation
of RNA pol I in the ESB is unaffected by DNase I treatment, implying that this compartment is
not reliant on DNA binding or transcription (Navarro and Gull, 2001), which our data agrees with
(Park et al., 2014), a similar experiment with RNase has not yet been performed. If CITFA’s
localization would be RNA-dependent, then preparation of total RNA from purified CITFA in
conjunction with RNA-seq may reveal the identity of the interacting RNA, a method known as
RNA immunoprecipitation sequencing, or RIP-seq. If RNase or nuclease treatment does not affect
CITFA localization, it would reveal that the ESB had a protein-based architecture.

VI-7. The increasing therapeutic potential of LC8
Our results add T. brucei to the list of pathogens that rely on LC8 for viability. LC8 silencing
caused defects in both transcription and cytokinesis, and resulted in an extremely rapid death
phenotype of cultured BF T. brucei that is rarely observed in this system. The importance of LC8
to infectious agents has also been shown for HIV (Jayappa et al., 2015), Ebola (Luthra et al., 2015),
rabies (Tan et al., 2007), and Toxoplasma gondii (Qureshi et al., 2013), previously. Additionally,
LC8 has been shown to have a role in promotion of cancerous phenotypes (Asthana et al., 2012;
Vadlamudi et al., 2004). Given the nearly universal nature of LC8 (Wickstead and Gull, 2007),
and the lack of available small molecule inhibitors, LC8 therapeutics remain strictly conceptual.
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However, it may be feasible to target LC8’s binding partners, kinases, or phosphatases, if such
were able to be detailed. While not promising in the near term, the reliance of various pathogens
on this molecule make it an exciting potential target.
VI-8. The role of RPB7 in RNA pol I transcription
We investigated whether RPB7, a known subunit of RNA pol II, was being utilized by
RNA pol I in T. brucei, a claim published by the research group of Dr. Miguel Navarro (Spanish
National Research Council, Granada, Spain) (Peñate et al., 2009). Immunoprecipitation and
tandem affinity purification of RPB7 identified numerous RNA pol II subunits, yet failed to
produce any subunits of RNA pol I, as shown in Chapter IV. Consistent with these results, ChIP
experiments revealed a profile for RPB7 consistent with it functioning solely within RNA pol II.
In vitro transcription assays revealed that depletion of RPB7 had no effect on either VSG or RRNA
transcription, while it did affect an RNA pol II-transcribed gene. Lastly, immunofluorescence
showed that RPB7 failed to co-localize with a nucleolar marker, the site in which RNA pol Imediated transcription occurs. Taken together, these data clearly show that RPB7 is a bona fide
RNA pol II subunit, while they fail to provide any evidence for an involvement of RPB7 in
transcription by RNA pol I
Both we and the Navarro group published letters addressing the incongruent nature of the
data from our two research teams (Günzl et al., 2011; Navarro et al., 2011). While specific
arguments will not be fully covered here, a few key points are worth making. First, we feel that
our data are clear and decisive on the topic of RPB7 involvement in RNA pol I. Secondly, it is
possible, due to their using polyclonal antisera, that the Navarro group has correctly detailed the
importance of a protein for RNA pol I-mediated transcription that is simply not RPB7. Since it is
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very likely that trypanosome RNA pol I requires an RPA43 orthologue (Kuhn et al., 2007), the
identity of which has not yet been determined in T. brucei and which would be an RPB7 paralog,
it is possible that their antisera and experiments have identified the function of this protein, instead.
We avoided this potential problem by tagging RPB7, which allowed us to use specific antibodies
for RPB7 detection and purification. In addition, the data by Penate et al. (2009) overwhelmingly
depended on RPB7 silencing. Since this likely affected expression of nearly all protein coding
genes, it is possible that they were observing secondary effects on RNA pol I transcription.
Therefore, we avoided this approach and used biochemical assays that directly addressed RPB7’s
role in RNA pol I-mediated transcription.
We do not claim, however, that RPB7 has no effect upon transcription by RNA pol I or the
transcripts it produces. RPB7 is an interesting member of RNA pol II, as it forms a heterodimer
with RPB4 and appears to participate in cellular processes which are separate from the immediate
transcription process by RNA pol II, as reviewed in Sharma (2013). These include DNA repair,
mRNA export and decay, and translation. Thus, it is possible that some of the phenotypes that Dr.
Navarro’s group attributes to RPB7’s role in RNA pol I are, in fact, the result of RPB7’s role
outside of the context of RNA polymerases entirely. It will be interesting to see if future
investigations of RPB7 (an RPB4 homolog has not been identified in trypanosomes yet) implicate
these proteins in the same diverse functions in T. brucei as they have in other organisms.
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